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ABSTRACT 
Immunoglobulins (Igs) are expressed exclusively in B lymphocytes to protect 
vertebrates from invading pathogens. This dissertation is designed to better understand 
the mechanism by which B cells and plasma cells produce functional lg proteins. An lg 
molecule consists of two identical heavy and two identical polypeptide light chains. The 
genes encoding heavy and light chains are assembled from gene segments (V, D, and J) 
through DNA rearrangements during B cell development. If these rearrangements do not 
preserve the translational reading frame, the resulting lg gene very likely contains a 
premature translational stop (a nonsense codon) and is, therefore, a nonproductive gene. 
Since both lg alleles can be rearranged, a B cell might end up with a productive (i.e., 
a gene without a nonsense codon) and a nonproductive lg gene. The µ gene encodes the 
heavy chain of IgM, which is the main lg isotype produced in a primary immune 
response. Our laboratory has previously shown in hybridomas and pre-B cell lines that 
a µ gene with a nonsense codon is transcribed at the same rate as a µ gene without a 
nonsense codon. In contrast, the cytoplasmic steady-state level of µ mRNA with a 
nonsense codon is 30-100 times lower than the steady level of µ mRNA without a 
nonsense codon. Based on these data we proposed that µ mRNA with a nonsense codon 
is degraded faster than µ mRNA without a nonsense codon in B cells. 
To elucidate the mechanism of this nonsense codon-mediated reduction of lg 
mRNA, I first determined in which subcellular compartment this reduction in lg mRNA 
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level occurs. By using Northern blot analysis, I found that the level of matureµ mRNA 
containing a nonsense codon is reduced in the nucleus by approximately seven fold when 
compared to the level of µ. mRNA without a nonsense codon. In contrast, µ precursor 
RNA increases in the nucleus of hybridomas that contain nonsense codons in their µ 
genes by at least 2 fold, suggesting that a nonsense codon decreases the splicing 
efficiency ofµ precursor RNA. I also showed that the presence of a nonsense codon 
correlates with an accelerated turnover rate ofµ mRNA in the cytoplasm, suggesting that 
in the cytoplasm the reduction of µ mRNA level with a nonsense codon is, at least 
partially, due to the increased degradation rate. From these data, I conclude that the 
reduction of cytoplasmic level ofµ mRNA with a nonsense codon results from both a 
nuclear as well as a cytoplasmic event. These events may contribute to the potent 
efficiency of humoral immune response by preventing the translation of nonproductive 
lg mRNAs in B cells. 
I have also attempted to test a possible mechanism, the translational translocation 
model, which explains how a nonsense codon triggers the reduction of mRNA in the 
nucleus. From the results of three different approaches, I suggest that the translational 
translocation model is not the mechanism by whichµ mRNA with a nonsense codon is 
reduced in the nucleus of plasma cells. 
CHAPTER I 
REVIEW OF RELATED LITERATURE 
1.1 Nonsense Codon-Mediated RNA Degradation 
A nonsense codon is a premature translational termination signal that is in-frame 
with the translational initiation codon in a messenger RNA (mRNA). Nonsense codon-
mediated RNA degradation refers to the phenomenon by which nonsense codons can 
trigger the rapid degradation of a mRNA. It is a unique phenomenon because there are 
many out-of-frame stop codons in a mRNA that have no effect on RNA metabolism. 
Only those stop codons that are in-frame with the translation initiation codon in a mRNA 
can trigger RNA degradation (Daar and Maquat, 1988; Belgrader and Maquat, 1994; 
Pulak and Anderson, 1993). In other words, a single nucleotide change may result in 
RNA degradation. This is a fascinating system for cell biology because it prevents the 
production of truncated proteins. Although not all truncated proteins are disruptive to a 
cell, a cell is protected from those that are deleterious by eliminating all mRNAs 
containing nonsense codons. Nonsense codons have been reported to be responsible for 
many human diseases, such as the B-globin gene of B-thalassemia (Humphries et al. , 
1984; Takeshita et al., 1984) and the human fibrillin (FBNl) gene of Marfan syndrome 
(Diatz et al., 1993). Nonsense codons in the unc-54 myosin heavy chain gene of 
Caenorhabditis elegans have been reported to disrupt the body-wall muscle ultrastructure. 
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The affected C. elegans have reduced brood size (Pulak and Anderson, 1993). 
The steady-state level of mRNA actually represents a balance between the rate of 
nuclear RNA synthesis (transcription), the rate of nuclear RNA precursor processing, the 
extent of intranuclear mRNA degradation, the rate of mRNA transport from the nucleus 
to the cytoplasm, the rate of cytoplasmic mRNA degradation, and the efficiency of 
protein translation (Ehretsmann et al., 1992; Belasco and Brawerman, 1993). Among 
them, the regulation of mRNA stability has been shown to be a major control mechanism 
in gene expression in the last decade (Atwater et al., 1990; Sachs, 1993; Decker and 
Parker, 1994). The decay rates of mRNAs can differ from each other by more than 50 
fold in eukaryotic cells (Ross, 1989; Atwater et al., 1990; Sachs, 1993). The high degree 
of stability of some mRNAs, such as the globin mRNAs, contributes to their 
accumulation to high steady-state levels (Aviv et al., 1976). Highly unstable mRNAs 
with half-lives of about 10-15 minutes, such as the lymphokine and protooncogene 
mRNAs, are normally present at low steady-state levels (Kelly et al., 1983; Greenberg 
and Ziff, 1984). Although low mRNA steady-state level could be achieved through a low 
rate of transcription, the time course of changing the mRNA level in response to a 
stimulus is determined solely by the turnover rate of the mRNA, which permits rapid 
cessation of the production of a protein and its more rapid induction (Ross, 1989). This 
is of particular importance in the case of proteins that play critical regulatory roles for 
brief periods during a development process or physiological transitions. Notably, shifts 
in mRNA stability (i.e., massive reorganization of the pattern of gene expression) 
contribute to Xenopus oocyte and early embryo development and erythroid differentiation 
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(Richter, 1991; Krowczynska et al., 1985); the synthesis of histones, which takes place 
only during the S phase of the cell cycle (Gallwitz, 1975). 
A nonsense codon might potentially influence the steady-state level of a mRNA 
by influencing any or all of the regulatory processes described above. Indeed, nonsense 
codons have been reported to have various effects on mRNA metabolism. Among them, 
the importance of translation to mRNA stability is particularly important for mRNAs with 
nonsense codons (see reviews in Atwater et al., 1990; Belasco and Brawerman, 1993). 
Consistent with the assumption that nonsense codons are recognized during translation 
in the cytoplasm of eukaryotic cells, the lower steady-state level of most mRNAs that 
contain nonsense codons is attributed to their increased turnover rates in the cytoplasm. 
Some examples are the yeast URA3 mRNA (Losson and Lacroute, 1979) and HIS4 
mRNA (Herrick et al., 1990), Rous sarcoma virus gag mRNA (Barker and Beemon, 
1991), human and mouse {j-globin mRNA (Maquat et al., 1981; Takeshita et al., 1984; 
Lim et al., 1992), and mouse histone mRNA (Graves et al., 1987). However, several 
recent studies suggest that nonsense codons may decrease the steady-state level of their 
mRNAs by influencing of nuclear processing, and/or transport without affecting their 
cytoplasmic stability. Several examples are human {j-globin mRNA (Humphries et al., 
1984), mouse lg heavy chain µ mRNA (Connor et al., 1994), hamster dihydrofolate 
reductase mRNA (Urlaub et al., 1989), human {j-globin mRNA under the control of the 
simian virus 40 promoter in Syrian hamster cells (Baserga and Benz, 1992), nonstructural 
protein NS2 mRNA of the minute virus of mice (MVM) (Naeger et al., 1992), human 
triosephosphate isomerase (TPI) mRNA (Cheng and Maquat, 1993), the T cell receptor 
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13 mRNA (Qian et al., 1993), v-src mRNA of avian sarcoma virus (Simpson and 
Stoltzfus, 1994), and mouse lg K light chain mRNA (Lozano et al., 1994). In all of these 
cases the exact degradation mechanism has not been elucidated; however, for 
nonstructural protein NS2 of the minute virus of mice (MVM) (Naeger et al., 1992) and 
mouse lg K light chain (Lozano et al., 1994), it has been suggested that nonsense 
mutations influence the nuclear RNA processing events by inhibiting splicing. It is 
puzzling, however, how nonsense codons can affect nuclear mRNA processing, since 
nonsense codons are recognized in a fully spliced transcript (mRNA) in the cytoplasm 
during protein synthesis. Possible mechanisms are discussed in section 1.2 in detail. 
Many cis-acting elements have been reported to be involved in nonsense codon-
mediated mRNA degradation, such as the coding regions (Cleveland, 1988; Parker and 
Jacobson, 1990; Peltz et al., 1993), introns (Cheng et al., 1994), and 3'-untranslated 
regions (Jackson, 1993). Genes encoding factors that specifically degrade certain 
mRNAs with nonsense codons, while having no effect on functional mRNA, have been 
cloned and characterized as up frameshift (UPF) genes in yeast Saccharomyces cerevisiae 
(Leeds et al., 1991; Leeds et al., 1992) and smg genes in C. elegaris (smg denotes 
.s_uppressor with morphogenetic defects on genitalia) (Pulak and Anderson, 1993). The 
mammalian gene encoding for the nonsense codon-specific degradation factor has not yet 
been cloned. 
1.2 Mechanism of Nonsense Codon-Mediated mRNA Reduction in the 
Nucleus 
Although little is known about the mechanism of nonsense codon-mediated 
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reduction of mRNA, several models have been proposed to explain nonsense codon-
mediated RNA reduction in the nucleus. Since the only identified and accepted system 
that can recognize a nonsense codon is the translational machinery in the cytoplasm of 
eukaryotic cells, it has been reasoned that mRNA with a nonsense codon should be 
recognized and degraded in the cytoplasm. Based on this assumption, Urlaub et al. 
(1989) proposed an elegant model to link the cytoplasmic translation event to the nuclear 
RNA processing and nucleus-to-cytoplasmic transport events. The essence of Urlaub's 
model suggests that the initiation of cytoplasmic µ protein translation starts before the 
completion of RNA processing in the nucleus and the nucleus-to-cytoplasm transport. 
Once the 5' end of the RNA transcript has been processed with a cap structure and 
spliced, the partially processed RNA begins transport to the cytoplasm via the nuclear 
pore. The binding of ribosome subunits and initiation factors to the free 5' end of the 
RNA transcript on the cytoplasmic side of nuclear membrane initiates µ protein 
translation. The translation in the cytoplasm serves as a force to facilitate not only the 
splicing of the 3' part of the RNA transcript but also the export of fully spliced nuclear 
mRNA from the nucleus to the cytoplasm. This model requires that recognition of a 
nonsense codon occurs after splicing in the cytoplasm, and has been best studied by 
Maquat and colleagues with human TPI mRNA. 
Maquat et al. showed that nonsense codons located within the first three-fourths 
of the coding region of TPI mRNA reduce the level of TPI mRNA to 20 to 30 % of 
normal (Cheng et al., 1990; Cheng and Maquat, 1993). This reduction is not attributable 
to a decrease in the half-life of cytoplasmic TPI mRNA (Cheng et al., 1990). Maquat et 
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al. further determined that this reduction of TPI mRNA is dependent on the 
translatability of mRNA with nonsense codons. They showed that nonsense codon-
mediated reduction of TPI mRNA is at least partially inactivated by a stem-loop in the 
5'-UTR (that acts in cis to inhibit translation initiation by the 40S ribosomal subunit), or 
by a suppressor tRNA (that acts in trans to suppress the nonsense codon (Belgrader et 
al., 1993). Maquat et al. have further shown that deletion of a 5' splice site of the TPI 
gene results predominantly in the removal (by skipping) of the upstream exon (that 
contains the nonsense codon) as a part of the flanking introns (Belgrader et al., 1994). 
Based on these data, Maquat et al. concluded that translation is required in the nonsense 
codon-mediated reduction of TPI mRNA in the nucleus, and that the recognition of a 
nonsense codon occurs after splicing. Since they did not separate the cytoplasmic 
compartment from the nuclear compartment in their studies, they did not distinguish 
whether the recognition of nonsense codons occurs in the cytoplasm or in the nucleus. 
They also did not rule out the possibility that the stem-loop in the 5'-UTR or a 
suppressor tRNA abrogated the effect of nonsense codons on TPI mRNA level by 
competitive binding to the translational machinery. Thus, I do not think they have tested 
the translational translocation model. 
A variation of the translational translocation model proposes that the recognition 
of nonsense codons in the cytoplasm sends out a degradation signal to the nucleus via the 
continuous cellular network or tracks with which both nuclear and cytoplasmic mRNAs 
may associate (Maquat, 1991; Belgrader et al., 1993). The mRNA localization pathway 
involved in processing and transport was reviewed by Wilhelm and Vale (1993); and the 
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relationship between mRNA and the cytoskeletal framework was reviewed by Pachter 
(1992). This model argues against the pulling effect of translation on RNA processing. 
I think there are two main requirements to validate this model. First, mRNA export from 
the nucleus into the cytoplasm travels in a locomotive track; and secondly, disruption of 
the transport track (such as the important components) abrogates the nonsense codon-
mediated reduction of mRNA. 
An alternative model, the nuclear scanning model, proposes that the recognition 
of a nonsense codon occurs in the nucleus and not in the cytoplasm before or at the time 
of RNA splicing (Urlaub et al., 1989; Nagger et al., 1992). The recognition of nonsense 
codons before RNA splicing is hard to imagine since it requires that the recognition 
system distinguish exons from introns and recognize the correct open reading frame in 
separate exons. There is as yet no convincing biochemical or structural data showing that 
the nucleus has translational machinery like that of the cytoplasm. Thus, no direct test 
for this model has been carried out. The best data supporting this model are that 
nonsense codons trigger exon skipping in mutated genes (Diatz et al., 1993; Belgrader 
and Maquat, 1994). If these data are true, a nuclear process is clearly involved in the 
nonsense codon-mediated mRNA degradation because exon skipping has to occur at the 
time of splicing. Recently, Maquat et al. showed that TPI mRNA with nonsense codons 
is degraded in the nucleus (Belgrader et al., 1994). This result suggests that the 
recognition of a nonsense codon occurs on the mature mRNA in the nucleus. This is a 
variation of the nuclear scanning model. In summary, to validate the nuclear scanning 
model, one needs to show that: 1) the recognition of stop codons that are in-frame with 
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the translational initiation codon on unspliced and spliced RNAs in the nucleus; and 2) 
there are, at least part of, the translational-like machinery (such as ribosomal subunit or 
tRNA) in the nucleus to perform the function of scanning. 
1.3 lg Gene Expression during B Cell Development 
Immunoglobulins (Igs) are exclusively expressed in B lymphocytes of higher 
vertebrates. An lg molecule consists of two identical heavy (H) and two identical light 
(L) polypeptide chains. In bone marrow stem cells, there are no complete genes for lg 
chains, only gene segments. During differentiation of B cells from stem cells in the bone 
marrow, these gene segments are randomly shuffled by an ordered progression of DNA 
rearrangements that are capable of generating tremendous different specificities (Alt et 
al., 1984; Okada and Alt, 1994). This tremendous diversity in lg structure allows a 
vertebrate to respond to a vast number of potential antigens (Kuby, 1994). 
For example, at the H chain locus of chromosome 12 in the mouse, there are 
about 300-1,000 VH, about 12 diversity (D~, and 4 joining (J~ gene segments. In the 
pre-B cells, a H chain gene is formed by assembling one gene segment of each type. 
Thus, there is a large combinatorial diversity for the H chains. Further diversity of lg 
molecules is mainly generated by somatic mutations (Tonegawa, 1983; Honjo, 1983). 
The mutation rate in pre-B cell line is reported to be 0.3-1 X 104 per cell generation 
(Wabl et al., 1985). B cells also rearrange light chain genes through a similar process, 
and express both heavy and light chains that are assembled into functional lg molecules. 
These lg molecules are expressed on the cell surface of B cells (Wall and Kuehl, 1983; 
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Tonegawa, 1983). Thus mature B cells are antigenically committed to specific epitope. 
When these cells encounter their corresponding antigen they become activated and 
differentiate into plasma cells that secrete more than 2,000 molecules of lg per second 
(Tonegawa, 1985). This B cell differentiation process is accompanied by a 10-100 fold 
increase in the cytoplasmic steady-state level oflg mRNA (Perry and Kelley, 1979; Jack 
et al., 1989), which is regulated by post-transcriptional mechanisms (Gerster et al., 
1986; Kelly and Perry, 1986), mainly at the level of mRNA stability (Mason et al., 
1988; Jack et al., 1989; Cox and Emtage, 1989; Genovese and Milcarek, 1990). The 
half-lives of lg mRNA increase from 2 to 5.5 hr in B cell lines to 13-34 hr in plasma cell 
lines, depending on the cell lines and the methods used (Mason et al., 1988; Cox and 
Emtage, 1989; Genovese and Milcarek, 1990). 
µ mRNA encodes the heavy chain oflgM, which is the major lg isotype produced 
during the primary response (Ku by, 1994). The µ gene consists of a leader, a VDJ, four 
constant, and two membrane exons. Generation of a functionalµ gene requires first a D-
to-J and then a V-to-DJ rearrangement event, which generates a VDJ exon. These 
rearrangements do not always preserve the correct reading frame and the resulting lg 
mRNA transcribed from that gene may encounter premature termination codons 
(nonsense codons). A B cell contains two lg alleles. If one allele rearranges 
nonproductively, the cell goes on to rearrange the other allele. In mouse, 40-80 % of B 
cells rearrange the second allele of lg genes. Thus a B cell may contain both productive 
and nonproductive lg genes (Altenburger et al., 1980; Reth and Alt, 1984; Alt et al., 
1984; Atkinson et al., 1991). If both alleles fail to rearrange productively, B cell 
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differentiation will be terminated (Alt et al., 1984). 
1.4 B Cells Have a Mechanism to Eliminate lg mRNA Containing Nonsense 
Codons 
Jack et al. have shown by nuclear run-on assays that both productive and 
nonproductiveµ genes are transcribed at the same rate (Jack et al., 1989); therefore, one 
would expect to find a large amount of nonproductive lg mRNAs in B cells. But by use 
of RNA dot blot analysis, they found that the cytoplasmic steady-state level of 
nonproductive µ mRNAs is 60-100 fold lower than the level of the productive µ mRNAs 
(Baumann et al., 1985; Jack et al., 1989). A similar phenomenon was also observed in 
the pre-B cell lines (Jack et al., 1989). Based on these observations, l propose that B 
cells have a mechanism to eliminate immunoglobulin RNA containing nonsense codons. 
This is consistent with emerging data in the field of that almost all cytoplasmic lg heavy 
chain mRNAs (approximately 99 % ) in peripheral B cells are productive as revealed by 
sequencing µ cDNA clones obtained from the spleen cDNA libraries. 
l reason that it is very important for B cells to have a mechanism to eliminate lg 
mRNAs that contain nonsense codons. As discussed before, the tremendous diversity for 
antigens is a phenomenon unique to lgs. It is mainly generated by assembling variable 
regions from hundreds of gene segments of H and L chain genes and by somatic 
mutation. Thus the probability for B cells to generate nonsense codons in lg genes is 
higher than for other genes. Ifµ mRNA with nonsense codons could be translated at the 
same rate as µ mRNA without nonsense codons, the resulting truncated µ protein may 
assemble with a complete µ protein and two functional light chains to form a chimeric 
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antibody. Heavy chains translated from productive and nonproductiveµ mRNAs very 
likely encode different antigen-binding specificities. The one expressed from 
nonproductive allele may be self-reactive. Thus, if B cells do not reduce the amount of 
µ mRNA with nonsense codons, they would express bi-specific antibodies on the surface, 
which may result in autoimmunity. 
It is also important for plasma cells to have a mechanism to eliminate lg mRNAs 
that contain nonsense codons. Plasma cells are terminally differentiated B lymphocytes, 
in which more than 2,000 molecules of Igs are produced per second (Tonegawa, 1985). 
In plasma cells, lg mRNA comprises about 10% of poly (A)+ mRNAs in the cytoplasm 
(Schibler et al., 1978), and accounts for 20-30% of the total protein synthesis in plasma 
cells. In the case of heavy chain µ mRNA, if both µ mRNAs with or without a nonsense 
codon could be translated intoµ chains,µ mRNA with a nonsense codon (nonproductive) 
will compete with the µ mRNA without a nonsense codon (productive) for the 
translational machinery. In addition, the truncatedµ heavy chains will compete with the 
functional heavy chains for the binding with the light chains. Thus, the amount of 
functional antibody molecule will be decreased. Since the amount of lg protein has been 
shown to be crucial for the success of an effective humoral immune response, the 
production of large amounts of truncated µ chains would interfere with an efficient 
humoral immune response. That is, the production of antibodies would not be large 
enough to eliminate the pathogen. The efficiency of the humoral immune response could 
also be decreased because the truncated proteins would lack the carboxyl-terminal ends 
that mediate important functions of Igs, such as binding to the Fe receptor, binding to 
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the heavy chain binding protein Bip (a chaperone) within the endoplasmic reticulum, or 
binding and activating complements (Kuby, 1994). In addition, the truncatedµ proteins 
could not be secreted into the extracellular environment, presumably they would be 
trapped in the endoplasmic reticulum (Li and Jack, see Chapter IV). The accumulation 
of truncated µ proteins in the endoplasmic reticulum of plasma cells might destroy the 
architecture of cells, as it has been shown in C. elegans (Pulak and Anderson, 1993). 
1.5 The Mechanism of Nonsense Codon-Mediated Reduction ofµ mRNA in 
Plasma Cells 
The main observation leading to this dissertation is that the amount of cytoplasmic 
µ mRNA with a nonsense codon is 60-100 fold lower than the amount of µ mRNA 
without a nonsense codon, although their transcriptional rates are the same (Jack et al., 
1989). The objective of this dissertation is to understand the mechanism of nonsense 
codon-mediated µ mRNA reduction in plasma cells. 
The lower cytoplasmic steady-state level ofµ mRNA with a nonsense codon 
might result from either a cytoplasmic or a nuclear event, or both. These events include 
nuclear RNA processing (capping, splicing, or polyadenylation), nuclear RNA 
degradation, nucleus-cytoplasm export of RNA, cytoplasmic RNA degradation. To 
determine whether a cytoplasmic or a nuclear event is involved in the reduction of µ 
mRNA with nonsense codons, I will isolate RNA from the nuclear and cytoplasmic 
fractions of plasma cells, and quantify the levels of µ RNA in the two cellular 
compartments by Northern blot analysis. Ifµ mRNA with a nonsense codon is reduced 
only in the cytoplasm and there is no blocking of RNA export from the nucleus to the 
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cytoplasm, I would expect to find that the nuclear RNA level is the same forµ mRNA 
with or without a nonsense codon. In contrast, if µ mRNA with a nonsense codon is 
reduced in the nucleus, I would expect to find that the nuclear µ RNA level with a 
nonsense codon is lower than that ofµ mRNA without a nonsense codon. Additionally, 
the cytoplasmic degradation could be an independent event from the nuclear degradation. 
Therefore, I will further determine whether µ mRNA with a nonsense codon is also 
degraded in the cytoplasm by measuring the cytoplasmic decay rates of endogenous µ 
genes using two well established inhibitors of RNA synthesis, Actinomycin D and DRB. 
If µ mRNA with a nonsense codon is degraded faster in the cytoplasm than µ mRNA 
without a nonsense codon, I would expect to find µ mRNA without a nonsense codon has 
a decreased half-life. The results of these experiments are presented in Chapter III. 
Knowing thatµ mRNA with a nonsense codon is degraded in both the nucleus and 
the cytoplasm of plasma cells, I modified the testable translational translocation model 
(Urlaub et al., 1989) to explain the mechanism of how a nonsense codon triggers the 
reduction of µ mRNA in the nucleus. The preliminary results of three different 
approaches to test the model are summarized in Chapter IV. 
CHAPTER II 
MATERIALS AND METHODS 
2.1 Chemicals and Reagents 
2.1.1 General Chemicals and Reagents 
All general chemicals were molecular biology grade and were purchased from 
Fisher Scientific (Pittsburgh, PA), Sigma Chemical Co. (St. Louis, MO) and Boehringer 
Mannheim (Indianapolis, IN). DRB and hygromycin B were purchased from CalBiochem 
(San Diego/La Jolla, CA); Actinomycin Cl, ampicillin (sodium salt) and potassium 
acetate from Boehringer Mannheim (Mannheim, Germany); polyacrylamide, AGR501-X8 
(D) (Mix bead resin), APS, gelatine, glycerol, TEMED, BIS and Tween 20 from Bio-
Rad (Richmond, VA); antibiotic medium, tryptone, yeast extract and Bacto-agar from 
Difeo (Detroit, MI); mycophenicol acid (MPA), Geneticin (G-418 Sulfate), cesium 
chloride (ultra pure), DTT, LB base, Penicillin-Streptomycin (500 units/ml) and RPMI 
1640 powder from Gibco BRL Life Technologies, Inc. (Gaithersburg, MD); dextran 
sulfate from Pharmacia (Uppsala, Sweden); ethyl alcohol (absolute) from Aaper Co 
(Shelbyville, Kentucky); FCS from HyClone (Logan, Utah); universal autoradiography 
enhancer (Intensify Part A and B) from DuPont NEN (Boston, MA); iodoacetamide and 
Triton X-100 (pure) from Serva (Heidelberg, Germany); Non-fat dry milk from Real 
(Los Angeles, CA); sodium hydroxide from Mallinckrodt (St. Louise, MO); scintillation 
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liquid (Econo-Safe) from RPI (Mount Prospect, IL). All solutions were prepared in 
deionized water unless otherwise indicated. 
2 .1. 2 Radiochemicals 
[a-32P] dCTP (PB.165/10165/10385) 
Redivue [a-32P]dCTP (AA0075) 
[a-35S] dATP (SJ.264/1304) 
L-[35S] Methionine (SJ. 204) 
[ 14C] methylated proteins (CFA.626) 
Trans 35S-label (Cat# 51006) 
[ -y-32P] dATP (Cat# 35020) 
2.1.3 Kits 
Cytoplasmic RNA isolation kit 
DNA 5'-end labeling kit 
Magic mini prep kit 
Nick-translation kit 
pGEM-T vector system I 
Sequenase kit (version 2.0) 
Site-directed mutagenesis kit 
Amersham, Arlington Heights, IL 
Amersham, Arlington Heights, IL 
Amersham, Arlington Heights, IL 
Amersham, Arlington Heights, IL 
Amersham, Arlington Heights, IL 
ICN Biomedicals, Irvine, CA 
ICN Biomedicals, Irvine, CA 
5 Prime-+3 Prime, Inc.®, West 
Chester, PA 
Boehringer Mannheim, Germany 
Promega, Madison, WI 
Gibco BRL, Gaithersburg, MD 
Promega, Madison, WI 
United States Biochemical, 
Cleveland, OH 
Promega, Madison, WI 
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Superscript cDNA library kit GIBCO BRL, Gaithersburg, MD 
RNAzol™ B Tel-Test, Inc., Friendswood, TX 
TRizol™ Reagent GIBCO BRL, Gaithersburg, MD 
(Total RNA Isolation Reagent) 
2.1.4 Antibodies 
2.1.4.1 Antibodies Used for Immunofluorescence Analysis 
Goat anti-mouse µ-FITC Fisher Biotech, Pittsburgh, PA 
Goat anti-mouse K-Tex Red Fisher Biotech, Pittsburgh, PA 
2.1.4.2 Antibodies Used for Immunoprecipitations 
Goat anti-mouse IgM Southern Biotech, Birmingham, AL 
2.1.5 Molecular Weight Standards 
Bacteriophage c/>Xl 74 DNA markers Gibco BRL, Gaithersburg, MD 
lKb DNA Ladder Gibco BRL, Gaithersburg, MD 
A DNA/HindIII fragments Gibco BRL, Gaithersburg, MD 
0.24-9.7 Kb RNA Ladder Gibco BRL, Gaithersburg, MD 
Rainbow protein marker Amersham, Buckinghamshire, 
England 
[ 14C] methylated proteins (CFA.626) Amersham, Arlington Heights, IL 
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2.2 Oligonucleotides and Linkers 
2.2.1 Oligonucleotides 
All oligonucleotide primers for the polymerase chain reaction (PCR) and site-
directed mutagenesis were designed with the aid of an oligonucleotide software analysis 
program (OligoTll, National Bioscience, Plymouth, MN) and synthesized by National 
Biosciences (Plymouth, MN). 
2.2.1.1 Sequencing 
V8 17.2.25.2: 17 bases; Tm=61.1°C 
5' -CATAAGGACA TTCCAGC-3' 
SP6 primer: 19 mer; 
5'-d(GATTTAGGTGACACTATAG)-3' 
T7 primer: 20 mer; 
5'-d(TAATACGACTCACTATAGGG)-3' 
M13 primer (-40): 17 mer; 
5' -d(GTTTTCCCAGTCACGAC)-3' 
2.2.1.2 Site-Directed Mutagenesis 
Leader mutated primer: 57 bases; Tm=92.7°C 
5'GCCCCTTCCCTGTATCCTCTTCCTCCCGGGAGTAGGT ACTCG 
Smal 
AGCTGCA TTTCA TTG-3' 
(Italized nucleotides represent the mutated sequences.) 
3'Ck.Clal: 26 bases; Tm=77.6°C 
2.2.1.3 
2.2.1.3.1 
5'-AAGATAGGATCGATCTGGGGAGCTGG-3' 
Cl al 
Polymerase Chain Reaction (PCR) 
Sense Oligonucleotides 
VH81X.Forward: 34 mer; Tm=81.6°C; 
5' -AGCGGCCGCACCATGGACTTCGGGCTCAGCTTGG-3' 
Not I 
5'Cµl.Forward: 27 mer; Tm=92.0°C 
5' -TGGCCATGGGCTGCCTAGCCCGGGACT-3' 
991µ3.Forward: 22 mer; Tm=51.6°C 
5'-ACTGACTCAAACCATGGAATGG-3' 
99lk3.Forward: 28 mer; 
2.2.1.3.2 
5'-TTGGTACCATCAGCATGAGGGTCCTTGC-3' 
BamHI 
Antisense Oligonucleotides 
Cµ2Bam.Backward: 27 mer; Tm=65.0°C; 
5'-GGGGTGTGGATCCTTTCTTCTCGATGG-3' 
3'Cµ4.Backward: 28 mer; Tm=86.0°C 
5'-GCCTGACTGAGTTCACACACAAGGAGGA-3' 
3'UT.µl: 20 mer; 
5 '-GGA'ITITI'I"I'I'A TTTCTAAT-3' 
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3'UT.µ2: 20 mer; 
5'-TATGCAACATCTCACTCTGAC-3' 
3'UT.µ3: 21 mer; 
5' -A(c)GACACCCAG(a)GGCCTGCCTGG-3' 
991µ3.Backward: 24 mer; 
5'-ATCGATTCATGACCTGAAATTCAG-3' 
Cl al 
991k3.Backward: 28 mer; 
5'-ATATCGATTAGGTAGACAATTATCCCTC-3' 
Cl al 
2.2.2 Phosphorylated Linkers 
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Clal linker [d(pGATCGATC}] and Spel linker [d(pGACTAGTCTC}] were 
purchased from New England Biolabs (Beverly, MA). Clal linker [d(pATCGAT}] was 
purchased from National Biosciences (Plymouth, MN). EcoRI linker 
[d(pCGGAATTCCG)] was purchased from Amersham (Arlington Heights, IL). Nhel 
amber stop linker with nonsense codons in all three reading frames [5 ' -
pd(CTAGCTAGCTAG)-3'] was purchased from Pharmacia (Piscataway, NJ). 
2.3 Enzymes 
Restriction endonucleases were obtained from either Boehringer Mannheim 
(Mannheim, Germany) or Gibco BRL Life Technologies, Inc. (Gaithersburg, MD); 
AmpliTaqTll DNA polymerase from Perkin Elmer Cetus (Norwalk, CT); T4 DNA ligase 
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and Klenow fragment from Pharmacia (Piscataway, NJ) or Promega (Madison, WI); 
DNase I, RNasin (40u/µl), SI nuclease and Mung bean nuclease from Promega 
(Madison, WI); RNAse A (bovine pancreas) and lysozyme from Sigma Chemical 
Company (St. Louis, MO); DNA sequenase version 2.0 from United States Biochemical 
(USB, Cleveland, OH); Proteinase K from Boehringer Mannheim (Indianapolis, IN); 
Superscript reverse transcriptase from Gibco BRL (Gaithersburg, MD). 
2.4 Bacterial Strains 
2.4.1 Bacterial Strains 
Escherichia coli (E. coli) strain HBlOl or JM109 or DH5a from Bethesda 
Research Laboratories (BRL) and BMH 71-18 mut S from Promega were made 
competent using a calcium chloride procedure (Sambrook et al., 1989). For some vectors 
(such as pGEM-Zf series and pSELECT™-1) that contain a sequence coding for the E. 
coli (j-galactosidase (lac Z) a-peptide, interrupted by a multiple cloning site, blue/white 
color selection was used for insert selection. Colonies containing plasmids with no inserts 
were blue, while those containing inserts were white when grown on Luria Broth agar 
plates (1.5% Bacto-agar in LB medium, pH 7.0) containing 100 µg/ml ampicillin, 40 
µg/ml X-Gal, and 5 mM IPTG. 
2.4.2 
2.4.2.1 
Preparation of Competent Bacterial Cells 
Solutions and Reagents 
y-a plate (per liter) 20 g Bacto-tryptone 
y-b medium (per liter) 
Tbfl 
Tbt'2 
5 g Bacto-yeast extract 
5 g MgS04 
(Adjust pH to 7.6 with KOH) 
14 g Bacto-agar 
20 g Bacto-tryptone 
5 g Bacto-yeast extract 
5 g MgS04 
Adjust pH to 7.6 with KOH. 
30mM 
100 mM 
lOmM 
50mM 
15 % 
KAc 
KCI 
CaC12 
MnC12 
Glycerol 
Adjust pH to 5.8 with 0.2 M acetic acid. 
lOmM MOPS 
75 mM CaC12 
10 mM KCl 
15 % Glycerol 
Adjust pH to 6.5 with KOH. 
23 
2.4.2.2 
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* All solutions were filter-sterilized through a 45-µm filter and stored at 4 °C. 
Procedure for the Preparation of Competent Bacterial Cells 
Bacteria of interest were streaked from a frozen storage onto a y-a plate. (JM 
stains must be streaked onto a minimal plate that contains no proline to maintain the F' 
episome. HB 101 might start from a fresh LB plate.) A single colony of the bacteria was 
inoculated into 5 ml of y-b media and shaken at 300 rpm overnight at 37°C (Gyrotory® 
Shaker, Model GlO, New Brunswick Scientific Co., Inc., Edison, NJ). A secondary 
culture was prepared by inoculating 500 µl of the overnight culture into 50 ml of pre-
warmed y-b media, and aerating at 300 rpm and 37°C for 2 to 4 hours until the OD550 
has reached 0.48. The culture was chilled on ice for 5 min and centrifuged at 3000 rpm 
for 5 min at 4 °C (Beckman tabletop centrifuge, Model GPR, Palo Alto, CA). Bacteria 
pellet was resuspended in 40 ml of ice-cold Tbfl and incubated on ice for 5 min. After 
pelleting, the bacteria was resuspended in 4 ml of ice-cold Tbf2 and further incubated 
on ice for 15 min. The competent bacteria were pipetted in aliquot (e.g. 250 µl) into pre-
chilled microcentrifuge tubes placed in an ethanol-dry ice bath, and stored at -70°C. 
Efficiency of transformation was determined by transforming 50 µl of competent bacteria 
with 20 ng of a plasmid DNA as described in section 2.6.8. Efficiency should approach 
1 X 108 cfu/µg supercoiled DNA. 
2.5 Plasmids and DNA Probes 
2. 5 .1 Plasmids 
pABµ-11 
pBluescript II KS + /-
pBR-H4 
pBR-VH 17.2.25 
pBS-myc 
pCR™ II 
pCEP4 
p5.1 
p-y2b(l 1)7 
pGEM-zfs 
pGEM™-T Vector System 
pGm/j-actin 
pP2-5' 
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From Dr. I. Haas (Bothwell et al., 1981) 
Strategene, San Diego, CA 
Dr. R. Grossschedl, UCSF, San Francisco, 
CA (Grossschedl and Baltimore, 1985a; 
Grossschedl et al., 1985b) 
Dr. R. Grossschedl, UCSF, San Francisco, 
CA (Grossschedl and Baltimore, 1985a; 
Grossschedl et al. , 1985b) 
Dr. Jeff Ross, University of Wisconsin, 
Madison 
Invitrogen Corp., San Diego, CA 
Invitrogen Corp., San Diego, CA 
From Dr. I. Haas (Reth et al., 1984) 
Dr. P. Tucker (Tucker et al. , 1979) 
Promega, Madison, WI 
Promega, Madison, WI 
From Dr. Joel Pachter (Tokunaga et al., 
1986) 
Dr. Nahum Sonenberg, McGill University, 
Montreal, PQ, Canada (Pelletier et al., 
pRGAPDH 
pUHDl0-1 
pSV2gpt 
pSV2neo 
pTlgpt 
pu• 
2.5.2 DNA Probes 
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1988) 
Dr. K. Marcus (Fort et al., 1985) 
Dr. H. Bujard (Deuschle et al., 1989) 
Dr. J. Murnane (Mulligan et al., 1981) 
Dr. J. Murnane (Southern et al., 1982) 
Dr. Falkner (Altenburberg et al., 1980) 
Dr. R. Grossschedl, UCSF, San Francisco, 
CA (Grossschedl and Baltimore, 1985a; 
Grossschedl et al. , 1985b) 
Jack et al. , 1992 
Li and Jack (unpublished, see section 
4.2.1.1 in Chapter IV) 
mouse {3-actin 1.9 kb HindIII/BamHI fragment from 
pGm{3-actin 
human c-myc 1 kb Clal/ Smal fragment from pBS-myc 
mouse cDNA (Cµl-4) 1.1 kb Smal/Apal fragment from pABµ-11 
enhancer probe of mouseµ gene 1.0 kb Xbal fragment from pµ•gpt 
'Y 2b 1.0 kb Asp718/BamHI or 320 bp Sstl 
fragment from pB"f2b 
ratGAPDH 1.3 kb BamHI!EcoRI fragment from 
gpt 
Histone 2b 
neo probe 
5 '-UTR of poliovirus 
VX.l 
2.6 DNA Manipulations 
2.6.1 Plasmid DNA Preparation 
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pRGAPDH 
1. 9 kb BamHII Hindlll fragment from 
pSV2gpt. 2Xhol 
Oncor. Inc. (Gaithersburg, MD) (Grandy et 
al. 1982) 
2.4 kb BamHI/Hindlll fragment from 
pSV2neo 
0. 7 kb Hindlll/EcoRV fragment from pP2-5' 
1.0 kb Hindlll/Xbal fragment 
Plasmids used for cloning and transfection were prepared by the alkaline lysis 
method for small and large scale plasmid preparation as described by Sambrook 
(Sambrook et al., 1989). A rapid, small-scale plasmid preparation method (Magic 
minipreps kit, Promega Corporation, Madison, Wisconsin) was used for restriction 
enzyme analysis of recombinant plasmids or small-scale DNA probe isolation (see section 
2.6.4.2 below). 
2.6.1.1 Solutions and Media 
1 X M9CA media 2mM 
2% Glucose 
LB-Amp medium 
Lysis buffer 
Lysozyme solution 
Alkali solution 
Potassium acetate (pH 4.8) 
(per lOOml) 
0.1 mM CaC12 
0.0025% Nicotinic Acid 
0.005 % Thiamine 
100 µg/ml Ampicillin 
2.5% LB 
0.2% maltose 
5 mM glucose 
100 µg/ml ampicillin 
1% 
lOmM 
25 mM 
glucose 
EDTA (pH 8.0) 
Tris (pH 8.0) 
30 mg/ml in lysis buffer 
1% SDS 
0.2 N NaOH 
(prepare fresh) 
60 ml of 5M KAc 
11.5 ml of glacial acetic acid 
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Proteinase K buffer 
Proteinase K stock 
RNase A stock 
Sodium acetate (3M, pH 5.2) 
TE buffer 
TE-saturated phenol/ chisam 
50mM Tris, pH 8.0 
10 mM CaC12 
10 mg/ml in proteinase K buffer 
(store at -20°C) 
10 mM Tris-HCI, pH 7.5 
15 mM NaCl 
(store at -20°C) 
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Dissolve 12.3 g NaAc (MW 82.03) in about 
40 ml deionized water (0.1 % DEPC water 
in the case of RNA solution). Adjust with 
glacial acetic acid to pH 5. 2. Bring the 
volume to 50 ml with water. 
lOmM 
lmM 
Tris-HCl, pH 8.0 
EDTA 
Thaw phenol at RT before melting at 65°C 
2.6.1.2 
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for about 30 min. Add 8-Hydroxy Qunodine 
to final concentration of 1 mg/ml phenol. 
Extract the phenol with equal volume of 1 
M Tris-HCl (pH 8.0) for 3 to 5 times until 
the pH in TE reaches pH 7-8. Then mix 1 
part of the lower, phenol phase with 1 part 
of chisam (chloroform +isoamyl alcohol = 
24+1). 
Small Scale Preparation of Plasmid DNA (Miniprep) 
A fresh, single colony was inoculated into 5 ml of LB medium (containing 
antibiotics). The cultures were aerated at 300 rpm overnight at 37°C in a shaker 
(Gyroto~ Shaker, Model GlO, New Brunswick Scientific Co., Inc., Edison, NJ). Next 
morning, 1.5-3 ml of the overnight culture was centrifuged in an Eppendorf tube for 30 
seconds at room temperature and the plasmids were isolated using a magic mini prep kit 
from Promega (Madison, Wisconsin) according to manufacturer's instructions. 
2.6.1.3 Large Scale Preparation of Plasmid DNA 
2.5 ml of a fresh overnight culture was inoculated into 250 ml of M9CA medium 
in a 1 liter flask. The bacteria culture was grown at 300 rpm and 37°C to an OD550 of 
0.5-0.6 (about 4 hours) before adding 25 mg of Chloramphenicol (final concentration is 
100 µg/ml, Sigma), and further aerated overnight. The next morning, the bacteria was 
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pelleted by centrifugation in a swinging bucket rotor in a Beckman centrifuge (Model 
GPR) at 3,500 rpm for 20 minutes at 3°C. The supernatant was discarded and the 
bacterial pellet was resuspended in 5 ml of ice-cold lysis buffer on ice. 1 ml of freshly 
prepared lysozyme solution (30 mg/ml in lysis buffer) was added to the suspension, and 
incubated at room temperature for 5 min, followed by incubation on ice for 5 min. The 
bacteria were completely lysed by incubating with 12 ml of freshly prepared alkali 
solution on ice for 10 min. Proteins and chromosomal DNA were precipitated with 9 ml 
of ice-cold potassium acetate solution for 20 minutes on ice and centrifuged in a Sorvall 
SS34 rotor at 18,000 rpm and 3°C for 30 min (Sorvall® RC-SB Refrigerated Superspeed 
Centrifuge, Du Pont Instruments, Wilmington, DE). Plasmid DNA was precipitated from 
the supernatant with 1 volume of ice-cold isopropanol on ice for 20 minutes and then 
centrifuged in a Sorvall SS34 rotor at 12,000 rpm and 3°C for 30 min. DNA pellet was 
air-dried at room temperature for approximately 20 min. RNA in the sample was digested 
by dissolving and incubating the pellet with 2 ml of TE buffer containing 50 µl of 10 
mg/ml RNAse A at 37°C for 15 to 30 min. Proteins in the sample were digested by 
denaturing with 125 µl of 10% SDS followed by incubating with 50 µl of 10 mg/ml 
proteinase Kat 42°C for 1 hour. To extract plasmid DNA, the solution was extracted 
once with an equal volume of TE-saturated phenol, twice with an equal volume of 
phenol/chisam (1+1) and once with an equal volume of chisam at room temperature. 
DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5 
volume of ethanol and incubating on ice for at least 20 min or at -20°C overnight. 
Precipitated DNA was centrifuged at 12,000 rpm and 4 °C for 40 minutes, washed twice 
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with 1 ml of70% ethanol, dried in a Speed Vac Concentrator (Savant, Farmingdale, NY) 
and then dissolved in 250 µl of TE. 1 µl of midi-prep DNA was quantitated by restriction 
enzyme digestion as described in section 2.6.2 and 2.6.5. 
2.6.2 DNA Digestion 
Plasmid DNA was digested with restriction endonucleases. Usually, 2-5 units of 
an enzyme was added to per µg of DNA. Digestion reactions were carried out in buffers 
provided by the manufacturer for each enzyme and under reaction conditions 
recommended by the manufacturer. Reaction mixtures were run on 0.8-1.2% agarose 
gels, as described in section 2.6.3, from which purified DNA fragments were extracted, 
as described in section 2.6.4. 
2.6.3 DNA Agarose Gel Electrophoresis 
DNA fragments were separated on 0.8-1.2% (w/v) agarose gels. 1.12-1.68 g of 
agarose (weighed in an Analytical Balance, Model XL-400D, Fisher Scientific, 
Pittsburgh, PA) was dissolved in 140 ml of TAB buffer (1 X TE is 40 mM Tris-HCI, 
pH 8.0, 20 mM sodium acetate, 2 mM EDTA) by boiling in a microwave. The agarose 
solution was cooled to approximately 60°C at room temperature before 7 µl of ethidium 
bromide (EtBr) (stock solution is 10 mg/ml) was added to a final concentration of 0.5 
µg/ml. The mixture was stirred gently before it was poured into a horizontal gel casting 
tray (15 X 10 cm gel tray, 15 or 20 well comb, 1.5 mm, Bio-RAD, Richmond, CA). 
The gel was allowed to solidify at room temperature for about 20 min prior to being 
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transferred to a horizontal electrophoresis chamber (Wide Mini-SubTll DNA 
Electrophoresis Cell, Bio--RAD, Richmond, CA) filled with TAB buffer. DNA samples 
containing tracing dye (0.025% bromophenol blue in 2.5% ficoll and lX TAB) were 
loaded into the sample wells of the gel and the electrophoresis was run under constant 
voltage of 60 V (Power supply: Model FB 135, Fisher Scientific, Pittsburgh, PA) until 
the dye front migrated to the bottom of the gel. Lambda DNA cleaved with HindIII 
endonuclease and 1 kb DNA ladder (Gibco BRL) were run simultaneously to serve as the 
molecular weight standards. DNA bands were viewed under an ultra violet light box (312 
nm Variable Intensity Transilluminator, FBTIV 614, Fisher Scientific, Pittsburgh, PA) 
and photographed on a Polaroid 667 film by a Polaroid Camera (Model DS34, Polaroid 
Corp. Cambridge, MA). 
2.6.4 DNA Band Isolation from the Agarose Gel 
Digested DNA samples were size fractionated on 0. 8-1. 2 % agarose gels stained 
with ethidium bromide. DNA fragments were visualized using ultraviolet light as 
described in section 2.6.3. The appropriate fragments were cut out with a scalpel and 
extracted from the agarose using the 6 M Nal isolation method described below. 
2.6.4.1 6 M Nal Method of DNA Band Isolation 
6 M Nal was prepared by dissolving 44.97 g of Nal (FW 149.9 g/mole) in 50 ml 
deionized water at RT. The DNA-containing agarose was cut into small pieces with a 
scalpel and transferred into a pre-weighed appropriate tube (either an Eppendorf tube or 
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a 15 ml-Falcon tube). 2.5 to 3 volumes of 6 M Nal solution per µg of agarose was added 
in the tube and incubated at 45-56°C for 10 to 20 minutes until the agarose had melted. 
The tube was inverted several times during the incubation. 1 ml of Magic Mini Prep 
Resin (Promega) per 30 µg of DNA was added to the melted agarose, and incubated at 
room temperature for 5 min. The isolated DNA was eluted from the resin by the 
procedures as described in Magic Mini prep DNA preparation provided by Promega. 
2.6.5 Quantitation of DNA 
The concentration of the isolated DNA fragment or plasmid was estimated by 
DNA agarose gel electrophoresis (see section 2.6.3). At least 0.1 µg of DNA was loaded 
on 0.8-1.0% agarose/TAE gel and the intensity of its EtBr staining was compared to the 
intensity of a fragment of similar size in >. DNA/HindIII standards (Gibco BRL, 
Gaithersburg, MD) for plasmid and DNA fragments that were larger than 1.6 kb or to 
Bacteriophage c/>Xl 74 DNA markers (Gibco BRL, Gaithersburg, MD) for DNA 
fragments that were smaller than 1.6 kb. 
2.6.6 Dephosphorylation of DNA Fragment (CIP-treatment) 
A kinase reaction is required to prevent the cloning vector from self-ligation. 
Dephosphorylation mixture: 
DNA digestion mixture: 
1 Ox CIP buffer: 
20-30 µl 
5 µl 
Calf intestinal phosphatase (CIP): 0.01 unit/pmol DNA for 5' overhang) 
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Deionized H20 to 50 µl total volume 
For 5'-overhangs: the reaction mixture was incubated at 37°C for 30 min, after 
which another aliquot of CIP was added and the incubation was repeated. For 3 ' -
overhangs or blunt ends: the reaction mixture was incubated at 37°C for 15 min then at 
56°C for 15 min, after which another aliquot of CIP was added and the incubation at 
both temperatures was repeated. 
To inactivate the CIP enzyme, 20 µl of 500 mM EGTA (pH 8.0) was added to 
the reaction mixture followed by heat inactivation at 65°C for 45 min or at 68°C for 15 
min. 
2.6.7 
2.6.7.1 
DNA Ligation 
Solutions 
10 X ligation buffer 
10 X Kienow buffer 
10 X dNTPs 
250 mM 
100 mM 
100 mM 
Tris-HCl, pH 7.6 
MgC12 
DTT 
100 mM ATP 
100 mM 
500mM 
50mM 
Tris-HCI, pH 7.5 
NaCl 
DTT (optional) 
0.125 mM of each dNTPs 
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2.6.7.2 Sticky End Ligation of DNA Fragment 
A 5-10: 1 molar ratio of insert: vector DNA was used to obtain the optimal ligation 
efficiency. Usually, 0.1 µg of vector DNA was used in the total volume of 15 µl of 1 X 
ligation buffer. One Weiss unit ofT4 DNA ligase (Pharmacia) was added to each ligation 
mixture. Ligation reactions were allowed to proceed at 15°C overnight (10 to 18 hours). 
T4 DNA ligase was heat-inactivated at 70°C for 10 minutes before transformation. 
2.6.7.3 Blunt-End Ligation of DNA Fragment with Phosphorylated Linkers 
A 100-200 molar ratio ofphosphorylated linker:phosphorylated vector (see section 
2.6.6) was usually used for each ligation. Ligation reactions were performed as described 
in the above section except following the overnight incubation, the ligation reactions were 
further incubated at room temperature for 4 hours. 
2.6.7.4 Two-Step Ligation of DNA Fragments 
Two-step ligation is a procedure to ligate two fragments that are compatible with 
only one of their ends. 
A. First round ligation mixture for enzyme 1 ends: 
CIP-treated vector 
insert DNA 
10 X ligase buffer 
T4 DNA ligase 
0.5 µg 
5-10: 1 molar ratio of insert:vector 
1.5-2.0 µl 
1 unit 
to final volume 15 µl-20 µl 
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Ligation reactions were allowed to proceed at 15°C overnight. T4 DNA ligase 
was heat inactivated at 70°C for 10 minutes. (The vector self-ligation was stored at -
20°C for use as a transformation control.) 
B. Klenow enzyme filling in the remaining sticky end: 
DNA ligation mixture 
10 X Klenow buffer 
0.125 mM dNTPs 
100 mM DTT 
Kienow 
15-20 µl (from the above) 
3 µl 
3 µl 
1.5 µI 
1 unit (diluted in 1 X Klenow buffer) 
sterile H20 to final volume 30 µl 
Incubate at RT (22°C) for 30 min. 
C. Second round ligation for the blunt ends: 
1) Ligation mixture 
10 X ligase buffer 
40% PEG 
100 mM DTT 
T4 DNA ligase 
12 µl 
15 µl 
1.2 µl 
1 unit 
to final volume 120 µl 
2) the ligation mixture was added to the 30 µl of Klenow reaction mixture; 
3) the mixture was incubated at 15°C overnight; 
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4) the following morning, the mixture was incubated at RT for an 
additional 3 hours; 
5) the ligase was heat inactivated at 68°C for 10 min. 
D. The ligation mixture was transformed into competent HB 101 cells as 
described in 2.6.8. 
1) for vector+insert: 50 ng or 100 ng/100 µl HB 101; 
2) for vector control: 100 ng/100 µl HB 101. 
2.6.8 DNA Transformation 
For transformation, a 50-100 µl aliquot of competent cells (the amount depends 
on the number of cells) was measured into a cold microcentrifuge tube containing 50-500 
ng of plasmid DNA or ligation mixture. The cell/DNA suspension was mixed gently and 
incubated on ice for 20-30 min, followed by a heat shock in a 42°C water bath for 45 
seconds. The tubes were chilled on ice for 2 min and 1 ml of S.O.C. (2% Bacto-
tryptone, 0.5 % yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgC12, 10 mM 
MgS04, 20 mM Glucose) was added. The suspension was incubated for 1 hour at 37°C 
with shaking (225 rpm) to allow expression of the antibiotic-resistant gene before plating 
onto a LB plate containing ampicillin (100 µg/ml) or tetracycline (15 µg/ml). 
Transformants were selected by standard methods described below. 
2.6.9 
2.6.9.1 
Screening for Recombinant DNA 
Blue/white Color Screening 
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JM109, which contains an F' episome that carries a nutritional requirement for 
growth (proline biosynthesis), is used for blue/white color screening of the pGEM-Z and 
pGEM-Zf plasmids (Promega). To prepare plates containing IPTG and X-Gal, 50 µl of 
2% X-Gal and 100 µl of 100 mM IPTG were spread on LB plates and allowed to absorb 
for 30 min at 37°C prior to plating transformed JM109 cells. The plates were incubated 
overnight at 37°C. Recombinant colonies were white while nonrecombinant colonies 
were blue. 
2.6.9.2 Colony Lift 
The following protocol was modified after the procedures described in 
manufacturer's instruction and Sambrook et al. (1989). LB plates with selective agent 
containing single isolated colonies were cooled at 3 °C before use. Nylon membrane 
(HyBond"'-N, Nylon, 0.45 µM, X82 mm, Cat# RPN.82N, Amersham, Arlington 
Heights, IL) was overlaid onto the agar plate to allow uniform wetting. The nylon 
membrane and agar gel were marked in several places with India ink. The nylon 
membrane was then placed on a Whatman paper (Whatman 4 filter paper, 9.0 cm, 
Whatman limited, England) soaked in denaturation solution (2 X SSC and 5 % SDS) for 
2 minutes (the colony side should be upward). The DNA was fixed to the nylon by 
microwaving the membrane at high power for 2.5 minutes (650 watts). The bacterial 
debris was rubbed off with a glove after soaking the membranes in 2- X SSC. 
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Prehybridization of the membrane was performed in a solution containing 0.5 M sodium 
pyrophosphate, 1 % BSA, 7% SDS, 1 mM EDTA at 65°C for at least 1 hour. 
Hybridization was performed overnight in the same solution as prehybridization except 
2 X 106 counts of denatured 32P-labeled DNA probe was added and incubation 
temperature was 65°C. The membrane was washed first in 2 X SSC at room temperature 
for 2-5 minutes and then in 0.1 SSC and 0.1 % SDS at 55°C until the background was 
low. The holes were labeled with a radioactive pen before autoradiography. 
2.6.10 
2.6.10.1 
Labeling of DNA Probes 
Nick Translation 
Radioactive probes were prepared by nick translation using nick translation kit and 
protocol supplied by BRL. One µg of probe was added to a mixture containing 100 µCi 
[a-32P]-dCTP (Amersham, Arlington Heights, IL), 5 µl of a 0.2 mM solution of three 
deoxyribonucleoside triphosphates (dNTPs: dATP, dGTP, dCTP), 5 µl of a solution 
containing 2 units DNA polymerase I and 200 pg DNase I in a total volume of 50 µI. 
The labeling reaction was incubated at 15°C for 1 hand then stopped by the addition of 
5 µl of 300 mM Na2EDTA solution on ice. The labeled DNA was immediately separated 
from unincorporated nucleotides by chromatography on a 0.9 X 1.5 cm G-50 Sephadex'I')( 
(Fine) column using the protocol provided by Boehringer Mannheim Corporation 
(Indianapolis, IN). The specific activity of the labeled probe is 5-10 X 107 cpm/ µg DNA. 
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2.6.10.2 Random Priming 
25-50 ng template DNA was added with distilled water to bring the total volume 
to 37 µl in a screw-capped microcentrifuge tube. The DNA was denatured by boiling for 
5 minutes, immediately placing the tube on ice. The following mixture was added to the 
DNA solution: 10 µl of 5 X c· buffer (containing 250 mM Tris-HCl, pH=8.0, 25 mM 
MgC12, 5 mM ,8-mercaptoethanol, 2 mM each of dA TP, dGTP and dTIP, 1 M HEPES 
(adjusted to pH 6.6 with 4 N NaOH) and 1 mg/ml random primers (mostly hexamers, 
BRL), 2 µl of 10 mg/ml BSA (BRL), 0.5 µl of [a-32P]dCTP (Amersham), and 1 unit of 
the Klenow fragment of E. coli DNA polymerase I. The reaction mixture was incubated 
at room temperature for at least 30 minutes. The specific activity of the labeled probe 
was determined by counting 1 µl of the total reaction mixture in liquid scintillation 
counter. 108-109 cpm/µg is suitable (Sambrook et al., 1989; protocols from GIBCO 
BRL). 
2.6.10.3 5' End Labeling 
100 pmol (or 50-100 ng) oligonucleotide was phosphorylated by adding 1 µl of 
T4 polynucleotide kinase (8 units/µl in the solution containing 50 mM Tris-HCl, 10 mM 
MgC12, 10 mM DTI, 1 mM spermidine, and 800 µCi ['y-32P] dATP {ICN). The reaction 
was incubated at 37°C for 30-45 minutes and the kinase was inactivated by heating at 
70°C for 10 minutes. The labeled oligonucleotide was immediately separated from 
unincorporated nucleotides by chromatography on a 0.9 X 1.5 cm of G-25 SephadexTll 
(Fine) column using the protocol provided by Boehringer Mannheim Corporation 
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(Indianapolis, IN). The specific activity of the labeled probe is 4 X HY to 1.2 X 106 
cpm/ng oligonucleotide. 
2. 7 Site-Directed Mutagenesis 
2. 7 .1 Solutions 
10 X annealing buffer 
10 X M9 solution (per liter) 
M9 agar plate (per liter) 
200mM 
100 mM 
500mM 
60 g 
30 g 
Tris-HCl, pH 7.5 
MgC12 
NaCl 
Na2HP04 (MW= 131. 96) 
KH2P04 (MW= 136.09) 
5 g NaCl 
10 g NH4Cl 
100 ml 
875 ml 
15 g 
10 X M9 solution 
distilled H20 
agar 
Autoclave, cool to 55°C and add 
1 ml 
100 µl 
10 ml 
1 ml 
MgS04 
CaC12 
20% (w/v) Glucose 
10 mg/ml Thiamine 
Phage precipitation solution 
10 X synthesis buffer 
TYP broth (per liter) 
Pour 20 ml in each plate 
20% PEG 8000 (Sigma) 
2.5 M NaCl 
100 mM 
5mM 
lOmM 
20mM 
16 g 
Tris-HCl, pH 7.5 
dNTPs 
ATP 
DTT 
Bacto-tryptone 
16 g Bacto-yeast extract 
5 g NaC12 
2.5 g K2HP04 
2. 7 .2 Preparation of Phagemid Single-Stranded DNA 
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The following protocol was modified from instructions of Promega Altered Sites 
kit protocol and an internal protocol. The DNA to be mutated was cloned into the 
pSelect-1 vector. Recombinant DNA was transformed into competent cells of JM109 or 
a similar host and selected by plating on the LB-Tet (tetracycline 15 µg/ml) and IPTG/X-
Gal plate. (The LB-Tet plate was spread with 100 µl of 0.1 M IPTG and 50 µl of 2% 
X-Gal, and these components were allowed to absorb for 30 minutes at 37°C prior to 
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plating cells.) The original pSelect-1 vector was used as a positive control and the 
pSelect-control phagemid (Promega) was used as a negative control. Several white 
colonies on the recombinant transformation plate were picked with toothpicks to do mini-
preps for confirmation of the correct recombinant clones. The overnight cultures of cells 
containing pSelect-1, pSelect-control, and correct recombinant DNAs were plated on M9-
Tet plate (15 µg/ml tetracycline) to select for the presence of F' which carries a 
nutritional requirement for growth and decreases the number of false positives. The 
incubation time was about 40 hrs. An overnight culture was prepared from each M-9 
plate by picking individual colonies on M9-Tet plates and inoculating 5 ml of TYP broth 
containing 15 µg/ml tetracycline and shaking overnight at 37°C. The next morning, 25 
ml TYP broth (15 µg/ml tetracycline) was inoculated with 500-1000 µl of overnight 
cultures. These were shaken vigorously at 37°C for 2-3 hrs until the A550 =0.5-1.0. This 
was the plating culture and could be stored at 3°C up to 1 week. The culture was 
infected with helper phage R408 (which obtains high yields when it is used in conjunction 
with the JM109 strain) at a multiplicity of infection (m.o.i.) of 10. 1 O.D. at 
A550=5Xl08 cells/ml. The cultures (10-20 ml) were incubated at 37°C for 20 minutes, 
and then shaken vigorously at 37°C for at least 6 hrs. After shaking, the cultures were 
transferred to SS34 tubes, and the culture supernatant was harvested by pelleting the cells 
at 12K rpm/4 °C/15 minutes. The supernatant was then transferred to a new SS34 tube, 
and spun again as described above. 1 ml of each supernatant was saved in 3°C 
refrigerator. The rest of supernatant was precipitated with 0.25 volume of phage 
precipitation solution (20% PEG and 2.5 M NaCl) overnight at 3 °C. The phage pellet 
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was then spun down at 12K rpm/3°C/15 min. The tubes were thoroughly drained, spun 
again for 2 min, and any liquid was removed with a pipeter. The pellet was resuspended 
in 0.5 ml of TE (pH=7.5-8.0), and transferred to a 1.5-ml microcentrifuge tube. The 
phagemid DNA was phenol extracted once; phenol:chisam extracted twice; and then 
chisam extracted once. The phagemid DNA was precipitated with 1/10 volume of 3M 
NaAc and 2.5 volume of ethanol at -20°C for 30 minutes or overnight. The pellet was 
spun down and dried in a Speedvac. The pellet was sometimes difficult to see, and was 
resuspended in 30 µl of TE. 2 µl was quantitated on 0.8-1.0% agarose gel. The helper 
phage band of R408 is 6.4 kb and pSelect-control is 5.6 kb. The single-stranded DNA 
standard from the sequencing kit (USB) may also be used as the size standard for 
estimation of single-stranded DNA. 
2.7.3 5' Phosphorylation of Oligonucleotides 
1) The following components were added to a microcentrifuge tube: 
oligonucleotide 
10 X kinase buffer 
10 X ATP (10 mM) 
T4 polynucleotide kinase 
100 pmol 
2.5 µl 
2.5 µl 
5 units 
to final volume 25 µl 
2) Incubated the reaction at 37°C for 30 minutes. 
3) Incubated the reaction at 70°C for 30 minutes to inactivate the kinase. 
4) The reaction products were stored at -20°C or added directly to the.annealing 
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reaction. 
2.7.4 Site-Directed Mutagenesis 
A phosphorylated mutagenic oligonucleotide (1.25 pmol) and ampicillin repair 
oligonucleotide (0.25 pmol, Promega) were annealed to the recombinant pSELECT-1 
ssDNA (0.05 pmol)in annealing buffer by heating to 70°C for 5 min followed by slowly 
cooling to room temperature. After extension with T4 DNA polymerase and ligation by 
T4 DNA ligase in synthesis buffer, DNA strands were used to transform the BMH 71-18 
mut S mismatch repair-deficient E. coli competent bacteria to select for ampicillin 
resistant transformants. Total plasmid DNA was prepared and transformed into the JM 
109 competent bacteria. Mutant colonies were first screened by the restriction enzyme 
specific to the site present in the mutagenic oligonucleotide and further confirmed by 
sequencing as described in section 2.9. 
2.8 Reverse Transcription Polymerase Chain Reaction (RT-PCRl 
RNA was prepared by using the GIT/CsCl method as described in section 
2.12.1.1, and cDNA was synthesized by using the Superscriptase library kit (Gibco 
BRL). 
2.8.1 
2.8.1.1 
Synthesis of cDNA Fragment by Reverse Transcriptase (RT) 
Reagents and Solutions 
Amplitaq DNA Polymerase 200 U/µl 
dNTPs 
First strand buffer (5 X) 
Oligo(dn 15 primer 
PCR buffer (10 X) 
sense oligonucleotide: 
antisense oligonucleotide: 
rRNasin® RNAse inhibitor 
2.8.1.2 Procedure 
0.1 M 
250 mM 
375 mM 
15 mM 
0.5 µglµl 
100 mM 
500mM 
25 mM 
0.1% 
50 pMole/µl 
50 pMole/µl 
40 U/µl 
Tris, pH 8.3 
KCl 
MgC12 
Tris/HCl (pH 8.0) 
KCl 
MgC12 
gelatin 
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5 µg of total cellular RNA in TE was precipitated with 1/10 volume of 3M NaAc 
(pH 5.2) and 2.5 volumes of EtOH overnight at -20°C. RNA was pelleted in a 
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microcentrifuge at 13,000 rpm for 1 hour at 3°C, washed twice in 70% EtOH, air-dried 
and resuspended in 22.5 µl of DEPC-water. The RNA was denatured in the presence of 
4 µl oligo (dT) primer (0.5 µglµl, Promega) by heating at 65°C for 3 minutes, chilled 
on ice for 2 minutes, spun briefly, followed by adding 10 µl 5 X RT buffer, 5 µl 5 mM 
dNTPs, 5 µl 0.1 M DTT, 2 µl rRNasin (40 U/µl, Promega, optional), and 1.5 µl 
Superscript Reverse Transcriptase (200 U/µl, GIBCO BRL). Incubated the samples for 
10 minutes at room temperature, followed by 1-hour incubation at 42 °C. To inactivate 
reverse transcriptase, the samples were heated for 3 minutes at 95°C in a heat block, 
chilled on ice and pulse spun. This RNA mixture was usually good for at least 10 PCR 
reactions. It was either frozen at -20°C, or immediately used for a PCR amplification 
(see section 2.8.2). 
2.8.2 PCR Amplification 
PCR was performed with 2 µl of the cDNA product from FH (0.2 µg) or 5 µl of 
the cDNA product (0.5 µg) from VXH or CH2XH in a 1.5-ml microcentrifuge tube 
containing 3.5 µl of 10 X PCR buffer, 3.5 µ12 mM dNTPs, 1.0 µl forward primer (50 
µM), 1.0 µl reverse primer (50 µM), 21 µl water, and 0.5 U AmpliTaq polymerase (Taq 
polymerase, BRL). The mixture was overlaid with 35-50 µl of mineral oil and the cDNA 
was amplified for 30 cycles under the following conditions for each segment in a DNA 
Thermal Cycler (Perkin Elmer Cetus, Model 480, Emergyville, CA): denaturation, 94 °C 
for 1 minute; annealing, 50°C for 1 minute; extension, 72 °c for 2 minutes. After the 
amplification reaction, 30 µl of the PCR products were analyzed on a standard 1 % 
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agarose TAB (or TBE) gel stained with ethidium bromide (Sambrook et al., 1989) to 
confirm the sizes of synthesized DNA fragments. 
PCR amplification of plasmid DNA fragment was performed as described above 
except that 1 ng of DNA template was used for 25-30 cycles of amplification. 
2.9 DNA Sequencin~ 
For single-stranded DNA sequencing, the gene segments of interest were 
subcloned into M 13 phage expression vector or pGEM vector (Pro mega Corp., Madison, 
WI) and the single-stranded DNA template was prepared as described before (see sections 
2.6 and 2.7.2). For double-stranded plasmid sequencing, the single-stranded template 
DNA was generated by denaturing 5-10 µg of plasmid DNA in 2 N NaOH and 2 mM 
EDTA solution at room temperature for 5 minutes. The mixture was neutralized by 
adding 0.1 volumes of 3M NH4Ac (pH=4.5) and the DNA was precipitated in ethanol 
at-70°C overnight. After washing the pelleted DNA with 70% ethanol, it was dissolved 
in 7 µl of distilled water for the sequencing reaction. Appropriate primer (see section 
2.2.1) and the reagents in the Sequenasen1 Version 2.0 Kit (United States Biochemical, 
Cleveland, OH) were used in the sequencing reactions as instructed by the manufacturer. 
The single-stranded bacteriophage M13mp18 was used as positive control for the 
sequence reaction. 
The samples were denatured at 80°C for 3-5 minutes prior to loading on 6% urea-
polyacrylamide gel. The electrophoresis was performed at 50 watts and 55°C gel 
temperature in 1 X TBE buffer. The gel was fixed in 10% methanol and 10% acetic acid 
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for 15 minutes at room temperature, transferred onto a Whatman filter and dried for 30 
minutes at 80°C (Hoefer Scientific, Model SE 1160, San Francisco, CA). The 
Fluorography was performed by exposing the dried sequencing gel to an X-ray film at 
room temperature for overnight or 1 day. 
2.10 Cell Culture Techniques and DNA-Mediated Cell Transfection 
2.10.1 Cell Maintenance 
Mouse plasmacytomas and hybridomas were maintained in RPMI 1640 medium 
supplemented with 10% (vol/vol) fetal calf serum (FCS, Hyclone Laboratories), 4 mM 
L-glutamine, 50 units or µg of a penicillin-streptomycin solution per ml, 0.05 mM {3-
mercaptoethanol and 1 mM sodium pyruvate at 37°C in a 5 % COrhumidified incubator 
(Heraeus Instrument, S. Plainfield, NJ). This media is referred to as complete RPMI 
1640 media. All cell culture reagents were from GIBCO BRL unless specifically 
indicated. 
2.10.2 Cell Lines That Were Used in the Dissertation 
Mouse pre-B cell line F (Jack et al., 1989) 
Mouse hybridoma FH (LOCB 83.13.13, Jack et al., 1989) 
Mouse hybridoma VXH (GAMO 12.8, Jack et al., 1989) 
Mouse hybridoma CH2XH (GAMO 62.12, Jack et al., 1989) 
Mouse plasmacytoma J558L (Oi et al., 1980) 
Mouse plasmacytoma NYCH.µK (Bornemann et al., 1995) 
51 
Mouse myeloma Ag8.653 (Kearney et al., 1979; Bornemann et al., 1995) 
2.10.3 Cell Harvesting 
Cells were harvested by centrifuging at 1, 100 rpm and 4 ° C for 5 minutes in 
polypropylene tubes (Silencer® S-103 NA, Rupp & Bowman, Tustin, CA). 
2.10.4 Freezing and Thawing of Cells 
About 2 X 107 cell were pelleted, resuspended in 1.5 ml of RPM! freezing media 
(RPMI 1640 with 30% FCS, 15% dimethyl sulfoxide, and 0.05 mM {j-ME), and 
transferred into an ice-chilled cryogenic tube (Vangard CRYOS,..., Sumitomo Bakelite 
Co., Ltd., Japan). The tubes were kept in a styrofoam box overnight at -70°C to allow 
for slow freezing and stored in liquid nitrogen (Nitrogen tank type 5k, Taylor-Wharton, 
Theodore, AL). 
To thaw cells, the frozen tubes were warmed up in a 37°C water bath until most 
of the cells were thawed, then completely thawed on ice. Then the cells were transferred 
into a 50-ml Falcon tube, washed once with 25 ml of complete RPMI 1640 media, and 
cultured in 10 ml of the complete media. 
2.10.5 Cell Counting 
Cells were diluted in an equal volume of trypan blue solution and counted in a 
Neubauer hemacytometer chamber (Bright-Line®, 0.1 mm, American Optical Co., 
Buffalo, NY). The cell number was determined by the following equation: · 
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Cells/ml = cells per large square x 2 x 104 
2.10.6 Subcloning 
Hybridoma cell lines were subcloned by limiting dilution in 96-well plates (0.15 
cells/100 µI/well, Costar, Cambridge, MA). 100 µI of the complete RPMI 1640 media 
was added to each well after 7-10 days. The wells were screened for colony growth 
under the light microscope (400 X, Labovert Inverted Microscope FS, Leitz Wetzlar, 
Germany) after 12 to 15 days. Subclones were analyzed for lg expression by cytoplasmic 
immunofluorescence analysis as described in section 2.13 .1, or the presence of µ gene 
by PCR as described in section 2.8.2. 
2.10.7 Transfection 
For electroporation, 5Xl06 cells were removed and washed twice in ice-cold 
protein-free RPMI 1640 medium (the complete RPMI 1640 media without FCS), and 
resuspended in 500 µI of the same medium. After addition of 5-20 µg DNA (in 1 X TE, 
total volume < 20 µl), the cells were incubated on ice for 10 minutes and subjected to 
1 pulse of 330 µF, 285 volts at low conductivity with a Cell Porator (BRL, Gaithersburg, 
MD). The transfected cells were immediately transferred into 50 ml-flasks and grown in 
10 ml of 20% FCS-RPMI 1640 media for 48 hours. To isolate stable transfectants, we 
grew the transfected cells that were plated in 96-well plates (Costar, Cambridge, MA) 
at the density of 5 X 1 Q4 cells per ml media, 100 µl media per well in growth media 
containing 2.5 µg of mycophenolic acid (MPA) and 250 µg of xanthine per ml for 7-10 
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days (Jack et al., 1989). The MPA positive stable transfectants were screened by 
cytoplasmic immunofluorescence forµ protein expression (see section 2.13.1). 
2.11 
2.11.1 
DNA Isolation from Mammalian Cells and Analysis 
DNA Isolation by Guanidinium Isothiocyanate (GIT)/Cesium Chloride 
(CsCl) Method 
High molecular weight DNA was isolated as described in Sambrook et al., 1989. 
Briefly, DNA bands in cesium chloride phase (see section 2.12.1.1 below) were aspirated 
into a pasteur pipette and washed twice with 10 ml of 70% ethanol in 50 ml-Falcon tube. 
After air-drying briefly, the DNA was digested with 200 µg/ml proteinase K (PK) in 10 
ml of PK buffer at 42°C overnight (about 16 hours). To remove the proteins, the DNA 
solution was extracted once with equal volume of TE-saturated phenol, twice with 
phenol/chisam (1+1) and once with chisam. The extracted DNA was then precipitated 
with 2 volumes of 100% ethanol, spooled onto a pasteur pipette, washed once in 80% 
ethanol, briefly dried, resuspended in TE (pH 8.0), and incubated overnight at 37°C to 
facilitate the dissolving process. The concentration of DNA was determined by 
photometric measurement at 260 nm as described in 2.11.2. DNA preparations were 
stored at 4 °c. 
2.11.2 Quantitation of DNA 
The concentration of DNA was quantitated by measuring the absorption or optical 
density (OD) at 260 nm (Spectrophotometer, Spectronic 20, Bausch & Lomb, Rochester, 
NY). 1 OD at 260 nm = 50 µg/ml DNA. 
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The purity of DNA was determined by the ratio of the absorbance of DNA at 260 
nm to its absorbance at 280 nm. Our samples were in the range of 1.8 to 2.2. 
2.11.3 
2.11.3.1 
Southern Blot Analysis 
Solutions 
Alkali solution 
Neutralization solution 
Washing solutions 
10 X SSC (pH 7.0) 
2.11.3.2 Procedure 
0.5 N Na OH 
1.5 M NaCl 
0.5 M Tris-HCl, pH 7.4 
3M NaCl 
1) 0.4 N 
2) 0.2 M 
2X 
0.15 M 
Na OH 
Tris-HCl, pH 7.5 
SSC 
Citric Acid 
1.5 M NaCl 
High molecular weight DNA that was prepared as described in section 2.11.1 was 
digested to completion (overnight) with the appropriate restriction enzymes, and 
electrophoresed on a 0.8% agarose gel. The gel was then denatured in 250 ml of alkali 
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solution under shaking at room temperature for 30 minutes and neutralized with 250 ml 
of neutralization solution for 30 minutes. The DNA was capillarilly transferred onto the 
concave side of genescreen plus• (DuPont Biotechnology System NE~ Research 
Product, Boston, MA) in 10 X SSC at room temperature overnight. The genescreen filter 
was washed first with 0.4 N NaOH for 30 seconds, and then washed with 0.2 M Tris-
HCl (pH 7.5) and 2 X SSC for 2 minutes. The filter was dried under an infrared lamp 
or between 2 Whatman papers (3MM). The filters were prehybridized in 10% Dextran 
sulfate, 1 % SDS and 1 M NaCl at 65°C for about 2 hours and hybridized with 100 µCi 
of 32P-nick-translation labeled DNA probes and 200 µg/ml of salmon sperm DNA in 10% 
Dextran sulfate, 1 % SDS and 1 M NaCl at 65°C overnight. The filter was washed as 
described in section 2.12.5 except at 65°C. 
2.12 
2.12.1 
2.12.1.1 
RNA Isolation from Mammalian Cells and Analysis 
Total RNA Isolation 
GIT/CsCl Method 
Total RNA was prepared from cells with guanidinium thiocyanate followed by 
centrifugation in cesium chloride solutions (Sambrook et al., 1989). Briefly, 1-2 X 107 
cells were removed and washed twice with ice-cold phosphate-buffered saline (PBS, 
GIBCO BRL) without calcium and magnesium. Then the cells were transferred in 1 ml 
of PBS into a 15 ml-Falcon tube and lysed in 2 ml of GIT homogenization buffer (4 M 
GIT, 0.12 M {3-Mercaptoethanol, and 25 mM Sodium acetate, pH 5. 6-6. 0). The resulting 
homogenate was then layered on a 2 ml cushion of cesium chloride (CsCl) solution (5. 7 
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M CsCl, 25 mM NaAc, pH 5.2) in a clear ultracentrifuge tube (NalgeneTll UltraTubes, 
thin wall/polyallomer, open-top, size 13 X 51 mm, Nalge Company, Rochester, NY). 
The tubes were balanced with GIT homogenation buffer. The gradient was centrifuged 
at 35 K rpm for at least 20 hours at 20°C in a Beckman SW50.1 rotor (Preparative 
Ultracentrifuge, Model L8-70, Beckman, Palo Alto, CA). After centrifugation, the DNA 
band was collected (if preparation of DNA was desired, see section 2.11.1), the 
remaining supernatant was aspirated until the CsCl layer. The rest of CsCl layer was 
poured off and briefly air-dried. The bottom of the tube was cut off with a razor blade, 
the RNA pellet (may be not visible) was resuspended in 270 µ1 (3 x 90 µ1) of TE, and 
transferred to an Eppendorf tube. 30 µ1 of 3 M sodium acetate (pH 5. 2) and 750 µ1 of 
absolute ethanol were added to precipitate the RNA at -20°C overnight. The precipitate 
was dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). 
2.12.1.2 Trizol or RNAzolTll B Method 
Total RNA was rapidly isolated for the screening of hybridoma subclones by a 
single-step method (Chomczynski and Sacchi, 1987; Kedzierski and Porter, 1991) using 
TRizol Reagent (GIBCO BRL Cat No. 15596-026) and protocol supplied by BRL. 
Briefly, 5 X 106 plasmacytoma cells were pelleted by centrifugation as described in 
section 2.10.3. The cells were lysed in 1 ml of the TRizol Reagent by repetitive 
pipetting, and the samples were transferred to microcentrifuge tubes. The homogenized 
samples were then incubated for 5 minutes at room temperature to permit the complete 
dissociation of nucleoprotein complexes. 200 µl of chloroform was added to the-samples, 
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shaken vigorously by hand for 15 seconds and incubated at room temperature for 2 to 
3 minutes. The samples were centrifuged at 12,000 X g for 15 minutes at 4 °C, and 500 
µl of the upper aqueous phase was transferred to a fresh tube. The RNA was precipitated 
by incubating samples with an equal volume of isopropanol at room temperature for 10 
minutes and centrifuging at 12,000 X g for 10 minutes at 4 °C. The RNA pellet was 
washed once with 1 ml 70% ethanol by centrifugation, briefly air-dried, and dissolved 
in 25 µl of RNase-free water or TE by passing the solution a few times through a pipette 
tip. If the RNA pellet was not completely dissolved, the tubes were incubated for 10 
minutes at 55°C-60°C. The isolated RNA had an A2601280 ratio of 1.6-1.8. 
The isolation of RNA using RNAzolni B solution (Tel-Test, INC., Friendswood, 
TX) is based on the same principle and similar procedures as suggested by the 
manufacturer. 
2.12.2 Cytoplasmic RNA Isolation 
Cytoplasmic RNA was isolated by the Nonidet P-40/Phenol method (modified 
from Favaloro et al., 1980). Briefly, 5 X 106 cells were removed, centrifuged, washed 
with PBS once in an Eppendorf tube. Cells were lysed in 200 µl of ice-cold lysis buffer 
(5 Prime to 3 Prime, Inc.®, 0.14 M NaCl, 1.5 mM MgC12, 0.5 % Nonidet-P40, 10 mM 
Tris, pH 8.6, and 0.05 unit/ml rRNasin from Promega) for 10 minutes on ice. The 
nuclei and unlysed cells were removed by centrifugation at 13 K rpm (12,000 X g) and 
4 °C for 5 minutes. 175 µl of the supernatant was transferred to a new Eppendorf tube 
and digested with 0.2 mg Proteinase K (Boehringer Mannheim) in 175 µl of preheated 
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2 X proteinase K buffer (0.3 M NaCl, 2 mM EDTA, 2% SDS, 0.2 M Tris, pH 7.6) at 
42°C for 1-2 hours. The RNA solution was then extracted three times with 300 µl of 
phenol/chloroform (1+1) and once with 300 µl of chisam at room temperature, and 
precipitated with sodium acetate and absolute ethanol as described above. The precipitate 
was dissolved in 25 µl of TE buffer. The concentration of RNA was determined by 
measuring the absorbance at 260 nm as described in section 2.12.4. The RNA yield was 
60 µg per 5 X 106 hybridoma cells and 35-40 µg per 5 X 106 plasmacytoma cells. 
Nuclear RNA Isolation 2.12.3 
2.12.3.1 RNA Isolation for Crude Nuclei Fractions 
To prepare nuclear RNA, the nuclear pellet from NP-40 lysis method was washed 
twice with 1 ml of ice-cold PBS, then 1 ml of GIT homogenization buffer (described 
previously) was added followed by vortexing for 15 sec to completely lyse the nuclei. 
The nuclear lysate was diluted with GIT homogenation buffer and layered over a 2 ml 
cushion of 5. 7 M cesium chloride (CsCl) solution as described above. The gradient was 
centrifuged in a SW50.1 rotor at 45 K rpm for at least 20 hr at 20-24 °C (Wilkinson et 
al., 1988). The rest of the procedures were as the same as those for total RNA isolation. 
2.12.3.2 RNA Isolation for Purified Nuclei 
2.12.3.2.1 Solutions and Reagents 
PBS (GIBCO) Dulbecco' s Phosphate-Buffered Saline, 
without CaC12 and MgC12 (GIBCO) 
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2 X Isotonic high salt lysis buffer 0.02 M 
0.28 M 
0.003 M 
1 % (v/v) 
0.1% 
Tris-HCl, pH 8.4 
NaCl 
MgC12 
Nonidet-P 40 
DEPC water 
2 X 0.88 M Sucrose 
0.88 M Sucrose-Lysis buffer 
2 M Sucrose 
2 M Sucrose cushion 
Dissolve 120.49 g Sucrose (MW 342.3 
g/molar) in 200 ml 0.1 % DEPC water at 
65°C. Vigorously shake until dissolving. 
Mix equal volume of 2 X lysis buffer with 
2 X 0.88 M Sucrose 
Dissolve 136.92 g Sucrose in 200 ml 0.1 % 
DEPC water at 65°C. 
2M 
5mM 
0.1 mM 
lOmM 
lmM 
sucrose 
magnesium acetate 
EDTA 
Tris, pH 8.0 
DTT 
10% Tween 20 
10 X Tween-Doc 
DNase I buffer 
2.12.3.2.2 Procedure 
10 % (w/w) in 0.1 % DEPC water 
3.3% (v/v) of 10% sodium deoxycholate 
6.6% (v/v) of 10% Tween 20 
0.5 M 
0.05 M 
0.01 M 
NaCl 
MgC12 
Tris-HCl, pH 7.4 
(Holtzman et al. , 1966) 
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The following protocol was generated by modifying several protocols (Nevins, 
1980; Birnie, 1978; and Penman, 1966). 2.5 X 107 hybridoma cells were collected by 
centrifugation at 1,100 rpm and 4°C for 5 minutes. The pelleted cells were resuspended 
with 10 ml of ice-cold PBS (GIBCO BRL), transferred into a 15-ml polypropylene tube 
(17 X 100 mm culture tube, Gemini, Chicago, IL), and centrifuged again. The pellet of 
washed cells was suspended in 5 ml of ice-cold isotonic-high salt lysis buffer by pipetting 
the solution 10 times. The samples were incubated for 10 minutes on ice and vortexed 
gently for 5 seconds. One drop of the lysis solution was placed on a glass slide (25 X 75 
mm, 1 mm, VWR Scientific, Media, PA) overlaid with a cover slide (18 mm square, 
VWR Scientific, Media, PA), and the nuclei were examined under the phase-contrast 
microscope (1,000 X, Biological Microscope, OPTIPHOT, Nikon Corporation, Tokyo, 
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Japan) to determine whether the cells were completely lysed and whether the cytoplasmic 
components are removed from the nuclei. If the majority of cells (95 % ) were lysed and 
there was no obvious cytoplasmic contamination to the nuclei, the homogenized nuclei 
solution was layered over 5 ml of 0.88 M sucrose-lysis buffer solution in a new 15-ml 
polypropylene tube, and the nuclei were purified by centrifugation at 800 X g (2750 rpm) 
(Silencet4 S-103 NA) and 4 °C for IO min. Cell debris was found at the interface 
between the lysis buffer and 0.88 M sucrose solutions. The nuclei were found at the 
bottom of the tube after centrifugation. The lysis and sucrose solutions were removed 
phase by phase by aspiration without disturbing the nuclei. The nuclei pellet was 
resuspended very well by tapping vigorously with the hand and repetitive pipetting. In 
most cases, the pellet could not be dispersed very well. Thus it was digested with 50 µl 
of RNase-free DNase I (40 units/µl, Promega) in 500 µl DNase I buffer for 20 to 40 
minutes at room temperature. 5 ml of lysis buffer and 500 µI of Tween-Doc solution 
were then added, vortexed for 5 seconds and incubated on ice for 5 minutes. This 
mixture was overlaid with either 5 ml of 0.88 M sucrose-lysis buffer and centrifuged as 
described above, or 5 ml of 2 M sucrose cushion in a SW41 polyallomer tube (NalgeneTM 
UltraTubes, thin wall/polyallomer, open-top, size 14 X 98 mm, Nalge Company, 
Rochester, NY) and centrifuged at 25 K for 1 hour at 4 °C (Preparative Ultracentrifuge, 
Model L8-70, Beckman, Palo Alto, CA). After purification of nuclei by centrifugation, 
a drop of the lysis solution was checked under the phase-contrast microscope to 
determine whether the nuclei were still intact and free of visible cytoplasmic 
contamination. The 0.88 M sucrose cushion centrifugation was repeated until no visible 
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cytoplasmic tab was attached to the pure nuclei. To remove the sucrose from nuclei 
preparation, the nuclei were washed twice with 1 ml of lysis buffer and the RNA isolated 
from nuclei by the GIT/CsCl method as described in section 2.12.3.2. 
2.12.4 Quantitation of RNA 
The concentration of RNA was quantitated by measuring the absorption or optical 
density (OD) at 260 nm. 
1 OD at 260 nm = 40 µg/ml RNA 
The purity of RNA was determined by the ratio of the absorbance of RNA at 260 
nm to its absorbance at 280 nm. My samples were in the range of 1.8 to 2.2. The typical 
yields of different cell lines are summarized in Table 1. 
Table 1. Average Yield of RNA Isolation 
Cell lines RNA (µg/107) 
Total Cytoplasmic Nuclear 
AgS.653 90 to 100 ND ND 
J558L 90 to 120 80 to 220 ND 
FH 180 to 220 80 to 180 12 to 15 
VXH 100 to 160 100 to 150 12 to 15 
CH2XH 100 to 120 50 to 90 12 to 15 
Values are determined from the results of several experiments 
ND, not determined. 
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2.12.5 
2.12.5.1 
Northern Blot Analysis 
Solutions 
10 X MOPS 
5 X RNA loading buffer 
RNA sampling buffer 
Gel overlay buffer 
0.2 M 
lOmM 
50mM 
0.1% 
MOPS (sodium base) 
sodium EDTA 
sodium acetate 
DEPC water 
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Adjust pH to 7.0 with glacial acid 
IX 
2.5% 
0.025% 
0.1% 
IX 
2.2 M 
50% 
0.1% 
IX 
2.2M 
O.I% 
MOPS 
Fi coll 
bromophenol blue 
DEPC water 
MOPS 
formaldehyde 
deionized formamide (dFA) 
DEPC water 
MOPS 
formaldehyde 
DEPC water 
deionized formamide (dFA) 
50 X Denhardt's reagent 
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formamide (Ultrapure, Boehringer 
Mannheim) was deionized with 5 g per 100 
ml AG 501-XS(O) and Bio-Rex MSZ 501 
mixed bed resins (Bio-Rad) by stirring very 
slowly at room temperature for about 1 
hour, filtered through 0.45-µm filter 
(Schleicher & Schuell) and stored at -20°C 
in aliquot. 
1% bovine serum albumin 
1 % polyvinylpyrrolidone 
1 % Ficoll (DL-400) 
0.1 % DEPC water 
1 M sodium phosphate buffer (NaP, pH 7.0, per liter) 
Prehybridization solution 
200 ml of 1 M NaH2P04 
600-700 ml of 1 M Na2HP04 
fill to 1 L with deionized water 
0.1% 
50% 
5X 
SDS 
dFA 
SSC 
Hybridization solution 
2.12.5.2 Procedure 
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5 X Denhardt's reagent 
50 mM sodium phosphate buffer 
0.25 mg/ml denatured sheared salmon 
0.1% 
50% 
5X 
IX 
20mM 
10% 
0.3 mg/ml 
sperm DNA (from 10 mg/ml 
stock solution) 
SDS 
dFA 
SSC 
Denhardt's reagent 
sodium phosphate buffer 
Dextran sulfate 
denatured sheared salmon 
sperm DNA 
5-10 µg RNA (with 3 µg of ethidium bromide per lane) was loaded in the sample 
wells of a formaldehyde agarose electrophoresis gel (1.2 % agarose, 2.2 M formaldehyde, 
1 X MOPS in 0.1 % DEPC water) submerged in overlay buffer. RNA size markers (RNA 
ladder, GIBCO-BRL) were usually also run on the gels. The electrophoresis was 
performed in 1 X MOPS buffer in a horizontal gel electrophoresis chamber (Model H3, 
BRL) under a constant current of 10-15 mA (about 35-40 volts) for 15-20 hours until the 
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bromophenol blue migrated to the bottom of the gel. After capillary transfer of RNA 
onto a nitrocellulose filter (0.45 µm, Schleicher & Schuell, Inc., Keene, NH) in 20 X 
SSC for overnight at room temperature, the blot was baked for 2 hours in 80°C vacuum 
oven (VWR 1410, VWR Scientific, San Francisco, CA). Hybridization was performed 
with an Omniblot system (ABN) according to the manufacturer's instructions. The 
prehybridization was performed in a 11 cm X 15 cm milliblot plastic bag (Millipore 
Corporation, Bedford, MA) at 42 °C for at least 1 hour in a 21 ml mixture of 0.1 % SDS, 
50% deionized formamide, 5 X SSC, 5 X Denhardt's reagent, 50 mM sodium phosphate 
buffer (NaP, pH 7.0), and 5 mg of denatured sheared salmon sperm DNA (from 10 
mg/ml stock solution). The radioactive DNA probe was denatured by boiling for 5 min 
and put immediately on ice. Once chilled, the probe was added to 15 ml hybridization 
solution containing 0.1 % SDS, 50% dFA, 5 X SSC, 1 X Denhardt's reagent, 20 mM 
NaP, 10% dextran sulfate, and 1.5 mg denatured sheared salmon sperm DNA. Then the 
blot was hybridized with 1-2 X 106 cpm per ml of a denatured 32P nick-translated µ 
cDNA probe (covering the region between Cµl and part of Cµ4) for 12-18 hours at 
42°C. The filter was washed consecutively with 2 X SSC and 0.1 % SDS for 10 minutes 
once and with 0.1 X SSC and 0.1 % SDS for 20-30 minutes at 55-60°C several times 
until the background detected by Geiger counter (Mini-Instrument, LTD., Model 900, 
Essex, England, through Research Products International Corp., Mount Prospect, IL) on 
the filter was low. After washing, the blot was dried briefly, and the position of RNA 
standards and ribosomal RNAs was labeled with radioactive ink. The blot was then 
wrapped with Saran wrap and exposed to X-ray film (Kodak X-OMAT"" AR or X-ONAR 
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LS, Eastman Kodak Company, Rochester, NY) between intensifying screens (Fisher 
Biotech, Pittsburgh, PA) for appropriate time at -70°C before processed by Developer 
X-Ray Film Processor (Model QX-60A, Konica, Tokyo, Japan). 
The amount of RNA on the blot was quantitated with a Betagen Radioanalytic 
imaging system (Betascope 603 Blot Analyzer, Betagen Corp., Mountain View, CA). 
The sizes of specific RNA bands were determined by measuring the distance from the 
loading well to each of the bands of RNA on the autoradiograph. The log10 of the size 
of the fragments of standard RNA was plotted against the distance migrated. The 
resulting curve was used to calculate the sizes of the RNA species detected by 
hybridization. RNA size standard used was RNA Ladder (GIBCO-BRL) and ribosomal 
rRNAs (Rogers et al., 1981). 
To control for the copy number of active transcripts of plasmids in stable 
transfectants, Northern blots from stable transfection with pµ1gpt~M plasmids, blots were 
stripped of hybridized DNA probe by washing them twice with boiled 0.1 % SDS-0.1 X 
SSC, and subsequently rehybridized to a 1.055 kb of HindIII-Apal fragment or a 1.335 
kb of Pvull-BamHI fragment of gpt gene from pSV2gpt.2Xhol (SF#189). The relative 
amount ofµ mRNA per sample was calculated by dividing the amount ofµ mRNA by 
the amount of gpt mRNA from the same blot. 
To control for RNA loading on each lane, Northern blots from hybridoma cell 
lines, the blots were rehybridized with a 1.3 kb BamHl-EcoRI fragment of rabbit 
GAPDH or a 1.918kb HindIII-EcoRI fragment of mouse {3-actin probe. 
2.12.6 
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mRNA Decay Rates Measured by Actinomycin C 1 or DRB Treatment 
Decay rates of individual mRNAs in different hybridoma cell lines were measured 
by two transcriptional inhibitors, Actinomycin Cl and DRB as described before (Jack et 
al., 1988). Briefly, cells were seeded in complete RPMI medium to a density of 5 X H>5 
cells/ml, and preincubated for 1 hr at 37°C before addition of Actinomycin Cl 
(Boehringer Mannheim, Mannheim, Germany) or DRB (Calbiochem, San Diego, CA). 
The final concentration of Actinomycin Cl was 5 µg/ml from a stock solution of 10 
mg/ml in dimethyl sulfoxide (DMSO). The final concentration ofDRB was 1.2 mM from 
a stock solution of 120 mM in DMSO. At 0, 4, and 8 hr, 20 ml (about 107) or 10 ml 
(about 5Xla6) of cells were removed, centrifuged, and subjected to total RNA isolation 
by the GIT method and cytoplasmic RNA isolation by the NP-40/phenol method, 
respectively. Total viable cell counts at each time point were determined using 5 µg/ml 
fluorescein diacetate (FDA) stain and a hemocytometer under a fluorescence microscope 
(630 X, Leica Photofluorescence Microscope, Leitz Wetzlar, Germany). This method is 
based on the principle that only living cells cleave diacetate from FDA, which releases 
the fluorescein molecule that can be visualized under the fluorescence microscope. The 
amount of mRNA left at each time point after the addition of the transcriptional inhibitor 
was determined by Northern blot analysis as described before. The absolute amount of 
radiolabeled probe hybridized to specific bands was quantitated on a Betascope Blot 
Analyzer (Betagen, Mountain View, CA) and normalized to the amount of {3-actin 
mRNA. The efficiency of transcriptional inhibition was determined by rehybridizing the 
blot with H2b or c-myc probe, whose mRNA has a short half-life of 15 to 120-min (Old 
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and Woodlane, 1984; Dani et al., 1984a; Herrick and Ross, 1994). Thus, I should not 
detect H2b or c-myc mRNA at 2 hr after the addition of the drug. 
2.12.7 ORB Titration Experiment 
The ORB titration experiment was performed as following: FH cells were 
maintained in complete RPMI 1640 media. After counting, 2 ml of FH cells (at a density 
of 5 X 1<>5 cells/ml) were distributed into wells of 24-well Costar plate and kept for 1 hr 
at 37°C before addition of ORB (Calbiochem, San Diego, CA). The final concentration 
of ORB is 0, 0.12 mM, 0.24 mM, 0.48 mM and 0. 96 mM, respectively, from a stock 
solution of 120 mM in dimethyl sulfoxide (DMSO, Sigma). At 0 and 4 hr, 2 ml (about 
H>6) of cells were removed, centrifuged, and subjected to cytoplasmic RNA isolation by 
the NP-40/phenol method. Total viable cell counts at each time point and after overnight 
incubation were determined using 5 µg/ml fluorescein diacetate (FDA) stain and a 
hemocytometer under a fluorescence microscope (630 X, Leica Photofluorescence 
Microscope, Model LABOVERT FS, Leitz Wetzlar, Germany). The amount of H2b 
mRNAs left at each time points after the addition of the transcriptional inhibitor were 
determined by Northern blot analysis. The absolute amount of radiolabeled probes 
hybridized to specific bands was quantitated on a Betascope Blot Analyzer (Betagen, 
Mountain View, CA) and normalized to the amount of GAPDH mRNA. The inhibitory 
effect of DRB on transcription was also determined by rehybridizing the blot with a 32P 
nick-translated 1 kb Clal-Smal human c-myc cDNA probe (Dr. Jeff Ross), whose mRNA 
is transcribed from a single copy gene and has a short half-life. 
2.13 
2.13.1 
Analysis of Proteins 
Immunofluorescence Analysis 
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To detect cytoplasmic proteins, 1-5 X la4 cells in 200-300 µl of RPMI 1640 
media were centrifuged onto a glass slide at 1200 rpm for 3 minutes (Shandon centrifuge, 
London, England). After air-drying the pellets, cells were fixed in ethanol for 5 minutes, 
and rehydrated in PBSF solution (PBS - 0.1 % bovine serum albumin - 0.1 % NaN3) for 
at least 1 hr. The expression of transfected mouse heavy chain genes was detected by 
incubating the cells with 10 µl of 1 :20 diluted FITC-conjugated goat antibodies (50 
µg/ml) specific for mouse heavy chain isotypes in a wet chamber for 10 minutes at room 
temperature (Burrows et al., 1981). After mounting with Cytoseal (VWR Scientific, 
Media, PA), the fluorescence-labeled cells were examined under a fluorescence 
microscope (Leica Photofluorescence Microscope, Model LABOVERT FS, Leitz 
Wetzlar, Germany). 
To detect membrane proteins, 2 X 106 cells in suspension were incubated with 
fluorescein (FITC)-labeled goat anti-mouse IgM antibody for 20 minutes on ice. The cells 
were centrifuged and fixed onto a glass slide in absolute ethanol and overlaid with 
Cytoseal (VWR Scientific, Media, PA) as described above. 
2.13.2 Metabolic Labeling and Immunoprecipitation 
2.13.2.1 Solutions and Reagents 
RPMI labeling medium 500 ml Methionine-free RPMI 1640 
(GIBCO) 
10 X NET 
1 X NET/Triton (100 ml) 
0.1 M PMSF 
10 X NET lysis buffer 
50 ml Fetal calf serum (Hyclone) 
10 ml 200 mM L-Glutamine(GIBCO) 
0.5 ml 1 M Sodium pyruvate 
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5 ml 500 units/ml Penicillin-Streptomycin 
(GIBCO) 
2.5 ml 10 mM (1-mercaptoethanol 
500 mM Tris base, pH 7.4 
1.5 M NaCl 
50 mM NaEDTA 
1 % NaN3 
Store at -20°C 
10 ml 10 X NET 
2.5 ml 20% Triton X-100 in water 
Store at -20°C 
0.1 M in ethanol, store at -20°C 
500 mM 
1.5 M 
50mM 
Tris base, pH 7.4 
NaCl 
NaEDTA 
10% Staphylococcus aureus 
S. aureus wash buffer 
SDS sampling buffer 
1% 
0.5% 
0.1 M 
NaN3 
Triton X-100 
PMSF 
S. aureus in PBS and Azide 
50mM Tris, pH 8.2-8.5 
5mM EDTA 
0.5 mM NaCl 
0.02% NaN3 
0.1% SDS 
0.5% Triton X-100 
0.5% NaDOC 
lmM methionine 
supplemented with 1 mg/ml 
(albumin chicken egg, Sigma) 
0.0625 M Tris-HCI, pH 6.8 
5% {3-mercaptoethanol 
2.5% SDS 
0.002% bromophenol blue 
10% glycerol 
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ovalbumin 
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2.13.2.2 Procedure 
For continuous labeling, 1-3 X 106 cells were starved for 1 hr in 1 ml methionine-
free RPMI 1640 medium with 10% dialyzed FCS and then metabolically radiolabeled 
with 75 µCi/ml Trans-[35S] label (1076 Ci/mmol, ICN) for 30-180 min in 5% C02 at 
37°C. After washing, cells were lysed with NET lysis buffer supplemented with the 
protease inhibitor phenylmethylsulfonyl fluoride (PMSF, 1 mM) by incubating on ice for 
20 minutes. lg proteins were precipitated from cell culture supernatants and cell lysates 
with goat anti-mouse IgM (µheavy chain specific) (Southern Biotechnology Associates, 
Inc., Birmingham, AL). The incubation was carried out at 4 °C shaker for 2-3 hours 
(sometimes overnight), followed by with formalin-fixed and heated-denatured 10% S. 
aureus that was prepared as described by Kessler (Kessler, 1975). The S. aureus pellets 
were washed in S. aureus wash buffer for 2 to 3 times and low salt washing buffer (50 
mM Tris, pH=8.0) once (Burrow et al., 1981). The washed precipitates were 
resuspended in equal volumes of SDS sample buffer, boiled for 3 minutes, cooled in a 
water bath to room temperature, and analyzed by 10% SDS-PAGE under reducing or 
nonreducing conditions as described below. 
2.13.3 
2.13.3.1 
Protein SDS Polyacrylamide Gel Electrophoresis 
Solutions 
40% Acrylamide/1.07% BIS Solve 40 g acrylamide and 1.07 g 
bisacrylamide in about 90 ml water, heat 
slightly up to solve and make the volume to 
3M Tris, pH 8.8 
0.5 M Tris, pH 6.8 
10% APS 
10 X Laemmli electrode buffer 
2.13.3.2 Procedure 
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100 ml. Filter sterilizes and store at 4 °C in 
an aluminium foil-wrapped bottle. 
Solve 72.7 g Tris in 170 ml water, pH to 
8.8 with 5 N HCl and make the volume to 
200 ml. Filter sterilizes and store at 4 °c. 
Solve 6.05 g Tris in 80 ml water, pH to 6.8 
with 5 N HCl and make the volume to 100 
ml. Filter sterilizes and store at 4 °C. 
100 mg APS in an Eppendorf tube, add 1 ml 
water. Prepare fresh. 
0.25 M 
1.92 M 
1% 
Tris 
Glycine 
SDS 
The SDS polyacrylamide gel electrophoresis was carried out according to the 
method of Laemmli with modifications (Laemmli, 1970). Immunoprecipitated proteins 
from about 106 cells in sample buffer was loaded in each well. The separating· gel was 
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made of7.5-12.5% (w/v) acrylamide, 0.20-0.33% (w/v) N,N'-methylene bisacrylamide, 
0.375 M Tris-HCl (pH 8.8), 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium persulfate, 0.05% 
(v/v) TEMED. The stacking gel was made of 3.8% (w/v) acrylamide, 0.09% (w/v) 
bisacrylamide, 125 mM Tris-HCl (pH 6.8), 0.1 % (w/v) SDS, 0.1 % (w/v) ammonium 
persulfate, 0.05% (v/v) TEMED. The electrophoresis was run in a vertical slab gel 
electrophoresis unit (Hoefer Scientific, Model SE 600, San Francisco, CA) under a 
constant current of 10 mA/1.5 mm gel overnight, or 40 mA/ 1.5 mm gel for 
approximately 4-5 hours. The gels were fixed by shaking in 5 % glacial acetic acid and 
5% methanol for 30 min to 1 hour. The gel was incubated with Intensify solutions 
(EN3HANCE™ Autoradiography Enhancer, E.I. DuPont de Nemours & Co., Boston, 
MA): A for 40 minutes and solution B for 40 minutes with shaking at room temperature. 
The gel was then dried at 80 °C for 2 hours under vacuum in a slab gel dryer (Hoefer 
Scientific, Model SE 1160, San Francisco, CA). The dried gel was exposed to X-ray 
films (Kodak X-Omat OR) between 2 intensifier screens at -70 °C for appropriate time. 
Selected bands were quantitated by counting the radioactivity in dried gels with a 
Betascope blot analyzer. 
CHAPTER III 
IMMUNOGLOBULIN µ mRNA WITH A NONSENSE CODON IS DECREASED 
IN BOTH THE NUCLEUS AND THE CYTOPLASM OF PLASMA CELLS 
3.1 Characterization of the Cell Lines That Are Used in This Chapter 
The 18-81 cell line is the Abelson-virus-transformed mouse pre-B cell line that 
synthesizes only H chain (as well as some that synthesize no lg chain) (Alt et al., 1982; 
Burrow et al., 1981). The majority of cells synthesize µ chain, while some cells can 
switch fromµ to -y2b chain synthesis in vitro (Burrow et al., 1983). The 18-81 cell line 
is diploid for the H chain loci (Burrows et al., 1881) on chromosome 12 (Meo et al., 
1980). Both alleles have correctly joined VDJ segments, containing either a J2 or a J3 
gene segment (Alt et al., 1982; Burrow et al., 1983). Thus the variable region alleles are 
named V2 and V3, respectively. Cells of the 18-81 line usually express only the V3 
allele, because the V2 allele contains an amber nonsense codon codon in the Cµ2 exon 
(Alt et al., 1982). However, a few cells continuously produce H Chain from both alleles 
by reversion of the amber nonsense codon (Wahl et al., 1984; Jack and Wahl, 1987). 
In order to study the expression ofµ mRNA from a single allele, variants of the 
18-81 cell line that have switched from µ to -y2b chain synthesis were fused with the 
myeloma P3X63-Ag8.653 (called Ag8.653 here after, which has lost its functional lg 
genes) to generate hybridomas (Wahl and Burrows, 1984). This switch of heavy chain 
77 
78 
from µ to -y2b is accompanied by a loss of DNA sequences between the joining region 
and -y2b constant region gene segments, including the Cµ gene segments, on the V3 allele 
(Burrow et al., 1983). However, all these cells retain theµ gene without (FH) or with 
(VXH or CH2XH) a nonsense codon on the V2 allele (Jack et al., 1989). Thus, these 
hybridomas contain two alleles of lg genes: the V2 allele expresses µ transcript and the 
V3 expresses -y2b transcript. The genomic configuration of endogenous µ gene on the V2 
allele in hybridomas used in this chapter is diagrammed in Figure 1. Hybridoma FH has 
a functional µ gene that directs the synthesis of full-length µ chain. Hybridoma VXH has 
an amber nonsense codon (TAG) in its diversity (D) segment ofµ gene, and CH2XH has 
an opal nonsense codon (TGA) in the Cµ2 exon of µ gene. The gene dosage is 
approximately the same in the three hybridomas as determined by Southern blot analysis 
(Jack et al., 1989). One characteristic of the 18-81 cell line is that it has spontaneous 
deletions at the H chain locus at high rate (Jack and Wahl, 1987). The spontaneous 
deletions in the largest J8 -Cµ intron accumulate during growth in vitro (Alt et al., 1982; 
Burrow et al., 1983), and contribute to the different lengths of precursor µ transcript in 
hybridomas FH, VXH and CH2XH. The sizes of these deletions were determined by 
Southern blot analysis (Figure 2B), and are depicted in Figure la. 
Since hybridomas are polyploid cells that often lose chromosomes and 
spontaneous deletions at lg H chain locus occur at high rate, we subcloned all three 
hybridomas by limiting dilution just before using them in the experiments described 
below. The subclones were screened for the presence of the -y2b (that is expressed from 
the V3 allele) by cytoplasmic immunofluorescence (CIF) using Texas Red-labeled goat 
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anti-mouse -y2b. In the case of FH subclones, the expression ofµ chain was determined 
by CIF using FITC-labeled goat anti-mouse lgM antibodies. Since the µ chain is not 
expressed in hybridomas VXH and CH2XH. that contain nonsense codons in their µ genes 
on the V2 allele (Figure la), the presence of the µ gene in these hybridomas was 
determined by PCR using two sets of primers. Primer A and B amplified the genomic 
Cµ gene segments in the µ gene, and the resulting products are revealed in Figure 2A. 
One subclone from the µ-producing hybridoma FH, FH. 8, was used as a positive control. 
As shown in panel b of Figure 2A, we identified seven subclones of CH2XH. and five 
subclones of VXH, all of which contain the complete Cµ region of 2.0 kb (only visible 
on the original gel). The presence of variable region in all subclones was also confirmed 
by PCR using primers that are specific for the VH exon (Beck-Engeser, unpublished 
result). These data suggest that VH exon and the constant region ofµ genes are present 
in all subclones. 
To determine the size of the large JH-Cµ intron in theµ gene, we isolated cellular 
DNAs from various subclones, digested them with different restriction enzymes, and 
analyzed the DNA fragments containing lg gene segments using Southern blotting (Figure 
2B). We found thatµ gene in FH had a deletion of 1.3 kb and µgene in VXH had a 
deletion of 1. 85 kb when compared to the µ gene in CH2XH.. All these deletions are in 
the region of a 4.8 kb Hindlll fragment in the large JH-Cµ intron. However, the CH2XH. 
itself was shown to have a deletion of 4.25 kb in this region (Wabl and Burrows, 1984). 
The sizes of these deletions were determined by Southern blot analysis (Figure 2B), and 
are depicted in Figure la. 
Figure 1 
80 
Schematic Representations of DNA Structures, Hybridization Probes 
and p. Transcripts. (a) DNA structures of endogenous µ genes in 
hybridomas that are used in this Chapter. For the V2 allele that has a 
completely assembled µ gene, open boxed and interspersed lines 
designate, respectively, exons and introns of the mouse µ gene in 
hybridoma FH. The numbers above indicate the size of respective exons 
and introns in base pairs (not drawn to scale). Arrows above the structure 
specify the sites at which spontaneous point mutations have generated 
nonsense codons in the µ gene of hybridomas VXH and CH2XH. The 
variations of spontaneous deletions in the large JH-Cµ intron as determined 
by Southern blot analysis (Figure 2B) have also been shown with an 
inverted triangle above the structure. (b) Bold lines represent the DNA 
probes used in the hybridizations. (c) Expected sizes of precursor and 
matureµ transcripts. Pre, precursor transcript. TAG, an amber nonsense 
codon; TGA, an opal nonsense codon. 
a 
b 
c 
L1kb 
TAG - TGA FH 5.55 
(in VXH) VXH 6.10 (in CH2XH) 
4.25 
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i CH2XH 
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L VH81X D JH2 JH3 JH4 
J34 probe intron 
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Cµ1 
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Cµ2 Cµ3 
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Cµ4 pAS 
Expected sizes 
Preµ 1 AAA 7.3 kb 
Preµ 2 ~ / " / , AAA 2.8 kb 
µmRNA AAA 2.15 kb 
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-
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Figure 2A PCR Analysis to Screen for the Presence of Cµ. Gene Segments in 
Hybridoma Subclones. (a) Schematic representation of the positions of 
primers A and B used in the PCR and the expected size of PCR product. 
(b) DNA isolated from 2.5 x 104 cells of each subclone was amplified by 
PCR using 5'Cµl. Forward (Primer A) and 3'Cµ4. Backward (Primer B) 
primers (For primer sequences, see section 2.2.1.2.1) for 35 cycles under 
the following conditions for each cycle: denaturation at 94 °C for 20 
seconds; annealing at 65°C for 1 minute; extension at 72°C for 1 minute. 
The resulting products were resolved by electrophoresis in a 1 % TBE 
agarose gel and visualized by ethidium bromide staining. The Cµ gene 
segments (2.0 kb) were present in all sample lanes on the original gel, 
including lanes 5 to 8 and lanes 13 to 16 even though the bands are not 
visible in this figure. DNA isolated from F (the progenitor cell line) and 
FH (a hybridoma that contains a functionalµ gene) were used as positive 
controls. Asterisk (*) indicates nonspecific priming products of PCR. 
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Figure 2B 
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Southern Blot Analysis to Identify the Deletion in the J11Cp. lntron of 
p. Gene on the V2 Allele. (a) Restriction enzyme cleavage map of the 
embryonic DNA that contains the JH and Cµ gene segments. The DNA 
probes used in the hybridizations are diagrammed below. (b and c) 
Southern Blot Analysis of the hybridomas. High molecular weight DNA 
was isolated from the various hybridomas, digested to completion with 
different restriction enzymes, electrophoresed in a 0.8% agarose gel and 
transferred to nitrocellulose filters. The filters were hybridized with a µ 
cDNA probe (b), stripped and rehybridized with the J34 probe (c). The 
size of respective bands (in kb) was determined on a semi-logarithmic plot 
of the apparent size of standard DNA fragments versus their migration 
distance (indicated in kb). A copy of the autoradiogram (exposed for 2 
weeks at -70°C) for Cµ hybridization was used in panel b because the 
original film is lost (as suggested by Dr. H.M. Jack). The autoradiogram 
for J34 hybridization was exposed for 1 week at -70°C. Ba, BamHI; H, 
HindIII; E, EcoRI; Ag, Ag8.653 (the fusion partner). 
a 
b 
Cµ 
c 
J34 
H 
V2(6.8) 
5.0 
V2+ V3( 
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85 
B/E B 
86 
3.2 Nonsense Codons Decrease the Level ofµ mRNA but not Precursor µ 
RNA in Hybridomas 
To determine the level of µ RNAs expressed in the subclones, I isolated total 
cellular RNA by the Trizol method, and performed a Northern blot analysis using a Cµ 
cDNA probe (panel a in Figure 3A). The same blot was sequentially rehybridized to ')'2b 
and 13-actin probes after stripping (panel band c, respectively). Radioactivity of bands 
was determined by a betascope blot analyzer, which detects the counts per minute (cpm) 
of the bands. The relative amount ofµ mRNA ([µ]) was calculated by dividing the 
hybridization signal ofµ mRNA by the signal of 13-actin mRNA. Table 2A summarizes 
the results of Figure 3A. I found that all subclones that contain µ gene with nonsense 
codons produced less µ mRNA than the subclone that expresses productive µ gene (in 
hybridoma FH.8): subclones of hybridoma VXH produce about 30 fold lessµ mRNA, 
while subclones of hybridoma CH2XH produce about 125 fold less µ mRNA. These 
values are the averages calculated from four different subclones in Figure 3A. The 
expression ofµ mRNA also varied within subclones of the same hybridomas (e.g. lane 
7 to lane 10 in Figure 3A). The progenitor cell line 18-81 of the hybridomas acquires 
spontaneous deletions within the JH-Cµ intron during growth in vitro (Alt et al., 1982b; 
Burrow et al., 1983). Although the enhancer element in the JH-Cµ intron is not required 
for the a high level of H chain production (Wabl et al., 1984), the deletion around this 
region (Figure 2B) still might be responsible for the variation ofµ mRNA expression in 
subclones in Figure 3A. The levels of ')'2b mRNA ([')'2b] in Table 2A) also varied 
between subclones, probably for the same reason. From these data, I confirmed that the 
presence of a nonsense codon in the µ gene decreases the steady-state level ofµ mRNA 
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in plasma cells. 
In contrast to the decrease in the level of µ mRNA with a nonsense codon, I 
found that the presence of a nonsense codon did not decrease the level of precursor µ 
RNA ([preµ] in Table 2A). Since the transcriptional rates forµ gene with or without a 
nonsense codon are the same in hybridomas (Jack et al., 1989), this finding may result 
from theµ mRNA with a nonsense codon in the plasma cell being degraded faster than 
µ mRNA without a nonsense codon. Alternatively, the higher relative (rel) [preµ] level 
may result from a nonsense codon preventing the splicing of precursor µRNA. 
I also found that µ RNAs (including precursor µ RNA and µ mRNA) in 
hybridomas VXH and CH2XH (lane 5' and 7', respectively in Figure 3A) had different 
gel mobility thanµ RNAs in hybridoma FH (lane 6' in Figure 3A). Possible mechanisms 
that account for the differences in gel mobility of µ RNAs between hybridomas will be 
discussed and studied in detail in section 3. 4. 
Since the results of Northern blot analysis using total cellular RNA isolated by 
the Trizol method are sometimes not reproducible, I also isolated total cellular RNA by 
the conventional GIT/CsCl method, and quantified the levels ofµ RNAs by Northern blot 
analysis (Figure 3B). The results summarized in Table 2B are similar to those obtained 
by the Trizol method (Table 2A). The slower gel mobility of the precursorµ RNA and 
µ mRNA in hybridomas VXH and CH2XH than those in hybridoma FH is more obvious 
in Figure 3B than Figure 3A. 
In summary, the presence of nonsense codons decreases the level ofµ mRNA of 
the total cellular fraction in hybridomas by about 30 fold in VXH and about 100 fold in 
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CH2XH, when compared to the wild-type µ mRNA in hybridoma FH. Subclones FH. 8, 
VXH.10 (34 fold lower than FH. 8, calculated from the average of two experiments from 
Table 3A and 3B) and CH2XH.1 (16 fold lower than FH.8, calculated from the average 
of two experiments from Table 3A and 3B) were selected for further studies. Total 
cellular RNA will be only isolated by the GIT/CsCl method. 
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Figure 3A Northern Blot Analysis of Total Cellular RNA Isolated from Various 
Subclones. Total RNA from various subclones was isolated by the Trizol 
method. 5 µg of RNA was loaded onto each lane, electrophoresed on a gel 
(1.2% agarose; 1 X MOPS; 2.2 M formaldehyde), and transferred onto 
a nitrocellulose filter. The filter was hybridized, stripped, and 
rehybridized sequentially with 32P-labeled DNA probes. The filter was 
then washed, dried and exposed at -70°C to X-ray film between two 
intensifier screens. (a) Autoradiogram of the nitrocellulose blot that was 
hybridized with a Cµ cDNA probe, as indicated in Figure 1. Film was 
exposed for 18 hr at -70°C. The diminished exposure (film exposure was 
for 18 hr at room temperature) of lanes 5, 6 and 7 is shown on the right 
in Figure 3.1 as lanes 5', 6', and 7'. (b) The same blot was stripped, and 
rehybridized with a /j-actin probe to control for the amount of RNA 
loaded onto each lane. Film was exposed for 18 hr at room temperature. 
(c) The same blot was rehybridized with a ')'2b probe. Film was exposed 
for 24 hr at -70°C. (d) Ethidium bromide staining of the same gel 
revealed the integrity and the positions of pre-rRNA and rRNA markers. 
RNA standards used to determine the sizes of RNAs: 28S rRNA, 5.0 kb; 
18S rRNA, 1.84 kb (Rogers et al., 1981). The 4.4 kb in lane 6' (panel a) 
is present in several Northern blot analyses, although its identity is 
unknown. The results of this figure are summarized in Table 3A. 
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Table 2A Quantitation of Northern Blot Analysis in Figure 3A 
Hybridomas Method RNA Preµ µ 'Y 2b (3-actin rel [pre-µ] rel[µ] % [µ] [y 2b] 
loaded [cpm] {pre-µ/actin) (µ/actin) %FH.8 (y 2b/actin) 
FH.8 Trizol 5µg 4 1398.2 23.6 106.2 <0.1 13.2 100% 0.2 
VXH.12 Trizol 5µg 22.5 63.5 124.9 110.2 0.2 0.6 4.4% 1.1 
VXH.9 Trizol 5µg 19.2 32.6 108.7 34.8* 
VXH.10 Trizol 5µg 26.3 48.2 < 0.1 108.4 0.2 0.4 3.4% <0.1 
VXH.4 Trizol 5µg 19.5 22.7 125.8 124.8 0.2 0.2 1.4% 1.0 
VXH.1 Trizol 5µg 24.5 65.7 135.6 149.6 0.2 0.4 3.3% 0.9 
average 0.4 3.1% 
CH2XH.1 Trizol 5µg 8.2 30 16.8 132.9 0.1 0.2 1.7% 0.1 
CH2XH.12 Trizol 5µg 3.7 6.8 15.3 74.1 <0.1 0.1 0.7% 0.2 
CH2XH.13 Trizol 5µg 4.1 5.3 2.0 89.3 <0.1 0.1 0.5% <0.1 
CH2XH.11 Trizol 5µg 3.1 2.2 4.9 63.9 <0.1 0.0 0.3% 0.1 
average 0.1 0.8% 
Radioactivity of respective bands (cpm) was determined by betascope scanning of Northern blot analysis. 
Relative steady-state level ([x]) of respective RNA was calculated by dividing cpm of band x by cpm of (3-actin 
in the same lane. Background of respective bands have been subtracted. 
%[µ] is the percent of[µ] relative to that of FH.8 by setting FH.8 value equal to 100%. 
* Value is not included in the calculation for average because (3-actin hybridization is visibly not accurate. 
\0 
....... 
Figure 3B 
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Northern Blot Analysis of Total Cellular RNA Isolated from Various 
Subclones. Total RNA from various subclones was isolated by the 
GIT/CsCl method. 0.4 µ.g of RNA from FH and 8 µ.g of RNA from VXH 
and CH2XH were loaded onto each lane and Northern blot analysis was 
performed as described in Figure 3A using a Cµ. probe (panel a, film was 
exposed for 4 days at -70°C), or a /j-actin probe after stripping to control 
for the amount of RNA loaded onto each lane (panel b, film was exposed 
for 4.5 hr at -70°C), or a -y2b probe to detect the expression of -y2b 
mRNA (panel c, film was exposed for 18 hr at -70°C). In panel d, 
ethidium bromide staining of the agarose gel revealed the integrity and the 
positions of pre-rRNA and rRNA markers. Lane 7: Ag8.653 that does not 
express µ. mRNA was used as a negative control for µ. specific 
hybridization. The results of this figure are summarized in Table 3B. 
Asterisk (*) indicates an unidentified band that is hybridized to the Cµ. 
cDNA probe. 
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Table 28 Quantitation of Northern Blot Analysis in Figure 38 
Hybridomas Method RNA Preµ RNA µmRNA ~-actin mRNA relative pre-µ relativeµ 
loaded (cpm) (pre-µ/actin) (µ/actin) 
FH.8 GIT 0.4 µg 0.2 77.8 48.3 <0.1 1.6 
FH.1 GIT 0.4µg 1.1 40.6 29.0 <0.1 1.4 
VXH.12 GIT 8µg 4.6 25.5 425.3 <0.1 0.1 
VXH.10 GIT 8µg 3.8 27.4 717.2 <0.1 <0.1 
average <0.1 <0.1 
CH2XH.1 GIT 8µg 2.7 8.0 536.3 <0.1 <0.1 
CH2XH.13 GIT 8µg 1.5 13.6 711.0 <0.1 <0.1 
average <0.1 <0.1 
relativeµ 
{%) 
100.00A> 
87.0% 
3.7% 
2.5% 
3.1% 
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3.3 Nonsense Codons Reduce the Steady-state Level ofµ RNA in the Nucleus 
To determine whether the lower total steady-state level of µ mRNA with a 
nonsense codon results from either cytoplasmic or nuclear RNA reduction, I isolated 
RNA from the nuclear and cytoplasmic fractions, and quantified the levels ofµ RNA in 
the two subcellular compartments by Northern blot analysis. 
The isolation of nuclear RNA is a very difficult task, mainly because of its low 
abundance when compared with cytoplasmic RNA (Schilbler et al., 1978) and the 
technical difficulty in separating the nuclei from the endoplasmic reticulum in the 
cytoplasm. Endoplasmic reticulum binds the majority of cytoplasmic mRNA. Thus, I first 
compared several published methods to isolate nuclear RNA from hybridomas FH and 
CH2XH. Briefly, cell pellets from the lysate of NP-40-containing lysis buffer (the lysis 
buffer for cytoplasmic RNA isolation) were purified through 2 M sucrose cushion by 
either microcentrifugation or centrifugation, washed twice with PBS and taken as the 
crude nuclei. The nuclear RNA was isolated by either the GIT/CsCl or Trizol method, 
and quantified by Northern blot analysis (Figure 4). I found that the level of nuclearµ 
mRNA was visibly lower in CH2XH (lane 11 and 12 in panel b) when compared to that 
of FH (lane 4 to 7 in panel b). Since cytoplasmic RNA is about nine fold more abundant 
than nuclear RNA (Schilbler et al., 1978), this lower steady-state level of nuclear µ 
mRNA in CH2XH might result from either the nuclearµ mRNA level being lower, or 
the nuclear RNA measured in Figure 4 reflects the steady-state level of cytoplasmic RNA 
that was contaminated with nuclei during nuclear RNA isolation. Thus, I needed to 
establish a reliable protocol to exclude cytoplasmic RNA contamination in the procedure 
Figure 4 
96 
Comparison of Methods to Isolate Nuclear RNA from Hybridomas FH 
and CH2XH. Nuclei from FH and CH2XH were purified by either 
washing the pellets of NP-40 lysed homogenate twice with PBS (lane 5, 
6, 7, and 12) or centrifugation through a 2 M sucrose cushion in a 
microcentrifuge tube (lane 4 and 11). Nuclear RNA was either isolated by 
the GIT/CsCl method (lane 5, 6, and 12) or the Trizol method (lane 4, 7, 
and 11). Total RNA was isolated by either the Trizol method (lane 1 and 
8) or the GIT/CsCl method (lane 2 and 9). Cytoplasmic RNA was isolated 
by the NP-40/phenol method (lane 3 and 10). 5 µg of RNA from FH or 
10 µg RNA from CH2XH was loaded onto each lane and Northern blot 
analysis was performed as described in the legend to Figure 3A. (a) 
Ethidium bromide staining of a representative gel shows the integrity and 
the positions of pre-rRNA and rRNA markers. The identity of rRNA 
precursors (45S and 35S) is suggested by the sizes of RNAs measured on 
the autoradiogram correlate with the published sizes of precursor rRNAs 
(Penman, 1966). (b) Autoradiogram (65 hr exposure) of the nitrocellulose 
blot that was hybridized with a Cµ cDNA probe. (c) The same blot was 
rehybridized with a -y2b probe. Film was exposed for 24 hr at -70°C. (d) 
After stripping, the same blot was rehybridized with a (j-actin probe to 
control for the amount of RNA loading onto each lane. Film was exposed 
for 45 hr at -70°C. T, total cellular RNA; C, cytoplasmic RNA; and N, 
nuclear RNA. Since the hybridomas FH and CH2XH used in this 
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experiment were not subcloned after a long time in culture, the amounts 
of ')'2b expression are different from those shown in Figure 3A. 
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of nuclear RNA isolation in order to evaluate the level of nuclear RNA. Since the use 
of microcentrifugation and the Trizol method did not generate reproducible results (Li 
and Jack, unpublished results), I chose a 2 M sucrose cushion centrifugation method to 
purify the nuclei and the GIT/CsCl method to isolate nuclear RNA in future experiments. 
Since the outer membrane of nuclei is continuous with the membrane of the 
endoplasmic reticulum in the cytoplasm (Amstein and Cox, 1992), an efficient way to 
eliminate the cytoplasmic RNA contamination is to remove the outer nuclear membrane 
in the nuclear RNA isolation procedure. Thus I used ionic and nonionic detergents to 
remove the outer membrane of the nuclei (Nevins, 1980) and subsequently used 0.88 M 
(Birnie, 1978) or 2 M (Nevins, 1980) sucrose cushion centrifugation to remove the 
cytoplasmic RNA, polyribosomes, the outer membranes of nuclei and endoplasmic 
reticulum from the nuclei. As shown in Figure 5c by ethidium bromide staining of the 
agarose gel, I found that the rRNA precursors (45S and 35S) were enriched and the 
ratios of 28S rRNA to 18S rRNA were visibly increased in the nuclear RNA preparation 
of FH Oane 4 and 5). This suggested that the preparation was enriched in the nuclear 
fraction (Penman, 1966). The removal of cytoplasmic components was determined by 
phase-contrast microscopy after each step of nuclear RNA isolation. Representative 
photographs are shown in Figure 6. I found that there were no obvious cytoplasmic tabs 
in the examined fields after I purified the nuclei. I also attempted to examine the removal 
of outer nuclear membrane by electron microscopy (Holtzman, 1966) with the help of 
Dr. McNulty's laboratory. Due to the difficulty in counting enough nuclei to ensure their 
purity and DNase I-mediated disruption of the chromosome structure inside the nuclei, 
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I decided to use a novel approach to determine the removal of cytoplasmic components 
in nuclear RNA isolation. 
As discussed above, one efficient way to ensure the purity of nuclear RNA is to 
eliminate all cytoplasmic components in the procedure of nuclear RNA isolation. Since 
the nuclear and cytoplasmic fractions of the same cell type contain the same type of 
RNAs, it is hard to distinguish the nuclear RNA from the cytoplasmic RNA. However, 
hybridoma FH expresses only the heavy chain but no light chain of lg. Thus by mixing 
cytoplasmic RNA isolated from plasmacytoma J558L (that expresses only a lambda (A) 
light chain but no heavy chain) with the cell homogenate of hybridoma FH, I was able 
to determine whether my modified nuclear RNA isolation protocol can efficiently remove 
the exogenous cytoplasmic RNA. The main steps are illustrated in Figure 5A. Briefly, 
I mixed the cell homogenate from 2.5 X 107 hybridoma FH (that expresses onlyµ but 
no A mRNA) with post-nuclear supernatant containing cytoplasmic RNA either in 
polyribosome-bound form or free mRNA form isolated from same number of cells of 
plasmacytoma J558L (that expresses only A but noµ mRNA). The mixture was then 
subjected to the nuclear RNA isolation procedure, and the amount of A mRNA by 
Northern blot analysis was quantified by Northern blot analysis and betascope scanning. 
The extent of cytoplasmic RNA contamination was determined by comparing the signal 
of A mRNA in nuclear RNA isolated from FH (lane 5 in Figure 5B, panel a) to the signal 
of A mRNA in cytoplasmic RNA isolated from the same number of J558L cells (lane 6 
in panel a of Figure 5B and Table 3A). The amount of nuclear µ mRNA isolated from 
the mixture (lane 5 in panel b) was comparable to that of FH (lane 4 in ·panel b), 
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suggesting equal amounts of RNA were loaded in lane 4 and 5. These results are 
summarized in Table 3A. I found that the amount of cytoplasmic >.. RNA contamination 
in nuclear RNA isolated from FH was 0.001 % in the polyribosome-bound form of 
cytoplasmic RNA (experiment 2) and 0.009% in the free cytoplasmic mRNA form 
(experiment 1). Thus I concluded that the extent of cytoplasmic RNA contamination to 
the nuclear RNA isolation can be ignored in my modified protocol. 
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Nuclear RNA Isolation Procedure 
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Quantitation of the Extent of Cytoplasmic mRNA Contamination in 
Purified Nuclei by Northern Blot Analysis. Cell homogenate from 2.5 
X 107 hybridoma FH in 5 ml lysis buffer was mixed with either 5 ml post-
nuclear supernatant (for the polyribosome-bound cytoplasmic RNA) or 
cytoplasmic RNA extract (for the free cytoplasmic RNA) isolated from the 
same number of cells of plasmacytoma J558L, and the mixture was 
subjected to the subsequent established nuclear RNA isolation procedure 
as described in section 2.12.3.2. 8 µg of RNA was loaded onto each lane 
and Northern blot analysis was performed as described in the legend to 
Figure 3A. Table 3 summarizes the results of two independent 
experiments. (a) Autoradiogram of a representative nitrocellulose blot that 
was hybridized with a VAl probe. (b) The same blot was rehybridized 
with a Cµ cDNA probe to control for the amount of nuclear RNA (lane 
4 and 5) loaded onto each lane of the blot. (c) Ethidium bromide staining 
of the gel revealed the amount of RNA loaded on the gel, and the integrity 
and positions of pre-rRNA and rRNA markers. 
b 
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Table 3 Quantitation of the Amount of Cytoplasmic RNA 
Contamination in the Purified Nuclei (Fig 58) 
Experiment 1 
Cell line FH FH.Nuc+ 
RNA Isolation Total Cytoplasmic Nuclear JSSSL.Cyto 
RNA loaded (µg) 8 8 8 8 
Cell# (xl05) loaded 3.6 6.6 55.5 84.4 
At mRNA (cpm) <0.1 <0.1 0.2 2.5 
µ mRNA(cpm) 388.3 319.6 30.4 21.7 
(A.] (A./µ) <0.1 0.1 
[A.]/105 Cells <0.1 <0.1 
% (A.] left <O.l <0.1 
Experiment 2 
Cell line FH FH.Nuc+ 
RNA Isolation Total Cytoplasmic Nuclear J558L.Cyto 
RNA loaded (µg) 8 8 8 8 
Cell# (:1.105} 3.6 10.2 57.0 67.0 
At mRNA (cpm) <0.1 <0.l <O.l 3.7 
µ mRNA(cpm) 1681.7 1264.6 180.7 107.9 
[A] (A./µ) <0.1 <0.1 
(A]/105 Cells <0.1 <0.1 
% [A.] left <0.1 <O.l 
105 
JS58L 
Cyto 
8 
11.85 
1368.3 
7.8 
175.4 
14.8 
100.0 
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c 
8 
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37.6 
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Representative Photographs of Nuclei in the Nuclei Isolation 
Procedure. Intact cells of hybridoma FH (in panel a) were lysed in 5 ml 
NP-40 lysis buffer, and the resulting cell homogenate was centrifuged 
through a 0.88 M sucrose cushion to isolate nuclei (termed "crude 
nuclei"). Only about 5% of the crude nuclei had visible cytoplasmic tabs 
(in panel b). The outer membrane of crude nuclei was removed by ionic 
and nonionic detergents and pure nuclei were purified by centrifugation 
through either a 0.88 M or a 2 M sucrose cushion as illustrated Figure 
5A. None of the nuclei examined had visible cytoplasmic tabs. A 
representative picture is showed in panel c. All of the photographs were 
viewed at the same magnification (more than 1 OOX). 
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Representative Photographs of Nuclei 
in the Procedure of Nuclear RNA Isolation 
b 
C 
-s 
lOS 
By the established methods diagrammed in Figure 7, I isolated RNA from 
different compartments of hybridomas and analyzed the RNA by Northern blot analysis 
as revealed in Figure S. The Northern blot was first hybridized to a Cµ cDNA probe 
(Figure Sb). The relative amounts ofµ mRNA in each lane (Figure Sb) were normalized 
to the levels of {j-actin hybridization signal (Figure Sd). The steady-state levels ofµ RNA 
in each subcellular compartment (obtained from three Northern blot analyses of two 
independent RNA isolations) are summarized in Table 4 and illustrated in a bar graph 
(Figure St). I found that in both mutant hybridomas (VXH and CH2XH), the nuclear 
levels of nonsense codon-containing µ mRNA (lane 7 and lane 10 in Figure S, 
respectively; nuclear[µ] in Table 4) were decreased by about 7 fold as compared to the 
functionalµ mRNA in hybridoma FH Qane 4, p < 0.01). This suggests that lg mRNA 
with a nonsense codon starts to decrease in the nucleus. The same parameters as 
discussed before, such as the presence of enriched rRNA precursors and the increased 
ratio of 2SS to lSS rRNA (Figure Sa) and the lack of visible cytoplasmic tabs to the 
purified nuclei as determined by phase-contrast microscopy (data not shown), were used 
to determine the removal of cytoplasmic components in the nuclear RNA isolation 
procedure. In addition, since mature histone mRNA is exported rapidly to the cytoplasm 
(Sun et al., 1992), I should find the amount of H2b is lower in the nuclear fraction than 
in the cytoplasmic fraction of RNA isolations. Thus I rehybridized the Northern blot with 
a H2b probe and found the levels of H2b mRNA in nuclear fractions were low as 
predicted (lane 4, 7, and 10 in Figure 8e; H2b in experiment 2 of Table 4). 
The presence of precursor µ RNA in all fractions of hybridomas in Figure 8b was 
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verified by rehybridizing the blot with an intron probe (1.0 kb Xbal fragment of the lgH 
enhancer in the large JH-Cµ intron) as shown in Figure 8c. The presence of precursorµ 
RNA in the cytoplasmic fraction may result from the cytoplasmic RNA being 
contaminated with nuclear RNA during the isolation procedure. This possibility could not 
be ruled out by the lack of precursor 45S and 35S rRNAs in the RNAs isolated from the 
cytoplasmic fraction (lane 4, 7 and 10 in panel a of Figure 8), since the precursor rRNAs 
are processed in the nucleolus which is unlikely affected by the removal of nuclear 
membrane (Sommerville, 1986). However, the amount of nuclear lg RNA is only about 
one ninth that of the cytoplasmic lg RNA (Schibler et al., 1978). Thus the cells loaded 
in lanes of cytoplasmic RNA were far less than those of the nuclear RNA. Therefore, 
the majority of precursor µ RNA in Figure 8b and 8c should not have resulted from 
nuclear RNA contamination. Alternatively, the presence of precursor µ RNA is a unique 
phenomenon in hybridoma cells used in this study. Usually unspliced precursor RNAs 
are not exported from the nucleus, presumably by the effect of spliceosome-retention 
(Legrain and Rosbash, 1989; Green, 1991). However, the transport of precursor RNA 
can be facilitated by some RNA-binding proteins. The best example is the Rev protein, 
which binds to a specific sequence in the precursor RNA of human immunodeficiency 
virus-1 and facilitates viral precursor RNA nuclear export (Malim et al., 1989). The 
mechanism for the presence of precursor µ RNA might also be mediated by a Rev like 
protein. 
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Northern Blot Analysis to Quantify the Steady-state Levels of RNAs 
in Subcellular Compartments of Hybridomas. Total RNA was isolated 
by the GIT/CsCl method (lane 1, 2, 5, and 8). Cytoplasmic RNA was 
isolated by the NP-40/phenol method (lane 3, 6, and 9). Nuclear RNA 
was isolated by established protocol as described in section 3.3.3.2 (lane 
4, 7, and 10). 8 µ.g of RNA was loaded on each lane and Northern blot 
analysis was performed as described in the legend to Figure 3A. Table 4 
summarizes the results from three Northern blot analyses of two 
independent RNA isolations. (a) Ethidium bromide staining of a 
representative gel shows the amount of RNA loaded, and the integrity and 
positions of pre-rRNA and rRNA markers. (b) Autoradiogram (exposure 
time was 7 days at -70°C) of the nitrocellulose blot that was hybridized 
with a Cµ. cDNA probe (as shown in Figure 1). The diminished exposure 
(16 hr) of FH RNA (lanes 2, 3, and 4) was shown on the right as lanes 
2', 3', and 4'. (c) The identity of precursor µ.transcripts was verified by 
rehybridizing the blot with an intron probe in the large J8 -Cµ. intron (as 
illustrated in Figure lb) after stripping. Film was exposed for 8 days. (d) 
The same blot was rehybridized with a (3-actin probe after stripping to 
control for the loading of RNA. Film was exposed for 6 hr. (e) The same 
blot was rehybridized with a H2b probe to determine the level of H2b 
mRNA in different fractions of RNA isolation. Film was exposed for 3 
days. Lane 1: Ag8.653 that expresses noµ. RNA was used as a negative 
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control for µ specific hybridizations. By comparing RNA to RNA size 
markers (as indicated at left), I estimated the size of each RNA (as 
indicated at right). The mechanism for precursor µ RNA present in the 
cytoplasmic fractions of hybridomas (lane 3, 6, and 9) is unknown. (t) A 
bar chart indicates the levels ofµ transcripts in subcellular compartments 
relative to the wild-type µ RNAs in FH. The means and standard errors 
were calculated from the results of three Northern blot analyses of two 
independent RNA isolations and are listed in the summary tables in Table 
4 (the levels ofµ RNAs for each experiment in FH is defined as 100%, 
see [µ] and [pre µ] in Table 4). *: p < 0.01 when compared to the 
control in FH (Newman-Keuls' multiple range test). 
a 
28s 
18s 
c 
28s 
18s 
d 
e 
~o.;, 
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~458 
~358 
~288 
~188 
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~Preµ 
(7 .1-7.5 kb) 
•. ~µ(-2.1 kb) 
2' 3' 4' 
~Preµ (7.1-7.5 kb) 
~ µ (-2.1 kb) 
~ ~-actin (2.0 kb) 
~ H2b (0.5 kb) 
1 2 3 4 5 6 7 8 9 10 
Table 4. Steady-State Levels of RNA Transcripts 
Experiment 1 
Hybridoma RNA µ ere p.4 enh 4 H2b Jl·actin (µ]2 •,4[µ]3 [pre µ]2 %[pre µ]3 [enh) [Blb) 
Loaded [cpm]1 (µ/actin) % FH.8 (µ/actin) %FH.8 
a. Total Cellular RNAs 
FB.8 0.4 µg 70.6 N.D. N.D. N.D. 19.4 3.6 100.0 100.0 
VXH.10 8µg 27.0 13.3 1.8 N.D. 403.2 0.1 1.8 <0.1 <0.1 
CH2XB.l 8 f:l8 10.4 5.9 0.9 N.D. 571.0 <0.1 0.5 <0.1 <0.1 
b. Cyto2lasmic RNAs 
FB.8 0.4 µg 33.6 N.D. N.D. N.D. 15.0 2.2 100.0 100.0 
VXH.10 8 µg 21.4 8.4 1.1 N.D. 292.6 0.1 3.3 <0.1 <0.1 
CH2XH.1 8µg 10.3 4.4 0.6 N.D. 470.0 0.0 1.0 <0.1 <0.1 
c. Nuclear RNAs 
FB.8 8µg 54.0 4.8 N.D. N.D. 23.7 2.3 100.0 0.2 100.0 
VXB.10 8µg 9.7 17.7 2.2 N.D. 34.0 0.3 12.5 0.5 257.0 0.1 
CH2XH.l 8 µg 4.6 7.8 1.4 N.D. 30.5 0.2 6.6 0.3 126.3 <0.1 
1. Radioactivity of respective bands ([ cpm]) was determined by a betascope blot analyzer. 
2. [µ]and (preµ) were calculated by dividing cpm ofband µor preµ by cpm of Jl-actin in the same lane. 
3. %(µ)and %[preµ] are the percent of[µ] and [preµ] of respective cell line related to those ofFH.8 
4. preµ, precursorµ~ enh, enhancer. 
....... 
....... 
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Table 4. Steady-State Levels of RNA Transcripts (Continued) 
A. Experiment 2 (Figure 8) 
Hybridoma RNA µ ere ll4 enh4 Hlb P-actin [µ)2 %[µ]3 [pre µ)2 %[pre µ)3 [enh] [Hlb] 
Loaded [cpm]1 (µ/actin) % FH.8 (µ/actin) %FH.8 
a. Total Cellular RNAs 
FH.8 8 µg I74 2.6 1.9 5.0 497.9 0.3 100.0 <0.1 100.0 <0.1 <0.1 
VXH.10 8 µg 4.9 2.4 5.1 7.4 553.2 <O.I 2.5 <O.I 83.I <0.1 <0.1 
CH2XH.1 8 µg 2.5 1.6 2.4 6.0 661.6 <0.1 I. I <0.1 46.3 <0.1 <0.1 
b. ~to~lasmic RNAs 
FH.8 8 µg 58.9 1.4 0.6 9.5 414.I O.I 100.0 <O.I 100.0 <O.I <O.I 
VXH.10 8 µg 3.6 1.5 2.8 5.3 335.4 <O.I 7.5 <O.I 132.3 <0.1 <0.1 
CH2XH.1 ~g 2.4 1.4 1.8 7.0 440.5 <0.1 3.8 <0.1 94.0 <0.1 <O.I 
c. Nuclear RNAs 
FH.8 8 µg 5.9 0.5 1.3 1.3 34.4 0.2 100.0 <0.1 100.0 <0.1 <0.1 
VXH.10 8 µg 2.2 3.5 7.7 I.I 64.8 <O.I 19.8 O.I 371.6 0.1 <O.I 
CH2XH.1 8 µ~ 1.5 2.4 3.6 1 44.3 <0.1 19.7 O.I 372.7 O.I <0.1 
1. Radioactivity of respective bands ([ cpm]) was determined by a betascope blot analyzer. 
2. [µ]and [preµ] were calculated by dividing cpm of bandµ or preµ by cpm of P-actin in the same lane. 
· 3. %[µ]and %[preµ] are the percent of[µ] and [preµ] of respective cell line related to those ofFH.8 
4. preµ, precursorµ; enh, enhancer. 
,..... 
,..... 
VI 
Table 4. Steady-State Levels of RNA Transcripts (Continued) 
A. Experiment 3 
Bybridoma RNA 
Loaded 
µ pre 11' enh' Blb Jl-actin [µ)2 %(µ] 3 [pre µ)2 %[pre µ] 3 (enb] 
[ cpm]1 (µ/actin) % FH. 8 (µ/actin) % FH.8 
a. Total Cellular RNAs 
FH.8 8µg 2186 84.1 N.D. N.D. 656.5 3.3 100.0 0.1 100.0 
VXH.10 8 µg 60.0 23.9 N.D. N.D. 617.2 0.1 2.9 <0.1 30.2 
CHlXB.1 8 µg 30.3 8.1 N.D. N.D. 753.5 <0.1 1.2 <0.1 8.4 
b. Cytoplasmic RNAs 
FH.8 8 µg 1696 27.4 N.D. N.D. 461.5 3.7 100.0 0.1 100.0 
VXH.10 8µg 42.7 15.4 N.D. N.D. 499.5 0.1 2.3 <0.1 51.9 
CHlXB.1 8 µg 14.6 2.5 N.D. N.D. 185.l 0.1 2.1 <0.1 22.7 
c. Nuclear RNAs 
FH.8 8 µg 230.7 13.4 N.D. N.D. 58.1 4.0 100.0 0.2 100.0 
VXH.10 8mg 12.6 18.5 N.D. N.D. 38.1 0.3 8.3 0.5 210.5 
CH2XB.1 8ma 10.1 13.4 N.D. N.D. 24.8 0.4 10.3 0.5 234.3 
1. Radioactivity of respective bands ([cpm]) was determined by a betascope blot analyzer. 
2. [µ)and [preµ) were calculated by dividing cpm of bandµ or preµ by cpm of P-actin in the same lane. 
3. %[µ]and %(preµ] are the percent of[µ] and [preµ] of respective cell line related to those ofFH.8 
4. pre µ, precursor µ~ enb, enhancer. 
[Blb] 
...... 
...... 
O"I 
Summary of The Relative Steady-State Levels ofµ RNA 
Total Cellular µ Cytoplasmic µ 
FH.8 VXH.10 CH2XH.1 FH.8 VXH.10CH2XH.1 
Exp 1 100.0 1.8 0.5 100.0 3.3 1.0 
Exp2 100.0 2.5 1.1 100.0 7.5 3.8 
Exp3 100.0 2.9 1.2 100.0 2.3 2.1 
Mean 100.0 2.4 0.9 100.0 4.4 2.3 
SE 0.3 0.2 2.8 1.4 
Nuclearµ 
FH.8 VXH.10 CH2XH.1 
100.0 12.5 6.6 
100.0 19.8 19.7 
100.0 8.3 10.3 
100.0 13.5 12.2 
5.8 6.8 
,.... 
,.... 
-.....l 
Quantitation of 1..1 Transcripts 
in Subcellular Compartments 
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3.4 Cytoplasmic Decay Rates ofµ. mRNA With or Without a Nonsense Codon 
Since cytoplasmic degradation could be an independent event from nuclear 
degradation, I further determined whetherµ. mRNA with a nonsense codon is degraded 
in the cytoplasm of plasma cells in addition to the reduction observed in the nucleus. The 
cytoplasmic decay rates ofµ. mRNA were measured using two transcriptional inhibitors 
(Actinomycin Cl, Figure 9A and DRB, Figure 9B). 
Actinomycin Cl is a transcriptional inhibitor that blocks all DNA-dependent RNA 
polymerases by binding to guanine-rich region of duplex DNA (Perry and Kelly, 1970). 
Although various effects of Actinomycin Cl on mRNA stability have been reported in 
the literature (Belasco and Brawerman, 1993), 5 µ.g/ml of Actinomycin Cl was shown 
to almost completely inhibit the transcription in FH cell lines within an hour as measured 
by the [3H] uridine incorporation into RNA (Jack, 1988). Cytoplasmic RNA was isolated 
from the cells at 0, 4, and 8 hrs after addition of Actinomycin Cl to the culture. The 
levels ofµ. mRNA left in the cells were determined by Northern blot analysis using a Cµ. 
cDNA probe (Figure 9Aa). The amount ofµ. mRNA was quantitated by a betascope blot 
analyzer. The size of GAPDH mRNA is smaller thanµ. mRNA. Although the amount 
of GAPDH expressed in three different hybridomas is different, it remains the same 
within the same hybridomas. Thus GAPDH was used instead of /3-actin as the control for 
RNA loading at different time points of the same hybridoma (panel bin Figure 9A). The 
results from three independent experiments are summarized in Table 5A. I found that the 
relative level ofµ. mRNA ([µ.]) with a nonsense codon decreased by about 1.5 fold in 
both VXH and CH2XH during the 8-hour drug treatment. In contrast, the relative level 
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of µ mRNA without a nonsense codon was increased in the FH cell line during the 8-
hour drug treatment. This increase probably occurs because GAPDH mRNA, which has 
a half-life of 8 hr (Dani et al., 1984b), is less stable than functionalµ mRNA (that has 
a half-life of 13-34 hr) (Mason et al., 1988; Cox and Emtage, 1989; Genovese and 
Milcarek, 1990). The almost undetectable amount of GAPDH at 8 hr after addition of 
Actinomycin Cl probably accounts for the two-phase decay rate of µ mRNA in 
hybridoma VXH. Alternatively, VXH might be more sensitive to Actinomycin Cl 
treatment. At 4 hr and 8 hr after addition of the drug, rRNAs were degraded in 
hybridoma VXH as evidenced in lane 6 and 7 of panel e in Figure 9A. Thus it would be 
wise to isolate cytoplasmic RNA between time points 0 to 4 hr while the RNA in 
hybridoma VXH are not degraded. 
DRB, an adenosine analogue, is a protein kinase inhibitor, which only blocks the 
initiation of RNA polymerase II-mediated transcription (Zandomeni et al., 1983; 
Chodosh et al., 1989; Dubois et al., 1994). It does not influence the transcription of 
tRNA and rRNA (Zandomeni et al., 1983). I used this drug as an alternative to measure 
the decay rate ofµ mRNA without or with a nonsense codon. Unlike Actinomycin Cl, 
0.12 mM of DRB was shown to inhibit only the transcription of mRNA but not rRNA 
in the FH cell line within an hour as measured by the [3H] uridine incorporation (Jack, 
1988). As shown in Figure 9B and summarized in Table 5B, the half-life ofµ mRNA 
with a nonsense codon was decreased from being relatively stable in FH to 3-4 hours in 
hybridomas VXH and CH2XH during 8 hour-treatment. 
As time went by, µ mRNA in hybridomas VXH and CH2XH migrated faster 
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through the gel (panel a in Figure 9A and 9B). The degradation of mRNA in eukaryotic 
cells is initiated by endonucleolytic cleavage, by shortening of the poly A tail, or by 
decapping. Among them, control of poly A tail length has an important effect on RNA 
degradation. For some mRNAs, decapping requires prior deadenylation (Jackson, 1993). 
Thus the progressive shortening ofµ mRNA as a result of ribonuclease digestion most 
likely results from µ mRNA deadenylation. However, premature translational termination 
in yeast can trigger deadenylation-independent mRNA decapping (Muhlrad and Parker, 
1994). Thus it is also possible that µ mRNA with a nonsense codon is degraded by 
deadenylation-independent decapping mechanism. 
The inhibitory effect of Actinomycin Cl or DRB on transcription in each 
experiment was evaluated by rehybridizing the same blot with probes that detected the 
mRNAs with short half-lives of 15 to 30 minutes, including Histone 2b (Old and 
Woodland, 1984) or c-myc (Dani et al., 1984a; Herrick and Ross, 1994) (panel c and 
d, respectively, in Figure 9A and Figure 9B). I found that the levels of c-myc mRNA 
were visibly decreased with time in panel d of both Figure 9A and 9B, suggesting that 
the transcriptional inhibitors (Actinomycin Cl and DRB) efficiently blocked the 
transcription of mRNAs in each experiment. The differences in the size of c-myc mRNA 
in different cell lines are probably attributable to differential DNA rearrangements at the 
myc oncogene locus (Shen-Ong et al., 1982). The amount of H2b mRNA decreased 
significantly after 4 hours of treatment with Actinomycin Cl, which is consistent with 
the reported half-life of H2b mRNA as discussed above. Surprisingly, the amount of H2b 
mRNA was exceptionally stable after 8 hours of treatment with DRB. 
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Figure 9A Northern Blot Analysis of Cytoplasmic Decay Rates of p. RNA in 
Hybridomas by Using the Actinomycin Cl Method. Cytoplasmic RNA 
was isolated from 5 X H>6 cells at 0, 4, and 8 hours after the addition of 
Actinomycin Cl (5 µg/ml) to the culture, and analyzed by Northern blot 
analysis as described in the legend to Figure 3A. Table 5A summarizes 
the results from three independent RNA isolations. As time went by, the 
mRNAs migrated faster through the gel because they became 
progressively shorter as a result of ribonuclease digestion. Only the 
darkest band ofµ mRNA in each lane was quantified. (a) Autoradiogram 
(exposure time was 7 days at -70°C) of a representative nitrocellulose blot 
that was hybridized with a Cµ cDNA probe. (b) The same blot was 
rehybridized with a GAPDH probe to control for RNA loading onto each 
lane of the blot. Film was exposed for 10 days. The inhibitory effect of 
Act C 1 on transcription in each experiment was determined by 
sequentially rehybridizing the blot with a H2b probe (panel c, exposure 
time was 15 hr) or a 1 kb ClaI-SmaI human c-myc cDNA probe (panel d, 
exposure time was 7 days). The virtual disappearance of H2b, c-myc 
mRNAs at 4 hr in lanes 2, 6 and 9 shows that they were degraded faster 
thanµ mRNA in FH. (e) Ethidium bromide staining of the gel revealed 
the integrity and positions of pre-rRNA and rRNA markers. Lane 4: 
Ag8.653 was used as a negative control forµ specific hybridization. 
a 
Cytoplasmic Decay Rates 
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Table SA. Cytoplasmic Decay Rates of RNAs (the Actinomycin C1 Method) 
Hybridoma Time RNA µ H2b c-myc GAPDH [µ] %[µ] [H2b] %[H2b] 
(hr) Loaded (cpm] %t=O %t=O 
FH.8 t=O Exp 1 4 µg 262.4 12.1 0.9 5.0 52.5 100.0 2.4 100.0 
Exp 2 8 µg 297.6 83.4 N.D. 31.2 9.5 100.0 2.7 100.0 
Exp 3 8 µg 1041 161 N.D. 59.5 17.5 100.0 2.7 100.0 
FH.8 t=4 Exp 1 4 µg 289.1 1.2 0.2 4.5 64.2 122.4 0.3 11.0 
Exp 2 8 µg 239.6 0.4 N.D. 20.8 11.5 120.8 <0.1 0. 7 
Exp 3 8 µg 924.2 35.2 N.D. 60.1 15.4 87.9 0.6 21.7 
mean 
SE 
110.3 
8.7 
FH.8 t=8 Exp 1 4 µg 158.6 <0.1 0.1 1.7 93.3 177.8 <0.1 
Exp2 8µg 131.1 <0.1 N.D. 12.2 10.7 112.7 <0.1 
Exp 3 8 µg 443.5 17.6 N.D. 27.5 16.1 92.1 0.6 
VXH.10 
VXH.10 
VXH.10 
CH2XH.1 
CH2XH.1 
mean 
SE 
t=O Exp 1 8 µg 
Exp2 8µg 
Exp3 8µg 
t=4 Exp 1 8 µg 
Exp2 8 µg 
Exp3 8 µg 
mean 
SE 
t=8 Exp 1 8 µg 
Exp2 8µg 
Exp3 8µg 
mean 
SE 
t=O Exp 1 8 µg 
Exp2 8µg 
Exp3 8 µg 
t=4 Exp 1 8 µg 
Exp2 8 µg 
Exp3 8µg 
mean 
SE 
CH2XH.1 t=8 Exp 1 8 µg 
Exp2 8µg 
Exp3 8 µg 
mean 
SE 
14.5 26.8 3.0 
9.7 168 N.D. 
6.4 155 N.D. 
7.0 2.2 1.4 
2.9 21.8 N.D. 
3.7 39.3 N.D. 
1.7 <0.1 0.7 
1.5 13.8 N.D. 
2.3 24.0 N.D. 
4.9 23.3 2.3 
7.7 149 N.D. 
6.8 95.1 N.D. 
2.7 3.0 0.6 
2.4 14.7 N.D. 
2.7 47.7 N.D. 
1.4 <0.1 0.3 
0.8 13.6 N.D. 
1.5 45.2 N.D. 
7.1 
39.9 
15.2 
4.7 
19.6 
18.8 
0.6 
7.6 
9.3 
3.3 
22.6 
17.2 
2.6 
7.9 
15.7 
1.2 
4.2 
8.0 
2.0 
0.2 
0.4 
1.5 
0.1 
0.2 
2.8 
0.2 
0.2 
1.5 
0.3 
0.4 
1.0 
0.3 
0.2 
1.2 
0.2 
0.2 
127.5 
19.3 
100.0 3.8 
100.0 4.2 
100.0 10.2 
72.9 0.5 
60.9 1.1 
46.7 2.1 
60.2 
5.2 
138.7 <0.1 
81.2 1.8 
58.7 2.6 
92.9 
17.6 
100.0 7.1 
100.0 6.6 
100.0 5.5 
69.9 1.2 
89.2 1.9 
43.5 3.0 
67.5 
9.3 
78.6 <0.1 
55.9 3.2 
47.4 5.7 
60.6 
6.9 
11.1 
4.1 
<0.1 
<0.1 
23.7 
7.9 
6.1 
100.0 
100.0 
100.0 
12.4 
26.4 
20.6 
19.8 
2.8 
<0.1 
43.1 
25.4 
22.8 
8.8 
100.0 
100.0 
100.0 
16.3 
28.1 
54.9 
33.1 
8.4 
<0.1 
49.0 
102.2 
. 50.4 
19.9 
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Figure 9B 
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Northern Blot Analysis of Cytoplasmic Decay Rates of p. RNA in 
Hybridomas Using the DRB Method. Cytoplasmic RNA was isolated 
from 5 X 106 cells at 0, 4, and 8 hours after the addition of DRB (0.12 
mM) to the culture. 4 µg of RNA from FH and 8 µg of RNA from VXH 
and CH2XH were loaded onto each lane and Northern blot analysis was 
performed as described in the legend to Figure 9A. Table 5B summarizes 
the results from three independent RNA isolations. As time went by, the 
mRNAs migrated faster through the gel because they became 
progressively shorter as a result of ribonuclease digestion. Only the 
darkest band ofµ mRNA in each lane was quantified. (a) Autoradiogram 
(exposure time was 7 days) of a representative nitrocellulose blot that was 
hybridized with a Cµ cDNA probe. (b) The same blot was rehybridized 
with a GAPDH probe to control for the amount of RNA loaded onto each 
lane of the blot. Film was exposed for 8 days. The inhibitory effect of 
DRB on transcription in each experiment was determined by sequentially 
rehybridizing the blot with an H2b probe (panel c, exposure time was 15 
hr) or a c-myc probe (panel d, exposure time was 8 days). The virtual 
disappearance of H2b, c-myc mRNAs at 4 hr in lane 2 shows that they 
were degraded faster thanµ mRNA in FH. (e) Ethidium bromide staining 
of the gel revealed the integrity and positions of pre-rRNA and rRNA 
markers. Lane 4: Ag8.653 was used as a negative control forµ specific 
hybridization. 
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Table 58. Cytoplasmic Decay Rates of RNAs (the ORB Method, Figure 98) 127 
Hybridomffime 
(hr) 
RNA µ H2b c-myc GAPDH [µ] %[µ] 
Loaded [cpm] o/ot=O 
FH.8 
FH.8 
FH.8 
VXH.10 
VXH.10 
VXH.10 
t=O Exp 1 4 µg 304.2 17.9 3.6 
Exp 2 8 µg 977.6 30.8 N.D. 
Exp 3 8 µg 541.4 31.1 N.D. 
t=4 Exp 1 4 µg 316.8 15.0 1.0 
Exp 2 8 µg 921.9 23.8 N.D. 
Exp 3 8 µg 2260 70.5 N.D. 
mean 
SE 
t=8 Exp 1 4 µg 182.1 7.8 0.9 
Exp 2 8 µg 942.3 28. 7 N.D. 
Exp 3 8 µg 1926 59.1 N.D. 
mean 
SE 
t=O Exp 1 8 µg 14.1 35.6 7.4 
Exp 2 8 µg 26.8 76.7 N.D. 
Exp 3 8 µg 16.0 62.5 N.D. 
t=4 Exp 1 8 µg 
Exp2 8µg 
Exp3 8 µg 
mean 
SE 
3.7 23.1 
3.4 25.0 
12.5 124 
3.9 
N.D. 
N.D. 
t=8 Exp 1 8 µg 1.8 13.3 2.1 
Exp 2 8 µg 5.9 30. 7 N.D. 
Exp 3 8 µg 3.1 30.4 N.D. 
mean 
SE 
CH2XH.1 t=O Exp 1 8 µg 8.5 57.6 5.2 
Exp 2 8 µg 22.9 86.9 N.D. 
Exp3 8 µg 11.7 74.6 N.D. 
CH2XH.1 t=4 Exp 1 8 µg 
Exp2 8 µg 
Exp3 8µg 
mean 
SE 
2.3 42.5 2.1 
7.1 55.2 N.D. 
6.3 64.3 N.D. 
CH2XH.1 t=8 Exp 1 8 µg 1.8 31.2 1 
Exp 2 8 µg 5.2 57.2 N.D. 
Exp 3 8 µg 2.4 33.5 N.D. 
mean 
SE 
9.6 31.7 100.0 
18.0 54.3 100.0 
16.2 33.4 100.0 
5.5 57.6 181.8 
11.8 78.1 143.9 
62.9 35.9 107 .5 
144.4 
14.4 
4.7 38.7 122.3 
12.3 76.6 141.1 
57.3 33.6 100.6 
121.3 
8.0 
7.2 2.0 100.0 
29.8 0.9 100.0 
38.7 0.4 100.0 
5 
9.2 
87.4 
0.7 37.8 
0.4 41.1 
0.1 34.6 
37.8 
1.3 
3.7 0.5 24.8 
14.5 0.4 45.2 
19.2 0.2 39.1 
36.4 
4.4 
8.1 1.0 100.0 
27.2 0.8 100.0 
42.2 0.3 100.0 
5.1 0.5 43.0 
20.0 0.4 42.2 
53.2 0.1 42.7 
42.6 
0.2 
4.7 0.4 36.5 
15.8 0.3 39.1 
28.4 0.1 30.5 
35.4 
1.9 
[H2b] %[H2b] 
o/ot=O 
1.9 100.0 
1.7 100.0 
1.9 100.0 
2.7 146.3 
2.0 117.9 
1.1 58.4 
107.5 
18.9 
1.7 89.0 
2.3 136.4 
1.0 53.7 
93.0 
16.7 
4.9 100.0 
2.6 100.0 
1.6 100.0 
4.6 93.4 
2.7 105.6 
1.4 87.9 
95.6 
3.8 
3.6 72.7 
2.1 82.3 
1.6 98.0 
84.3 
5.3 
7.1 100.0 
3.2 100.0 
1.8 100.0 
8.3 117.2 
2.8 86.4 
1.2 68.4 
90.6 
10.2 
6.6 93.4 
3.6 113.3 
1.2 66.7 
91.1 
9.4 
Figure 9C 
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Cytoplasmic Decay Rates of p. mRNA in Hybridomas by the Use of 
Actinomycin Cl or DRB Method (Continued). 
The amount ofµ mRNA remaining in the cells after the addition of the 
drug at each time point was determined by a betascope blot analyzer, and 
normalized to the amount of GAPDH mRNA. Only the darkest band of 
µ mRNA in each lane was quantified. The relative amount ofµ mRNA 
([µ]) at 0 hr was defined as 100% and later time points were calculated 
as a percentage thereof. The log of these relative µ mRNA levels after 
addition of the drug was plotted as a function of time by SigmaPlot 5.0. 
The values represent the means of three independent RNA isolations and 
the error bars represent the standard errors of the mean. Solid circles, 
triangles and squares denote the curves obtained from the experiments 
depicted in Figure 9A and Table 5A; open circles, triangles and squares 
denote the curves obtained from the experiments depicted in Figure 9B 
and Table 5B. 
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Histone genes are intronless multicopy genes which encode small basic 
polypeptides that are essential elements of the eukaryotic nucleosome (Marzluff and 
Hanson, 1993). Unlike other eukaryotic mRNAs, histone RNAs in most organisms do 
not have poly A tails but instead contain a conserved stem-loop sequence at their 3' end 
(Marzluff and Pandey, 1988). All histone mRNAs with this 3' end stem-loop structure 
are regulated coordinately with DNA synthesis, mainly by changing the stability of 
histone mRNA (Gallwitz, 1975). Histone mRNA levels increase rapidly at the onset of 
DNA synthesis, and decline equally rapidly at the end of DNA synthesis. The levels 
varies 30- to 50-fold during the cell cycle (Marzluff and Pandey, 1988). Thus, the 
finding that the amount of H2b mRNA remained relatively stable during the 8 hour-
treatment with DRB might result if: 1) the concentration of DRB used in the experiment 
was not enough to block the transcription of abundant H2b mRNA or, 2) the regulation 
of H2b mRNA decay is different from those ofµ and c-myc mRNAs in the case of DRB 
treatment. To distinguish between these possibilities, I treated hybridoma FH with 
increasing concentrations of DRB (0, 0.12 mM, 0.24 mM, 0.48 mM and 0.96 mM, 
respectively), and quantified by Northern blot analysis the amount of H2B mRNA left 
at 0 and 4 hr after addition of DRB (Figure 10). If the concentration of DRB I used 
before (0.12 mM) was not enough to block all H2B mRNA transcription in FH, I would 
expect to find the amount of H2B mRNA left in the cells would decrease as the 
concentration of DRB increased. If the H2B mRNA is subjected to different regulation 
pathway, I would expect to find that the increased concentration of DRB has no 
significant effect on H2B mRNA level. As shown in panel a and summarized in panel 
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d of Figure 10, the increased concentration of DRB did not alter the amount of H2b 
mRNA (panel a in Figure 10). In contrast, the same amount of DRB reduced the amount 
of c-myc mRNA. From these data, I conclude that the exceptionally stable amount of 
H2b mRNA during the 8 hour-treatment with DRB is not due to DRB concentration too 
low to block the transcription of abundant H2b mRNA. Instead it might result from the 
metabolism of H2b mRNA being subjected to a different regulation pathway from that 
ofµ or c-myc mRNA. 
Figure 10 
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Northern Blot Analysis to Determine the Effect of DRB Concentration 
on the Level of H2b mRNA. After counting, 2 ml of FH cells (at a 
density of 5 X 1<>5 cells/ml) were distributed into wells of 24-well Costar 
plate and kept for 1 hr at 37°C before addition of DRB. The final 
concentration of DRB is 0, 0.12 mM, 0.24 mM, 0.48 mM and 0.96 mM, 
respectively. At 0 and 4 hr, 2 ml (about H>6) of cells were removed, 
centrifuged, and subjected to cytoplasmic RNA isolation by the NP-
40/phenol method. 8 µg of RNA was loaded onto each lane and Northern 
blot analysis was performed as described in the legend to Figure 9A. (a) 
Autoradiogram of the nitrocellulose blot that was hybridized with an H2b 
probe. (b) The same blot was rehybridized with a GAPDH probe to 
control for the amount of RNA loaded onto each lane of the blot. To 
quantify the effect ofDRB on transcription, the blot was rehybridized with 
a c-myc probe. Lane 4: Ag, Ag8.653, total RNA isolated from Ag8.653 
(that expressed no µ mRNA). (c) The amount of RNA loaded in each 
lane, and the integrity and positions of pre-rRNA and rRNA markers were 
visualized by staining with ethidium bromide. ( d) A graph. The relative 
amount of H2b or c-myc mRNA without DRB treatment at 0 hr was 
defined as 100% and later H2b or c-myc mRNA amounts were calculated 
as a percentage thereof. The relative H2b or c-myc mRNA levels after 
addition of DRB was plotted as a function of concentration by SigmaPlot 
5.0. 
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3.5 Nonsense Codons Affect the Size ofµ mRNA 
I showed previously thatµ mRNA in hybridomas VXH and CH2XH (lane 5' and 
7', respectively in Figure 3A) had slower gel mobility than µ mRNA in hybridoma FH 
(lane 6' in Figure 3A). The differences in gel mobility ofµ mRNA may be attributed to 
the different amounts of RNA loaded on the agarose gel (0.4 µg for FH and 8 µg for 
VXH and CH2XH). This possibility was further studied by a mixing experiment (Figure 
11). I made five serial dilutions of 1:5 each of 5 µg RNA isolated from FH and 
compensated for the amount of RNA in each lane to 5 µg by the addition of RNA 
isolated from Ag8.653 (that does not expressµ mRNA). With equal amounts of RNA 
loaded onto each lane, I still detected differences in the size ofµ mRNA in hybridomas 
VXH and CH2XH from FH (panel a in Figure 11). Thus, I concluded that the differences 
in gel mobility of µ mRNA in different subclones were not due to different amounts of 
RNA loaded on the agarose gel. 
Alternatively, the difference in gel mobility of µ mRNA may result from the 
observation that µ mRNA in hybridomas VXH and CH2XH is larger in size than µ 
mRNA in FH. There are several possibilities which may explain the larger size of µ 
mRNA in hybridomas VXH and CH2XH (that contain nonsense codons in theirµ genes), 
such as: 1) the µ transcripts in different hybridomas use different transcriptional start 
sites, 2) the µ transcripts in different hybridomas use different polyadenylation sites or 
the length of their poly A tail is different, or 3) the presence of a nonsense codon 
prevents the splicing of small introns that are in the constant region ofµ RNA, which 
results in the increase in the size ofµ mRNA by 300 to 500 hp. The last possibility was 
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studied here by using 3 sets of primers that are specific for the coding region of µ 
mRNA. If the presence of a nonsense codon prevents the splicing of small introns in the 
constant region ofµ RNA, I should be able to detect the RT-PCR products from 
hybridomas VXH and CH2XH as being bigger than that from hybridoma FH. As shown 
in Figure 12, all RT-PCR products detected by 3 sets of primers were the same in all 
hybridomas. Thus, I suggest that the presence of a nonsense codon does not prevent the 
splicing of small introns in the constant region ofµ mRNA, which may contribute to the 
size increase in µ mRNA with a nonsense codon in hybridomas VXH and CH2XH. 
The possibility that the presence of a nonsense codon affects the use of different 
polyadenylation sites in µ gene or the length of the poly A tail in µ mRNA was studied 
by ribonuclease H digestion. Ribonuclease H is an enzyme that digests duplex RNAs. 
Total cellular RNA isolated from different hybridomas was incubated with oligo d(T), 
which hybridizes to the poly A tail. By treating the mixture with ribonuclease H, the 
RNA-DNA duplex of poly A tail and oligo d(T) was digested away. If the larger size of 
µ mRNA in hybridomas VXH and CH2XH (that contain nonsense codons in their µ 
genes) results from it having a longer poly A tail than that ofµ mRNA in hybridomas 
FH, they should have the same gel mobility after the ribonuclease H treatment. This was 
exactly what we found (data not shown). Thus, I conclude that the presence of a 
nonsense codon can influence the length of poly A tail in µ mRNA, which contributes, 
at least in part, to the slower gel mobility ofµ mRNA in hybridomas VXH and CH2XH. 
The remaining possibility is that the length of the 5'-untranslated regions may be 
influenced by a nonsense codon. This hypothesis can be studied by RNase protection 
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analysis using a probe that is specific for the 5'-untranslated region ofµ RNA. 
All these mechanisms that account for the size differences in µ mRNA can also 
apply to the size differences in precursorµ RNA. Since the precursorµ RNA contains 
introns, the variations in the size of introns, such as different deletions in the large JH-
Cµ intron on the V2 allele as discussed before, may be attributed to the size differences 
in precursor µ RNA with or without a nonsense codon. As revealed by Southern blot 
analysis, the µ gene in FH has a deletion of about 1.3 kb and VXH has a deletion of 
about 1.85 kb when compared to that of CH2XH (Figure 2B). Based on these results, I 
suggest that the various deletions in the large JH-Cµ intron on the V2 allele attribute, at 
least partially, to the size differences between precursor µ RN As with (in hybridomas 
VXH and CH2XH) or without a nonsense codon (FH). However, the relationship between 
the presence of a nonsense codon and deletion in the large JH-Cµ intron of µ gene is 
unknown. 
Figure 11 
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Northern Blot Analysis to Test the Effect of RNA Loading on 
Mobility. Total RNA isolated from hybridoma FH. 8 was serially diluted 
at 1:5 five times (lane 2, 3, 4, 5, 6, and 7), and then the amount of RNA 
was compensated by total RNA isolated from Ag8.653 (that does not 
expressµ transcripts) for 5 µgin each sample. The same amount of total 
RNA isolated from hybridomas VXH and CH2XH was also loaded on the 
gel and Northern blot analysis was performed as described in the legend 
to Figure 3A. (a) Autoradiogram (exposed for 72 hr) of the nitrocellulose 
blot that was hybridized with a Cµ cDNA probe. (b) The same blot was 
rehybridized with a GAPDH probe to control for the amount of RNA 
loaded onto each lane of the blot. Film was exposed for 24 hr. With equal 
amounts of RNA loaded onto each lane, there are still differences in the 
size of µ mRNA in hybridomas VXH and CH2XH from FH (panel a). 
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Figure 12 
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RT-PCR ~y to Compare the Length of Coding Region inµ mRNAs 
with or without a Nonsense Codon. 5 µg total cellular RNA isolated by 
the GIT/CsCl method from each hybridoma was used for cDNA synthesis. 
1120 (0.2 µg) of cDNA product from FH and 1/10 (0.5 µg) of cDNA 
product from VXH and CH2XH were amplified by RT-PCR as described 
in section 2.8.2, and the resulting products were resolved by 
electrophoresis in a 1 % TAB agarose gel and visualized by staining with 
ethidium bromide in panel a. All RT-PCR products detected by 3 sets of 
primers are the same as expected in three hybridomas. Panel b depicts a 
schematic representation showing the positions of three sets of primers 
that were used in RT-PCR and the expected sizes of RT-PCR product. 
Asterisk(*) indicates nonspecific priming products of RT-PCR. Primer A 
and Bare the same as described in the legend to Figure 2. Primer C is the 
VH81X. Forward primer, while primer D is the Cµ2Bam. Backward 
primer. All the sequences are listed in section 2.2.1.2.1. 
a 
b 
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3.6 Discussion 
Nonsense codons in mRNA are known to be recognized during translation in the 
cytoplasm. Nonsense codons have been shown to decrease the cytoplasmic steady-state 
level of µ mRNA by 60 to 100 fold (Jack et al., 1989). Since metabolism of µ mRNA 
with a nonsense codon is regulated by post-transcriptional mechanisms (Jack et al. , 
1989), this lower cytoplasmic steady-state level ofµ mRNA with a nonsense codon can 
result from either a nuclear or a cytoplasmic event, or both. The data presented in this 
chapter demonstrate that µ mRNA with a nonsense codon is reduced in both the nucleus 
and the cytoplasm of plasma cells. The involvement of a nuclear process in the nonsense 
codon-mediated RNA degradation has been extensively discussed in Chapter I. Thus this 
section of the dissertation focuses on the interpretation of the results obtained in this 
chapter. 
3.6.1 lg mRNA with a Nonsense Codon Starts to Decrease in the Nucleus of 
Plasma Cells 
To determine the level of nuclear RNA, one needs to exclude the cytoplasmic 
components in the procedure of nuclear RNA isolation. Since the outer membrane of 
nuclei is continuous with the membrane of the endoplasmic reticulum in the cytoplasm 
(Amstein and Cox, 1992), the outer membrane of nuclei should be removed with the 
cytoplasmic components. An ideal way to monitor the removal of cytoplasmic 
components to use specific markers for inner and outer nuclear membranes to stain the 
nuclei before and after preparation. If the outer membrane of nuclei has been exclusively 
removed, we would expect to find no staining of outer nuclear membrane after the 
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purification procedure. Although over 1,000 proteins have been reported in the nuclear 
pore (Forbes, 1992; Rout and Wente, 1994), our laboratory does not have these specific 
markers. In addition, our laboratory does not have a specific marker to detect 
polyribosome contamination in the nuclei preparation. Thus, I used an alternative 
approach to quantify the amount of cytoplasmic RNA contamination in the modified 
nuclear RNA isolation protocol (section 2.12.3.2 in Chapter II; Nevins, 1980; Birnie, 
1978; Penman, 1966). As shown in Figure 5B and summarized in Table 3A, I found that 
the cytoplasmic contamination in nuclear RNA preparation was less than 0.01 % , 
suggesting the effect of cytoplasmic RNA contamination on nuclear RNA isolation can 
be ignored in our current protocol. The removal of cytoplasmic components was also 
determined by several parameters, such as the absence of cytoplasmic tabs as revealed 
by the phase contrast microscopy (Figure 6), the presence of enriched rRNA precursors, 
the increased ratio of 28S to 18S rRNA (Figure 8a), and the decreased level of H2b 
mRNA (Figure 8e) in the nuclear RNA samples. 
As shown in Figure 8 and summarized in Table 4, I found that the nuclear µ 
mRNA levels of µ mRNA with nonsense codons (in hybridomas VXH and CH2XH) are 
decreased by about 7 fold when compared to that ofµ mRNA without a nonsense codon 
(in hybridoma FH). This lower steady-state level ofµ mRNA in hybridomas VXH and 
CH2XH does not result from the hybridomas having defects in the expression of mRNA 
or protein, because hybridomas VXH and CH2XH express comparable amounts of -y2b, 
H2b and c-myc mRNAs (Table 4 and Table 5) and -y2b protein (Beck-Engeser, 
unpublished result). Thus, I conclude that the reduction in the level ofµ mRNA with a 
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nonsense codon starts in the nucleus of plasma cells. 
The lower nuclear level of µ mRNA with nonsense codons could result from 1) 
µ mRNA with a nonsense codon being degraded faster in the nucleus; 2) the presence 
of a nonsense codon preventing the processing of precursor µ transcripts to µ mRNA; 
or, 3) both. Due to the low abundance of nuclear RNA, I did not measure the nuclear 
decay rate ofµ mRNA by the use of a transcriptional inhibitor. However, the second 
possibility is consistent with the finding that the steady-state level of nuclear precursor 
µ RNA with a nonsense codon increases by at least 2 fold over that of precursor µ 
transcript without a nonsense codon (Table 4). It has been reported that histone pre-
mRNA is rapidly degraded if it is not productively processed (Pandey et al., 1994), 
therefore, the effect of a nonsense codon on µ RNA processing could be more severe 
than what I found. In addition, I found that the length of precursor µ transcripts is 
independent of the position of a nonsense codon in the µ gene: In both VH.stop- and 
Cµ2.stop-containing hybridomas, precursorµ RNAs retain the large JH-Cµ intron (Figure 
8c). This evidence suggests that a nonsense codon does not specifically prevent the 
splicing of its downstream sequences. Instead, the accumulation of precursor µ transcripts 
probably results from interaction between the nonsense codon recognition system with 
the splicing system. 
A similar phenomenon has also been reported by Cheng and Maquat (1993). They 
found deletion of all splice sites that reside downstream of a nonsense codon does not 
abrogate the nonsense codon-mediated reduction of TPI mRNA. I do not know, however, 
whether there is a specific sequence in the large JH-Cµ intron that is subjected to the 
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regulation of the nonsense codon recognition system. The inhibitory effect of a nonsense 
codon on the splicing of precursor RNA transcripts has also been reported in the 
literature (Naeger et al., 1992, Lozano et al., 1994). Accumulation of the precursor 
RNAs has also been noticed by other groups studying the expression of T cell receptor 
fi gene (personal communication with Dr. Miles F. Wilkinson) and AHFR gene (Kessler 
et al., 1993) in mammalian systems. 
The presence of precursor µ transcripts that are 300-500 bp smaller than the 
largest precursor µ transcript in each hybridoma suggests that the splicing of primary µ 
transcript does not occur in the 5' to 3' order. Instead, the splicing of this large intron 
at proximal 5' end may occur after the splicing of small introns in the constant region 
of the µ gene. This is consistent with studies which show that the size of the intron and 
exon influence the efficiency of splicing: in eukaryotic genes that contain large exons 
(i.e. 300 bp in Cµ exons ofµ gene), an increase in the size of an intron correlates with 
decreased splicing efficiency (personal communication with Dr. Susan Berget). Out of 
order splicing has also been reported in other systems (Beyer and Osheim, 1988; 
Bingham, 1993). 
3.6.2 µ mRNA with a Nonsense Codon is Degraded Faster Than µ mRNA 
Without a Nonsense Codon in the Cytoplasm of Plasma Cells 
The best method to measure the decay rate of a mRNA is to use metabolic 
labeling. However, our previous experiments failed because uridine is toxic to B cells 
(Jack, unpublished data). Alternatively, I used two well established inhibitors of RNA 
synthesis to measure the cytoplasmic decay rates ofµ mRNA (Figure 9). Both DRB and 
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higher concentrations of Actinomycin Cl (over 5 µg/ml) were found to inhibit the 
phosphorylation of the C-terminal domain of the largest subunit of eukaryotic RNA 
polymerase II in Hela cells exposed to heat shock, which results in inhibition of 
transcription in Hela cells (Dubois et al., 1994). In contrast to the studies that show 
nonsense codons do not influence the cytoplasmic decay rates of mRNA (see review in 
Chapter I), I found that the levels ofµ mRNA with nonsense codons are decreased by 
about 1.5 fold during the 8-hour drug treatment of Actinomycin Cl, while the level of 
µ mRNA without a nonsense codon remains relatively stable during this period (Table 
5). In the case of DRB treatment, the half-life of µ mRNA decreases from relatively 
stable in FH (that contains functional µ mRNA) to 3 to 4 hr in VXH and CH2XH (that 
contain nonsense codons in theirµ mRNAs) during the 8 hr-treatment. Based on these 
data, I conclude that µ mRNA with nonsense codons is degraded faster than that without 
a nonsense codon. This is consistent with the assumption that the only identified 
translational machinery resides in the cytoplasm of an eukaryotic cell, thus mRNA with 
a nonsense codon should be recognized and degraded in the cytoplasm. 
In addition, I noticed the differences in the half lives ofµ mRNA when they were 
measured by the two transcriptional inhibitors. I proposed that the differences are 
probably due to the fact that Actinomycin Cl reduces the levels of cytoplasmic mRNAs 
more dramatically than DRB (compareµ and GAPDH hybridizations in the Figures 9A 
and 9B). Thus, the lower level of GAPDH mRNA at 8 hour after Actinomycin Cl 
treatment is not accurate enough to serve as a loading control to normalize the level of 
µ mRNA. This problem may be overcome by the use of a stable mRNA (such as 28S 
146 
rRNA or /3-actin mRNA) as a loading control. The levels of 28S rRNA on the gel can 
be visibly compared in panel e of Figure 9A and 9B, where rRNAs are revealed by 
ethidium bromide staining. 
3.6.3 DRB Does Not Influence the RNA Metabolism of H2b Gene 
The fact that the amount of H2b mRNA left in FH cells did not decrease as the 
concentration of DRB was increased (Figure 10) suggests that the metabolism of H2b 
mRNA is subjected to a different regulation pathway in the presense of DRB. The DRB-
specific stabilized effect of H2b mRNA would result if: a) DRB blocks the transcription 
of a short-lived degradation factor that is specific for histone mRNA; or b) DRB, a 
nucleotide analogue of adenosine, blocks the RNA binding site on H2b-specific RNA 
degradation factor, and thus inhibits the nuclease activity of the enzyme (personal 
communication with Dr. Jeff Ross). Dr. Ross' lab has recently purified a biochemically 
activated nuclease that is specific for histone mRNA. He is going to test whether DRB 
specifically blocks the histone-specific RNA degradation by using H2b mRNA +I- DRB 
as substrates of the nuclease activity of the purified protein. If DRB blocks the histone-
specific nuclease, they should find a high level of H2b mRNA when they include DRB 
in the substrate, while a low level of H2b mRNA when there is no DRB in the substrate. 
Alternatively, c) DRB may block the translation of the H2b mRNA. It has been shown 
that the degradation of histone mRNA is mediated by a ribosome-associated nuclease. 
Translation is needed to bring the nuclease to its specific substrate on the mRNA (Graves 
et al., 1987). Thus DRB can also exert its effect by inhibiting the translation process of 
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H2b mRNA. This hypothesis can be tested by an 35S methionine pulse-chase experiment. 
If DRB blocks the translation of H2b mRNA, I would expect to see a decrease in the 
level of 35S methionine-labeled H2b protein. d) DRB may not block the transcription of 
H2b mRNA. This hypothesis may be tested by a nuclear run-on experiment. If DRB does 
not block the transcription of DRB, I would expect to see the normal 3H-uridine 
incorporation of H2b mRNA after addition of DRB. 
I have summarized the findings of this Chapter in Figure 13. Briefly, I found that 
the reduction of cytoplasmic level of µ mRNA with a nonsense codon in plasma cells 
results from both a nuclear and a cytoplasmic event. In the nucleus, the presence of a 
nonsense codon inhibits the splicing of the largest J8 -Cµ intron in precursorµ RNA. In 
the cytoplasm, degradation is attributed to the lower cytoplasmic level ofµ mRNA with 
nonsense codons. This is the first report that has shown that both nuclear and cytoplasmic 
events are involved in the nonsense codon-mediated mRNA degradation. This could be 
a very unique phenomenon for lg mRNA. Thus, B cells have more than one mechanism 
to eliminate nonproductive lg mRNAs, which may contribute to the potent efficiency of 
humoral immune response. 
Figure 13 
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A Schematic Representation of µ RNA Metabolism in Plasma Cells. 
Two different splicing pathways for functional µ RNA (left) orµ RNA 
with a nonsense codon (right) in plasma cells. The genomic organization 
of the murine µ gene is presented at the top. Exons are represented by 
open boxes, and introns by solid lines. X designates the presence of a 
nonsense codon. Forµ transcript with a nonsense codon (i.e., a functional 
µ RNA), the presence of a nonsense codon prevents the splicing of the 
largest JH-Cµ intron in primary transcript, which might contribute to the 
lower nuclear level ofµ mRNA. Lower amounts ofµ mRNA escapes to 
the cytoplasm, where it is subjected to rapid cytoplasmic degradation. The 
effect of a nonsense codon on either nuclear degradation or nucleus-to-
cytoplasm export ofµ mRNA has not been determined. 
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CHAPTER IV 
TEST OF A MODEL TO EXPLAIN THE MECHANISM BY WHICH 
JG µ mRNA WITH A NONSENSE CODON 
IS DECREASED IN THE NUCLEUS OF PLASMA CELLS 
4.1 Introduction 
In Chapter III, I found that µ mRNA with a nonsense codon is decreased in both 
the nucleus and the cytoplasm of plasma cells. The presence of a nonsense codon 
prevents the splicing of the large J8 -Cµ intron. However, I have not elucidated how a 
nonsense codon can signal the reduction ofµ mRNA in the nucleus. Several models have 
been proposed to explain the mechanism of the nonsense codon-mediated mRNA 
degradation (see Chapter I). The main objective of this chapter is to determine whether 
the modified translational translocation model (Figure 14) is the mechanism by which a 
nonsense codon triggers the reduction of µ mRNA in the nucleus. 
Based on the assumption that cytoplasmic translational machinery is the only 
identified factor that can recognize a nonsense codon, Urlaub et al. (1989) proposed a 
translational translocation model. I have modified Urlaub's model to accommodate our 
secretory µprotein. As a secretory protein, µprotein is first synthesized as a precursor 
bearing an N-terminal signal peptide (also called leader peptide) (Kuby, 1994). Shortly 
after its synthesis, the signal peptide binds to the signal recognition particle (SRP) in the 
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cytoplasm. The SRP also interacts with the ribosome in which the nascent peptide 
resides, thus pausing theµ. protein translation in the free polysome fraction. There are 
many SRP-receptors and signal sequence receptors on the surface of endoplasmic 
reticulum (ER). The binding of theµ. mRNA-ribosome-bound SRP to its receptor targets 
the µ. mRNA-ribosome complex to the surface of ER. This targeting releases the 
translational pausing effect of SRP, thus allowing µ. protein translation to continue 
efficiently on the surface of ER (Amstein and Cox, 1992). Protein translation on the 
surface of ER not only facilitates the splicing of the 3' part of the RNA molecule in the 
nucleus, but also pulls the µ. mRNA into the cytoplasm. If translation is prematurely 
terminated by a nonsense codon, the splicing of the 3' part of RNA in the nucleus is 
inhibited. In addition, ribosomes fall off the RNA, thus the ribosomes cannot facilitate 
the export of RNA to the cytoplasm. The 'trapped' unspliced RNA in the nucleus is 
degraded, which leads to the reduction of nuclear µ. RNA and subsequently cytoplasmic 
RNA. 
Once the matureµ. mRNA is in the cytoplasm, its steady-state level is regulated 
by a cytoplasmic mRNA degradation event. This is consistent with my finding that µ. 
mRNA with nonsense codons have a shorter half-life than that of µ. mRNA without a 
nonsense codon. Mason et al. (1988) have shown that the change of µ. mRNA 
cytoplasmic location from the ER-membrane bound fraction to the free polysome fraction 
decreases its stability by about 6 fold. Additionally, protein translation on the surface of 
ER might increase the stability ofµ. mRNA, presumably by protecting the instability 
sequences downstream of the nonsense codon from attack by cytoplasmic degradation 
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factors. 
There are several predictions from our model. If a nonsense codon decreases the 
steady-state level of µ mRNA by inhibiting the nuclear splicing of downstream 
sequences, then: 
1) when a nonsense codon is present in different exons of a µ gene, the size of 
partially spliced µ transcripts should correlate with the position of a nonsense 
codon; 
2) when I introduce a nonsense codon in the last exon, the steady-state level of 
µ mRNA should not be affected since no downstream splicing is required for 
RNA processing; 
3) when I replace the genomic sequences downstream of the nonsense codon with 
their corresponding cDNA sequences, the steady-state level ofµ mRNA should 
be restored to its wild-type level since no downstream splicing is required for 
RNA processing; 
4) the presence of a nonsense codon should not influence the steady-state level of 
µ mRNA when it is derived from a cDNA clone since no intron splicing is 
required forµ mRNA expression. 
The first prediction is challenged by my finding that precursor µ transcripts in 
hybridoma CH2XH still contain the large JH-Cµ intron that resides upstream of the 
nonsense codon (see Chapter III). In this chapter, I have tested the other predictions by 
analyzing the RNA expression of functionally rearranged wild-type or in vitro modified 
µgenes that have been stably introduced into terminally differentiated B lymphocytes. 
Figure 14 
153 
A Modified Translational Translocation Model. I have modified 
Urlaub's model to accommodate our secretoryµ protein. Ribosomes begin 
to translate aµ RNA as it emerges from a nuclear pore and before the 
completion of its 3' processing. Protein translation on the surface of ER 
not only facilitates the splicing of the 3' part of the RNA molecule in the 
nucleus, but also pulls theµ mRNA into the cytoplasm. If translation is 
prematurely terminated by a nonsense codon, nuclear splicing of the 3' 
part of the RNA is inhibited. Ribosomes then fall off the RNA, and the 
ribosomes cannot facilitate the export of RNA to the cytoplasm. The 
'trapped' unspliced RNA in the nucleus is degraded, which leads to the 
reduction of nuclear µ RNA and subsequently cytoplasmic RNA. 
A Model To Explain How mRNA 
With A Nonsense Codon Is Degraded 
RNA polymerase 
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4.2 Results 
4. 2 .1 Construction of Plasmids 
All the constructs used in this study are generated in a pµ• based expression vector 
(Figure 15). The functionally rearranged murine µ gene isolated from the hybridoma 
17.2.25 contains the following sequences starting from the 5' end: a short leader exon, 
an intron, a joined VDJ (V iJ exon, a large JH-Cµ intron, and a series of constant gene 
exons of "a" allotype in genomic configuration (Loh et al., 1983; Grosschedl and 
Baltimore, 1984; Grosschedl et al., 1985). The insertion of E. coli enzyme, guanosyl-
phosphoribosyl transferase (gpt), into the expression vector allows the selection of stable 
transfectants in the media containing xanthine and mycophenolic acid (MPA). The 
expression of gpt mRNA was used as an internal control for the copy number of active 
transcripts of the plasmid. Several restriction endonuclease sites have been engineered 
into the pµ•gpt.dM vector for the purpose of convenient cloning. 
4.2.1.1 Deletion of the Membrane Exons in the pµ•gpt Plasmid 
The membrane exons in the µ gene were deleted to eliminate the effect of 
alternative splicing on the stability ofµ mRNA (Peterson, 1994). The plasmid pµ•gpt was 
linearized with EcoRV that cut between Cµ4 and membrane exons. After 
dephosphorylation treatment with CIP, the plasmid was re-ligated in the presence of a 
Spe I linker. Thus, the membrane exons were within a Spel fragment of 0.92 kb, which 
was subsequently deleted by Spel digestion and religation of the modified plasmid. The 
resulting plasmid is designed as pµ•gptAM. 
Figure 15 A Schematic Representation of the Plasmid pµ•gptAM. 
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4.2.1.2 cDNA Replacement and Deletion of Downstream Sequences of the 
Nonsense Linker in the pµ•gptAM Plasmid 
To study the effect of a nonsense codon on the splicing of downstream sequences, 
I replaced genomic sequences downstream of a nonsense codon with their corresponding 
cDNA sequences. A 3.316-kb Xbal-Spel fragment that includes sequences in Cµ exons 
was isolated from the pµ•gptAM vector and subcloned into pGEM9zf(-). The subcloned 
plasmid was then linearized with BamHI enzyme that cut in the middle of Cµ2 exon, and 
the BamHI ends were blunted with Kienow enzyme (Pharmacia). A Nhel-containing 
amber stop linker [5'-pd(CTAGCTAGCTAG)-3', Pharmacia, Lot # 2067220011] that 
includes three amber nonsense codons in each open reading frame was cloned into the 
Kienow blunted-BamHI site in the middle of Cµ2 exon. The plasmids were screened for 
the presence of amber stop linker by Nhel digestion. Then the 3.4-kb EcoRI-Spel 
fragments without or with a stop linker were cloned back to the pµ•gptAM vector, 
resulting in the deletion of a 3.512-kb EcoRI-Xbal fragment in the large V8 -Cµ intron 
(construct A and B in Figure 16a). 
The 1.244-kb BamHI-Nhel fragment that includes genomic sequences from the 
Cµ2 to Cµ4 exon was replaced by its corresponding 0. 862-kb cDNA sequence from 
plasmid 5.1 (Reth and Alt, 1984) in the Xbal-Spel subclone. The introduction of the 
Nhel-amber stop linker into the Cµ2 exon and the subsequent cloning procedure are the 
same as described above (construct G and Hin Figure 16a). To make construct J and L 
(in Figure 16a), a 0.86-kb Nhel fragment that contains the sequences downstream of the 
stop linker was deleted or was cloned back in opposite orientation. The accuracy of 
cloning was confirmed by several restriction enzyme digestions (Figure 16b). 
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4.2.1.3 Introduction of a Nonsense Linker into Four Exons of Constant Region in 
the pµ•gp~M Plasmid 
To determine whether the position of a nonsense codon influences the steady-state 
level ofµ mRNA in plasma cells, I generated DNA constructs containing wild-type and 
modifiedµ genes with a nonsense linker at different exons of theµ gene (Figure 17). The 
subclone plasmid that contains the 3.316-kb XbaI-SpeI fragment of Cµ exons in genomic 
configuration (as described in section 4.2.1.2) was linearized with SmaI, BgllI, BstXI, 
or ApaI, respectively. The 3'-overhangs of ApaI or BstXI were blunted with T4 DNA 
polymerase, and the 5'-overhangs of BgllI was blunted with Kienow enzyme. After 
dephosphorylation treatment with CIP, each plasmid was ligated in the presence of a 
Nhel-containing amber stop linker. The 3.328-kb XbaI-SpeI fragments of Cµ exons that 
contain nonsense codons in different Cµ exons were subsequently cloned back to the 
pµ•gp~M vector (Figure 17a). The presence of the Nhel-containing nonsense linker at 
the proper positions was confirmed by NheI digestion (Figure l 7b). 
4.2.1.4 Generation of a Pcmv-µ cDNA Clone With or Without a Nonsense Linker 
To determine whether the presence of a nonsense codon influences the splicing 
of precursor µ transcript, I generated aµ cDNA clone with or without a nonsense codon. 
Since µ cDNA clone does not express efficiently under the authentic IgH promoter, l 
replaced the IgH promoter with the human cytomegalovirus immediate early promoter 
(pCMV). A µ1 cDNA sequence, which was cloned from 991 hybridoma cells (Balb/c) 
into the pCR™ II vector, was cut out as 1.9 kb of EcoRI-NheI fragment and cloned into 
EcoRI/XbaI sites in pUHDl0-1.gpt expression vector by a two-step ligation as described 
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in Chapter II (Construct Min Figure 22a). The parent pUHDl0-1 vector contains a 746-
bp fragment of pCMV (Deuschle et al., 1989). A BstEII site in Cµ2 exon of µs cDNA 
was destroyed by Klenow treatment and cloned into a Nhel-containing amber stop linker 
[5'-pd(CTAGCTAGCTAG)-3', Pharmacia, Lot# 2067220011] (construct Nin Figure 
22a). 
4.2.1.5 Generation of Stable Transfectants Containing Modified µ Genes 
Plasmid DNAs containing modified functional rearranged µgenes were introduced 
into a mouse plasmacytoma cell line J558L (µ->.. +) by electroporation. The cells were 
maintained in MPA-containing growth media to select for the expression of gpt. The 
expression ofµ gene was screened by cytoplasmic immunofluorescence (CIF) using goat 
anti-IgM antibody:µ protein was detected in stable transfectants containing constructs A, 
C, F, G and J (data not shown). Further experiments were carried out using pools that 
were generated from 30-33 independent clones. 
Figure 16 
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Restriction Analysis of DNA Constructs Containing Wild-Type and 
Modified p. Genes. (a) Schematic representations of wild-type and 
modified µ. gene constructs, showing a nonsense linker (arrow) in the 
middle of the Cµ.2 exon and the cDNA replacement of genomic sequences 
downstream of the nonsense codon. Double lines depict the positions of 
the restriction endonuclease sites. Photographs of ethidium bromide-
stained 1.0% agarose gels are shown in panels b to d. All plasmids were 
diluted and quantitated to the same concentration for further experiments. 
1 µ.g DNA of each construct was digested with 0.2-0.5 units of enzyme 
and the digestion reaction was performed according to the manufacturer's 
instructions. DNA standards used to determine the size of DNA 
fragments: 1 kb DNA ladder (lane 1) and A!HindIII (lane 8). In panel b, 
the integrity of the constant region ofµ. gene was confirmed by EcoRI-
Spel digestion; In panel c, the accuracy of cDNA replacement in the 
constant region ofµ. gene was confirmed by BstEII digestion; and, in 
panel d, the presence of Nhel-containing nonsense linker at the proper 
positions was confirmed by Nhel digestion. All the digests had the 
predicted sizes as indicated on the right. The fragment (*) in lane 3 was 
not digested in panel b, but yielded expected products in an independent 
digestion. 
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Figure 17 
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Restriction Analysis of DNA Constructs Containing Wild-Type and 
Modified p. Genes Containing a Nonsense Codon at Different Positions 
of the Constant Region of p. Gene. (a) Schematic representations ofwild-
type and modifiedµ gene constructs, showing the nonsense linker (arrows) 
in different exons of the µ gene. Double lines depict the positions of 
restriction endonuclease sites. (b) A photograph of an ethidium bromide-
stained 1.0% agarose gel. All plasmids were diluted and quantified to the 
same concentration for further experiments. 1 µg DNA of each construct 
was digested with 0.2-0.5 units of Nhel and the digestion reaction was 
performed according to the manufacturer's instructions. The presence of 
the Nhel-containing nonsense linker at the proper positions was confirmed 
by Nhel digestion. The resulting digests have the predicted sizes as 
indicated at left. The integrity of the constant region of µ gene was 
confirmed by the EcoRI-SpeI digestion (data not shown). DNA standards 
used to determine the size of DNA fragments: 1 kb DNA ladder (lane 1) 
and "A/ HindIII (lane 8). 
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4.2.2 Positional Effect of a Nonsense Codon on the Steady-State Level ofµ. 
mRNA. 
Total RNA in stable transfectants was isolated by the GIT/CsCl method and 
analyzed by Northern blot analysis using a Cµ. probe. Results of two independent 
experiments with similar findings are shown in Figures 18A and 18B. In Figure 18A, the 
relative steady-state level ofµ. mRNA ([µ.])was calculated by dividing the hybridization 
signal fromµ. mRNA by the signal of gpt mRNA (panel c). I found that the levels ofµ. 
mRNA with nonsense codons in the middle of Cµ.l, Cµ.2, and Cµ.3 exons were decreased 
by at least 5 fold (lane 3, 5, and 6, respectively, in Figure 18A) when compared to 
control level (lane 2 in Figure 18A). In contrast, the level ofµ. mRNA with a nonsense 
codon in the middle of Cµ.4 exon (lane 7 in Figure 18A) was comparable to controlµ. 
mRNA (lane 2 in Figure 18A). These data are consistent with the translational 
translocation model. However, the level of µ. mRNA with a nonsense codon at the end 
of Cµ.l exon (construct C, lane 4 in Figure 18A) was about 80% of total[µ.] detected in 
µ. mRNA without a nonsense codon (construct A, lane 2 in Figure 18A). The relatively 
stable level ofµ. mRNA in stable transfectants containing construct C might result from: 
a) a cloning or transfection error; b) the mRNA has skipped the exon that contains a 
nonsense codon (i.e., Cµ.l exon in this case); or c) the translational translocation model 
is not the mechanism by whichµ. mRNA with a nonsense codon is degraded. This is 
because the translational machinery in the cytoplasm should recognize the nonsense codon 
and send out a degradation signal no matter where it is in the open reading frame. 
To distinguish among these possibilities, I performed immunoprecipitations using 
goat anti-IgM antibody. As shown in Figure 19, the presence of the nonsense codon at 
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F ofµ gene decreases the coding region ofµ mRNA by 142 nt, which results in the 
truncated protein being about 47 amino acids shorter (that correlates to 5.2 KD deletion 
in molecular mass) than the completeµ chain (lane 9 in Figure 19). For C-containing 
transfectants, the 1013 kb nucleotide sequence downstream of the nonsense codon 
correlates with 338 amino acids shorter in the truncated protein of 32 KD (lane 6 in 
Figure 19). Consistent with the lower levels ofµ mRNA expression (Figure 18A and 
18B), there were no detectable µ proteins in lysates isolated from stable transfectants 
containing constructs B, D and E (lane 5, 7 and 8, respectively, in Figure 19). Thus, I 
conclude that the size of truncated proteins are consistent with the expected products 
predicted from the positions of the nonsense codon. These data ruled out the possibility 
of a cloning or transfection error, or exon skipping. However, these truncated proteins 
were not secreted into the supernatant (lane 12 and 15, respectively). 
The multiple bands of µ mRNA in lanes 2 and 7 in Figure 18A were not 
reproducible, as shown in lanes 3 and 4 in Figure 18B. The different sizes ofµ mRNA 
might result from the alternative use of either a membrane or a secreted poly A site. This 
may result from the presence of two polyadenylation sites in the plasmid pµ•gp~M 
(Figure 15), although the membrane exons have been deleted. The distance between the 
two poly A sites is about 350 bp, which may account for the difference in size of 
multiple bands I found in Figure l 8A. Alternatively, the differences in the size of µ 
mRNA might result from the presence of a nonsense codon. This is unlikely because the 
multiple bands were also found in stable transfectants containing functional µ gene (lane2 
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Figure 18A Analysis of p. mRNA Expression in J558L Transfectants Containing a 
Nonsense Codon at the Different Positions of the Constant Region in 
the Gene. (a) Schematic representations of wild-type and modified µ 
gene constructs, showing the nonsense linker (arrows) at different 
positions of Cµ exons. (b) A representative autoradiogram of the 
nitrocellulose blot hybridized with a Cµ cDNA probe (as shown in Figure 
1). Total RNA (10 µg) from pooled J558L transfected cells was isolated 
by the GIT/CsCl method and subjected to Northern blot analysis as 
described in the legend to Figure 3A. The same blot was rehybridized 
with a gpt probe to control for the loading of RNA. (c) The radioactivity 
of the bands was determined by a betascope blot analyzer, and relative 
amounts of µ mRNA (indicated sizes of µ mRNA were scanned in each 
lane) were calculated by dividing the µ signal by the gpt signal. The 
presence of a nonsense codon in the middle of Cµl (construct B, 17%), 
Cµ2 (construct D, 15%), and Cµ3 (construct E, 20%) decreases the [µJ 
by at least 5 fold when compared to the control [µ] (construct A, setting 
to 100% ). The presence of a nonsense codon at the end of the Cµl exon 
(construct C, 135%) and in the middle of the Cµ4 exon (construct F, 
83 % ) did not decrease the [µJ when compared to the control. Lane 1, 
non-transfected J558L cells were used as a negative control. Arrows on 
the left indicate the positions of ribosomal RN As; on the right indicate the 
positions of µ and gpt mRNAs. 
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Figure 18B Analysis of p. mRNA Expression in J558L Transfectants Containing a 
Nonsense Codon at the Different Positions of the Constant Region in 
the Gene. (a) Schematic representations of wild-type and modified µ 
gene constructs, showing the nonsense linker (arrows) at different 
positions in Cµ exons. (b) A representative autoradiogram of the 
nitrocellulose blot hybridized with a Cµ cDNA probe (as shown in Figure 
1). Total RNA (10 µg) from pooled transfected J558L cells was isolated 
by the GIT/CsCl method and subjected to Northern blot analysis as 
described in the legend to Figure 3A. The same blot was rehybridized 
with a gpt probe to control for the loading of RNA. Lanes 5 and 8, 
nontransfected J558L cells were used as a negative control. Arrows on the 
right indicate the positions of precursor µ RNA and µ mRNA. The 
hybridization signals in this Figure were not quantitated. 
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Analysis of Intracellular and Secreted p. Heavy Chain Expr~ion in 
J558L Transfectants Containing a Nonsense Codon at the Different 
Positions of the Constant Region in the Gene. (a) Schematic 
representations of wild-type and modified µ genes, showing the nonsense 
linker (arrows) at different exons in µ gene. (b) A fluorograph of an 
immunoprecipitation experiment. [35S]-methionine biometabolically labeled 
cell extracts and supernatant of J558L transfectants were incubated with 
goat antisera against mouse IgM, followed by S. aureus. Solubilized 
proteins were analyzed by SDS-PAGE on a 10% acrylamide gel, and 
labeled proteins were detected by fluorography. Lane 1, J558L 
plasmacytoma cells; lane 2, NYCH.µK cells that express µand K chains; 
lanes 4 to 15, different pools of J558L cells transfected with wild-type and 
modified µ genes as depicted in a. The protein with a molecular weight 
(MW) of 32 KD (lane 6) was identified as ..::1Cµl-4, because it has the 
predicted MW of a nonsense codon at C site in panel a. For the same 
reason, a protein of 63.8 KD has been identified as ..::1Cµ4. All these 
truncated proteins are not secreted outside the cell (lane 11 and 15, 
respectively). 
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in panel b of Figure 18A. Thus the presence of multiple bands that hybridized to aµ 
cDNA probe is probably not due to the presence of a nonsense codon, and it may result 
from use of an alternative poly A site. 
4.2.3 cDNA Replacement of Sequences Downstream of a Nonsense Codon Does 
Not Restore its Steady-State Level of lg µ mRNA to Its Wild-type 
Another approach to test whether a nonsense codon decreases the steady-state 
level ofµ mRNA by inhibiting the splicing of downstream sequences is to replace the 
genomic sequences downstream of the nonsense codon with their corresponding cDNA 
sequences, and analyze its effect on the steady-state level ofµ mRNA. 
Total RNA in stable transfectants was isolated by the GIT/CsCl method and 
analyzed by Northern blot analysis using a Cµ probe (panel bin Figure 20A and 20B). 
The relative steady-state level ofµ mRNA was calculated by dividing the hybridization 
signal from µ mRNA by the signal of gpt mRNA (panel b of Figure 20A and 20B), and 
are summarized in panel c. G1 and G2 represent RNA isolated from stable transfectants 
that were generated by two independent constructs from the same cloning process (i.e., 
the genomic sequences downstream of the nonsense codon had been replaced by their 
corresponding cDNA sequences). G represents RNA isolated from the stable transfectant 
that was generated by mixing equal amount of G1 and G2• The undetectable level ofµ 
mRNA in G2 (lane 6 in Figure 20A and lane 4 in Figure 20B) might result from an 
unnoticed mutation in its DNA construct. The levels ofµ mRNA ([µ])in the transfectants 
of construct G and G1 (lane4 and 5 in Figure 20A, respectively) were 2 to 4 times lower 
than that of wild-type (lane 2). This might result from either another cloning or 
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transfection error, or small introns between Cµ2-3 and/or Cµ3-4 are required for good 
expression ofµ mRNA (See detailed discussion below). 
The level ofµ mRNA in the transfectants of construct H (cDNA replacement with 
a nonsense linker in the middle of Cµ2 exons) was at least 20 fold lower (lane 7 in 
Figure 20A and lane 5 in Figure 20B) when compared to the control (lane 2 in Figure 
20A and 20B). This result can be explained in two ways. One is that there is a cloning 
error. This possibility was excluded by the result of the immunoprecipitation, in which 
I found truncated µ protein in the lysate of H transfectants (lane 6 and 9, respectively, 
Figure 21) was 40 KD. Their sizes were consistent with the expected products predicted 
from the positions of the nonsense codon (that is, a deletion of 790 nucleotides 
correlating with the loss of 263 amino acids). These data also ruled out the possibility 
of a cloning or transfection error, or exon skipping. Since I have repeated these 
experiments twice, it is unlikely that the same error has been repeated. The other 
possibility is that this result also argues against the translational translocation model. 
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Figure 20A Analysis ofµ. mRNA Expression in J558L Transfectants Containing 
Modified µ. Genes. (a) Schematic representations of wild-type and 
modified µ. genes, showing a nonsense linker (arrow) in the middle of the 
Cµ.2 exon and the cDNA replacement of genomic sequences downstream 
of the nonsense codon. (b) Northern blotting of µ. mRNAs. Total RNA 
(10 µ.g) from J558L cells stably transfected with various µ. genes was 
isolated by the GIT/CsCl method and subjected to Northern blot analysis 
as described in the legend to Figure 3A. Nontransfected J558L cells were 
used as a negative control (lane 1). G1 and G2 represent RNA isolated 
from stable transfectants that were generated by two independent 
constructs of the same cloning process. G represents RNA isolated from 
a stable transfectant that was generated by mixing equal amounts of G1 
and G2• The presence of a nonsense codon in the middle of Cµ.2 exon 
(lane 3) decreases the[µ] by about 30 fold when compared to the control 
[µ] (lane 2). The levels ofµ. mRNA ([µ]) were 2 to 4 fold lower in the 
transfectants containing construct G and G1 (lane 4 and 5, respectively); 
4 fold lower in the transfectants containing construct J (lane 8); and 50 
fold lower in transfectants containing construct L (lane 9), than that of 
wild-type control (lane 2). The [µ] in transfectants containing constructs 
G2 and H was below the detectable limit ( < 0.1 % of the [µ] in 
transfectants containing construct A). 
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Figure 20B Analysis of p. mRNA Expression in J558L Transfectants Containing 
Modified p. Genes. (a) Schematic representations of wild-type and 
modifiedµ genes, showing a nonsense linker (arrow) in the middle of the 
Cµ2 exon and the cDNA replacement of genomic sequences downstream 
of the nonsense codon. (b) Northern blotting of µ mRNAs. Total RNA 
(10 µg) from transfected J558L cells was isolated by the GIT/CsCl method 
and subjected to Northern blot analysis as described in the legend to 
Figure 3A (upper panel). The same blot was rehybridized with a gpt probe 
to control for the loading of RNA (lower panel). (c) The relative steady-
state level ofµ mRNA was calculated by dividing the hybridization signal 
from µ mRNA by the signal to gpt mRNA on the same lane. Lane 1, 
non-transfected J558L cells were used as a negative control. Arrows on 
the left indicate the positions of ribosomal RN As; on the right indicate the 
positions of precursorµ RNA,µ mRNA and gpt mRNA. 
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Analysis of Intracellular p. Heavy Chain Expression in J558L 
Transfectants Containing Modified p. Genes. (a) Schematic 
representations of the wild-type and modified µ genes, showing a nonsense 
linker (arrow) in the middle of the Cµ2 exon and the cDNA replacement 
of genomic sequences downstream of the nonsense codon. (b) A 
fluorograph of an immunoprecipitation. [35S]-methionine biometabolically 
labeled cell extracts of J558L transfectants were first incubated with goat 
antisera against mouse IgM, followed by S. aureus. Solubilized proteins 
were analyzed by SDS-PAGE on a 10% acrylamide gel, and labeled 
proteins were detected by fluorography. The protein with a MW of 40 KD 
(lane 5, 10 and 11) was identified as ~Cµ2-4, because it has the predicted 
MW of a nonsense codon in the middle of Cµ2. Lane 1, J558L 
plasmacytoma cells; lane 2, NYCH.µK cells that expressesµ and" chains; 
lanes 4 to 15, different pools of J558L cells transfected with wild-type and 
modifiedµ genes as depicted in a. Mand N are RNA isolated from cell 
lines containing µ cDNA under the control of Pcmv (see panel a in Figure 
22 for illustration and section 4.2.4 for discussion). 
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4.2.4 Removal of Intron Sequences from lg µ. Gene Does Not Protect Its mRNA 
from Nonsense Codon-Mediated RNA Degradation. 
To determine whether a nonsense codon affects the steady-state level ofµ. mRNA 
by interfering with its splicing process, I cloned a µ. cDNA clone with or without a 
nonsense codon in the middle of the Cµ.2 exon into a cytomegalovirus promoter (pCMV)-
based expression vector and analyzed the steady-state level of µ. mRNA in stably 
transfected cells. 
While the level of µ. mRNA derived from a cDNA clone under the Pcmv (lane 
4 in Figure 22) was only 5 % of the level of genomic µ. gene under the IgH promoter 
(lane 2 in Figure 22), the level ofµ. mRNA derived from the µ. cDNA clone with a 
nonsense codon was undetectable (lane 5 in Figure 22). If these results are reproducible, 
they suggest that the removal of introns from the µ. gene cannot abrogate the effect of a 
nonsense codon on theµ. mRNA level. Thus, these data argue against the effect of a 
nonsense codon on splicing, at least as the only mechanism, inµ. mRNA metabolism. 
However, the low level of total µ. mRNA with a nonsense codon derived from a Pcmv 
may result from either the nuclear-cytoplasmic transport ofµ. mRNA being blocked, or 
the mature µ. mRNA with a nonsense codon being subjected to the effect of other nuclear 
or cytoplasmic degradation events. The effect of cytoplasmic RNA degradation is 
supported by my previous finding that additional cytoplasmic degradation contributes to 
the low steady-state level ofµ. mRNA with a nonsense codon (see Chapter III). 
Figure 22 
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Expr~ion of p. mRNA Transcribed from Pcmv-µ cDNA with or 
without a Nonsense Codon in J558L Transfectants. (a) Schematic 
representations ofµ. mRNA transcribed from Pcmv-cDNA with or without 
a nonsense codon, showing a nonsense linker (arrow) in the middle of the 
Cµ.2 exon. (b) Northern blotting ofµ. mRNAs. Total RNA (10 µ.g) from 
J558L cells stably transfected with various µ. genes was isolated by the 
GIT/CsCl method and subjected to Northern blot analysis as described in 
Materials and Methods and in the legend to Figure 3A. Nontransfected 
J558L cells were used as a negative control (lane 1). Lanes in this figure 
are pasted together from the same RNA agarose gel in Figure 20A. The 
autoradiogram of gpt hybridization is not shown here. The larger size of 
µ. mRNA in lane 4 results from the size of Pcmv is about 0.5-kb bigger 
than that of Pig (Deuschle et al. , 1989; Grosschedl and Baltimore, 1985). 
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4.3 Discussion 
4.3.1 A Nonsense Codon Does Not Affect the Steady-State Level ofµ mRNA 
by Preventing the Splicing of Its Downstream Sequences 
The level of µ mRNA with a nonsense codon at the end of the Cµ 1 exon 
(construct C) when compared to its wild-type counterpart (construct A) strongly argues 
against the translational translocation model (Figure 18A and 18B). This is strengthened 
by the finding that neither a cDNA replacement of downstream sequences to the nonsense 
codon (Figure 20A and 20B) nor cDNA clone with a nonsense codon expressed under 
a Pcmv (Figure 22) restored the level ofµ mRNA to its wild-type counterpart. Together 
with the data in Chapter III, in which I found long precursorµ transcripts in hybridomas 
VXH and CH2XH that contain nonsense codons in their µ genes, I suggest that 
degradation ofµ mRNA with a nonsense codon involves more complicated mechanisms 
rather than simply the cytoplasmic translational machinery sending out signals to inhibit 
the nuclear splicing process. An alternative explanation for the finding that a nonsense 
codon affects splicing of µ RNA is via nuclear scanning rather than cytoplasmic 
recognition: The nonsense codon is recognized by a nuclear degradation factor before, 
or at the time of, RNA splicing. Since the spliceosome or other nuclear RNA binding 
protein are bound to the RNA transcript in the nucleus (Green, 1991; Dreyfuss et al., 
1992), they might sequester the nonsense codon from recognition by a nuclear scanning 
system. However, I could not rule out the possibility of recognition being independent 
of RNA splicing and somehow interacting with the splicing process (see discussion in 
Chapter III). This hypothesis needs to be further tested. 
Consistent with my finding in Chapter III that the presence of a nonsense codon 
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reduces µ mRNA level by increasing the cytoplasmic turnover rate, I found that the level 
of µ mRNA derived from a µ cDNA with a nonsense codon in the middle of Cµ2 exon 
under the control of Pcmv was undetectable when compared to that of its wild-type 
counterpart. This suggests that an additional cytoplasmic event degrades µ mRNAs with 
nonsense codons even if they can escape the nuclear degradation event. However, this 
cytoplasmic degradation factor probably has a very short half-life or it only acts as a 
secondary surveillance after the nuclear degradation event (see discussion in Chapter III). 
Alternatively, the presence of a nonsense codon may also prevent the nucleus-cytoplasm 
transport of µ mRNA. It might be important for B cells to have more than one 
surveillance pathway to eliminate the lg mRNA with nonsense codons, and thus ensure 
an effective humoral immune response. 
4.3.2 Introns Are Required for Effective Expression ofµ Gene 
The difference between the µ mRNA steady-state levels of construct G and A was 
unexpected (Figure 20), and might argue that small introns between Cµ2-3 and Cµ3-4 
are required for effective expression ofµ mRNA. This is consistent with a study which 
showed that an intron is required for optimal expression of cytoplasmic µ mRNA 
(Neuberger and Williams, 1988). This intron requirement is not specific for a particular 
intron, but has a cumulative effect, i.e. as long as an intron is present in the expression 
vector, the steady-state level of cytoplasmicµ mRNA is increased; and the more introns 
that are present in the expression vector, the higher the steady-state level of cytoplasmic 
µ mRNA. Cooperation between introns has been reported to increase both the specificity 
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and the efficiency of splicing (Neel et al., 1993). On the other hand, this intron 
requirement has also been shown to be promoter-dependent: An intron is required in the 
case of lg or P-globin promoters, but not in the case of cytomegalovirus or heat-shock 
promoters (Neuberger and Williams, 1988). Furthermore, this intron requirement is also 
cell-type independent since it is also needed in fibroblast transfectants (Neuberger and 
Williams, 1988). 
lntron requirement has also been shown to be necessary for effective expression 
of other eukaryotic genes (Reviewed by Liu, 1994), such as human, mouse and rabbit 
P-globin (Hamer and Leder, 1979; Buchman et al., 1988; Collis et al., 1990), mouse 
dihydrofolate reductase (Gasser et al., 1982; Buchman et al., 1988), human 
triosephosphate isomerase (Nesic et al., 1993 and 1994), SV40 late transcripts (Ryu and 
Mertz, 1989), human purine nucleoside phosphorylase (Jonsson et al., 1992), mouse 
thymidylase synthase (Deng et al., 1989), and maize alcohol dehydrogenase-1 (Callis et 
al., 1987; Ryu and Mertz, 1989). In contrast, many cellular and viral genes do not 
contain introns, and introns are not needed for effective expression from most cDNA 
clones. I do not know what features of a gene determine the intron requirement of 
effective production of cytoplasmic mRNA. However, it is very interesting to find that 
at least four of the genes (lg, P-globin, and dihydrofolate reductase, TPI) degrade their 
nonsense codon-containing mRNAs via a unique nuclear mechanism, i.e. RNA 
processing and/or transport. Thus, I speculate that the intron requirement for effective 
gene expression might be a common feature for genes that are subjected to nonsense 
codon-mediated mRNA degradation via a nuclear process. 
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It has been shown that for most genes, the presence of introns does not 
significantly influence their transcriptional rates (Hamer and Leder, 1979; Ryu and 
Mertz, 1989; Ryu and Mertz, 1989; Collis et al., 1990); rather, their presence has very 
dramatic post-transcriptional effects on mRNA metabolism, including stabilization of 
primary transcripts within the nucleus, excision of introns, polyadenylation, and transport 
of mature mRNA to the cytoplasm (Hamer and Leder, 1979; Buchman and Berg, 1988; 
Ryu and Mertz, 1989; Collis et al., 1990; Huang and Gorman, 1990). When an intron 
cannot provide the function required for efficient precursor RNA processing, its own 
excision occurs inefficiently (Ryu et al., 1994). 
The mechanism of intron requirement in gene expression is only speculative. 
Introns might influence post-transcriptional processes via their sequences associating with 
appropriate ribonucleoprotein (Dreyfuss et al., 1992; Jarmolowski et al., 1992). For 
example, their promoter dependence might result from different promoters being 
transcribed at different locations in the nucleus via specific transcriptional factors. I 
propose that for certain promoters, such as CMV and heat shock, transcripts are 
synthesized near the nuclear pore and can be readily exported. However, in the case of 
lg and fj-globin promoters, they might transcribe their primary mRNAs far from the 
nuclear pore, which makes their RNA export difficult. In these cases, factors that bind 
to introns might not only help to stabilize or splice the RNA, but also help to locate the 
RNAs on a track towards the nuclear pore and facilitate RNA export. If small introns 
such as intron 4 and/or 5 ofµ gene in construct G are missing, even if there is no 
nonsense codon, µ transcript is degraded in the nucleus because it could not be 
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transported outside the nucleus. This also argues against the importance of the pulling 
effect of translation proposed by the translational translocation model (Urlaub et al., 
1989). The similar results from construct H, J and K might result from a scanning 
system that recognizing the nonsense linker as the authentic termination codon and the 
downstream sequences as different lengths of 3' untranslated region. Since there are no 
introns downstream to hold the RNA in the nucleus, µ transcripts might be easily 
exported. This is supported by the finding that the use of different RNA polymerase II 
promoters influences the cytoplasmic stability of fi-globin mRNA (Enssle et al., 1993). 
This possibility argues against the use of other promoters with or without cDNA clones 
in the study of nonsense codon-mediated mRNA degradation of the genes that require 
intron for efficient expression. 
4.4 Proposed Further Experiments 
4.4.1 For the Result of Positional Effect of a Nonsense Codon 
I showed that the presence of a nonsense codon at the end of Cµ 1 ex on did not 
decrease the µ mRNA level when compared to that of its wild-type counterpart. To test 
whether this results from RNA binding protein sequestering (e.g. spliceosome) the 
nonsense codon at the end of an exon, one can introduce a nonsense codon at the 
beginning or the end of the Cµ2 exon, and repeat all the experiments. According to the 
current central dogma of splicing, both the 5' end and 3' end of an exon participate in 
the formation of a spliceosome (see reviews in Green, 1991; Lamond, 1993). If the 
spliceosome sequesters the recognition of nonsense codons by nuclear degradation factor, 
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one should find that the amount of µ mRNA is comparable to that of its wild-type 
counterpart when the nonsense codon is present at either end of the Cµ2 exon. However, 
the final proof might come from the characterized degradation factor or splicing factor 
that is bound to the µ mRNA from the construct C-containing transfectant. The other 
obstacle is that we also do not have a way to dissect the nuclear and cytoplasmic 
compartments. Further plans depend on the results of these experiments. 
4.4.2 For the Result of cDNA Replacement on µ mRNA Expression 
To better control for the copy numbers between different transfectants, one might 
perform a nuclear run-on experiment to measure the transcriptional rate of µ gene in 
construct A, G and H. 
To rule out the possibility of unnoticed mutations in the H DNA construct that 
might affect our results, I have generated eight other independent clones. It would be 
unlikely that independent clones have the same unnoticed phenotype as observed before. 
4.4.3 For the Effect of a Nonsense Codon in µ mRNA Derived from Pcmv-µ 
cDNA 
Since µ gene expression in mammalian cells is promoter-dependent and intron-
dependent, the use of a Pcmv to express the µ gene from its corresponding cDNA clone 
might not reflect the µ gene expression from its genomic sequence under the lg 
promoter. Thus, one should be more cautious in interpreting data that are obtained from 
the use of a cDNA clone. 
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To better understand whether the use of a Pcmv to express µ gene represents in 
vivo µ gene expression, one can quantify the levels of nuclear µ mRNA and cytoplasmic 
µ mRNA by Northern blot analysis as described in Chapter III: 
Expected results: 
Result A 
Result B 
µ mRNA (WT): 
Total RNA 
Nuclear RNA 
Cytoplasmic RNA 
Nuclear RNA 
Cytoplasmic RNA 
cDNA 
lX 
lX 
lX 
lX 
lX 
cDNA+a stop 
decreased 
decreased 
decreased 
lX 
decreased 
Result A suggests that the nuclear degradation event is independent of the splicing 
process. Result B might result from either the presence of additional cytoplasmic 
degradation machinery that can degrade matureµ mRNA, or the blockage of nuclear-
cytoplasm transport ofµ mRNA derived from the Pcmv-cDNA clone. 
To determine whetherµ cDNA clone with a nonsense codon is degraded faster 
than its wild-type counterpart, one could use the Actinomycin C or DRB method as 
described in Chapter II and III. But one obstacle is that the amount ofµ cDNA expressed 
under the Pcmv is only 0.5% of the corresponding genomicµ gene expressed from lg 
promoter. Thus, one would probably start with too littleµ mRNA. 
SUMMARY 
In summary, I have demonstrated that the presence of a nonsense codon reduces 
µ mRNA levels in both the nucleus and the cytoplasm of plasma cells. In the nucleus, 
the presence of a nonsense codon prevents the splicing of the largest J H-Cµ intron in 
precursor RNA. In the cytoplasm, the presence of a nonsense codon reduces µ mRNA 
level by increasing the rate ofµ mRNA turnover. Thus, there are distinct cytoplasmic 
and nuclear mechanisms for the reduction of µ mRNA with nonsense codons. The 
probability of producing nonproductive lg mRNAs in the process of generating 
tremendous lg diversity is higher than most of other mRNAs; therefore, the existence of 
at least two mechanisms to prevent the translation of nonproductive lg mRNAs might be 
unique to B cells. However, the mechanism is much more complicated than one can 
imagine! To date, no model has been proposed that accounts for all the results emerging 
in the field. I think the main obstacle yet to be resolved is to determine whether the 
recognition of a nonsense codon occurs only in the cytoplasm, or only in the nucleus, or 
in both. 
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